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error, and make you think you see what you would wish to see. Remember 
that truth alone is the matter you search after; and if you have been 
mistaken, let not vanity seduce you to persist in your mistake.” 
 
From The Microscope Made Easy by Henry Baker (1742) 
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ABSTRACT 
Background: The development of the blood supply in the primate retina has 
been extensively studied; however the relationship of the differentiating retina 
to the choroidal blood supply is less well known. The interaction of astrocytes 
and vascular endothelial cells promotes the development of the retinal 
vasculature from 14 weeks’ gestation (WG). Initially, astrocytes lead the 
developing capillaries from the optic nerve towards the macular area. 
However, neither astrocytes nor endothelial cells enter a prescribed 
avascular area, within which the fovea later forms. This may be attributed to 
expression of a factor that inhibits astrocyte and endothelial cell proliferation 
in the fovea. A factor found in the CNS that is already known to have these 
effects is transforming growth factor-β (TGF-β). 
Aims: This thesis investigated the relationship between retinal maturation 
and choroidal blood vessel supply and the possible role for TGF-β as an 
antiangiogenic factor in maintaining an avascular fovea during primate retinal 
development. 
Methods:  Human eyes between 11 WG and 40 years were obtained with 
ethical approval from Prince of Wales Hospital and the NSW Lions Eye Bank 
and fixed and sectioned for histological procedures or prepared for 
polymerase chain reaction (PCR). Macaque eyes from foetal day (fd) 64 to 
postnatal 11years (p11y) were obtained from Bogor Agriculture University, 
Indonesia with the approval of the Ethics Committee of the University of 
Washington, Seattle, USA. Macaque eyes were also fixed and sectioned for 
immunohistochemistry and in situ hybridisation. 
RNA was extracted from human foetal retinas and used for RTPCR (Reverse 
Transcriptase PCR), QPCR (Quantitative PCR) and preparation of 
riboprobes. PCR products were analysed using both restriction digest and 
sequencing. RTPCR was used to identify TGF-β1, TGF-β2 and TGF-β3 in 
the developing human and in the developing and adult macaque retinas 
whilst QPCR was used to quantify the TGF-β isoforms in central compared to 
peripheral retina and in foetal compared to adult retina. 
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In situ hybridisation was performed according to a standard protocol and 
visualised using Roche HNPP Fast Red detection set with designed 
riboprobes for TGF-β1, TGF-β2 and TGF-β3 (DIG RNA labelling kit). Some 
sections were counterstained with vimentin antibody. 
Immunohistochemistry was performed on human retina and choroid sections 
using antibodies to CD34 and Ki67 and on human and macaque retina using 
antibodies to synaptophysin, vimentin, GFAP, calbindin, S-opsin, RG-opsin, 
rhodopsin, TGF-β1, TGF-β2, TGF-β3 and their receptors TβRI and TβRII. 
Sections of the retina were imaged and analysed using either a Leica 
Confocal microscope and TCSNT software or Zeiss Confocal microscope 
and LSM 5 Pascal software. Data from the human retina and choroid 
sections corresponding to different regions (foveal, parafoveal nasal, 
parafoveal temporal, nasal and temporal) was collected to measure the 
number of Ki-67 immunolabelled mitotic endothelial cells and the area of 
CD34 immunolabelled choriocapillaris using Adobe Photoshop version 5.0.2, 
NIH software version 1.62 (measurement macros) and Excel. In the human 
and macaque sections the intensity of TGF-β protein and mRNA expression 
was captured from different regions of the retina (foveal, parafoveal nasal, 
parafoveal temporal, nasal, temporal, nasal to disc) to compile montages. 
Montages were then re-imported into LSM 5 Pascal software to measure the 
optical density across each montage along the ganglion cell layer, outer 
neuroblastic zone and photoreceptor layer collecting data in Excel for 
graphical representation. In addition to the montages, individual sections 
were assessed for co-localisation of TGF-β and TβR to various retinal cell 
types. 
Results:   Analyses of choriocapillaris area and endothelial cell (EC) 
proliferation were able to demonstrate that the area of choriocapillaris 
endothelium is greater in the foveal region at all ages (14-18.5WG), that the 
rate of choriocapillaris EC proliferation declines dramatically over this same 
period and that the lowest rates of EC proliferation are at the incipient fovea. 
Most importantly these findings indicate that EC proliferation in the 
choriocapillaris does not appear to be promoted by increased metabolic 
activity in central retinal neurons which are more developed with higher 
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oxygen and nutrient demands, which is the mechanism widely thought to 
regulate development of the retinal vasculature. 
PCR showed all TGF-β isoforms to be present in the human developing and 
adult retina. QPCR revealed that TGF-β2 was the most predominant isoform, 
followed by TGF-β3 with very small amounts of TGF-β1 seen. The isoforms 
were more abundant in developing rather than adult retina and in central 
rather than peripheral retina. Studies of the distribution of TGF-β protein and 
mRNA using immunohistochemistry and in situ hybridisation confirmed the 
low levels of TGF-β1 protein and mRNA observed in QPCR and 
demonstrated distinct centroperipheral gradients in the photoreceptor layer 
for TGF-β2 and TGF-β3. Relative high amounts of TGF-β in the fovea could 
affect vascular patterning due to TβRI seen in astrocytes which lead the 
blood vessels at the foveal rim at the level of the ganglion cell plexus. TGF-
β2 and TGF-β3 expression is detected before formation of the foveal 
avascular zone (FAZ) at fd64 (~15WG) - fd73 (~17WG) with levels peaking in 
the foveal region at fd105 (~25WG) by the time the FAZ forms. 
Conclusions:  This thesis has shown that EC proliferation in the 
choriocapillaris does not appear to be promoted by increased metabolic 
activity in central retinal neurons as reduced rates of EC proliferation in the 
‘foveal’ chorioretinal location were observed at all ages studied between 14 
and 18.5WG. The findings suggest that mechanisms regulating proliferation 
and growth of the choroidal vasculature are independent of differentiation in 
the neural retina and are therefore different to those governing the formation 
of the retinal vasculature. 
All TGF-β isoforms are expressed in developing and adult human and 
macaque retina with TGF-β2 being the predominant isoform.  TGF-β 
isoforms are more abundant in central compared to peripheral retina and in 
developing compared to adult retina. Centro-peripheral gradients of TGF-β2 
and TGF-β3 across the photoreceptor layer and TβRI on astrocytes support 
the presence of TGF-β in the fovea as an antiproliferative and antiangiogenic 
factor by helping to define the FAZ early in development, well before 23-25 
WG in humans and before fd100 in macaques.  
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 CHAPTER 1 – INTRODUCTION
1 
Introduction 
INTRODUCTION 
 
1.1 DEVELOPMENT AND STRUCTURE OF THE HUMAN 
RETINA AND CHOROID 
 
1.1.1 OVERVIEW OF OCULAR DEVELOPMENT  
 
Prenatal development can be divided into three stages; embryogenesis (0-3 
weeks’ gestation (WG)), organogenesis (4-8WG) and differentiation (9WG – 
birth). Only aspects of development pertinent to retinal and choroidal 
development are summarised here.  
Eye formation is first evident at the beginning of the fourth week of 
development. This is where at the anterior end of the neural tube, optic sulci 
appear that later form optic vesicles (O'Rahilly, 1975). 
The optic vesicles form the optic cups between 5 and 6WG. The inner thicker 
layer of the optic cup becomes the sensory retina, the outer thinner layer 
forms the retinal pigmented epithelium (RPE) and the surrounding 
mesenchyme gives rise to endothelial blood spaces that form the 
choriocapillaris and the sclera. The optic fissure along the inferior cup allows 
the hyaloid artery and vein, which branch off the ophthalmic artery and vein, 
to supply the inner optic cup layer, lens and mesenchyme. When the optic 
stalk fuses, the optic nerve is formed and the enclosed blood vessels now 
form the central retinal artery and vein (Moore, 1988; O'Rahilly, 1975; Mann, 
1964; Duke-Elder, 1963) (Figure 1.1 and 1.2).  
Most ocular structures develop and mature after 9WG, except for the macula 
that continues to differentiate after birth (Hendrickson & Yuodelis, 1984). 
Mesodermal cells invade the optic cup by the end of the first month of 
gestation and differentiate into the hyaloid artery and its branches occupying 
most of the vitreal space between the lens and neural retina. The hyaloid 
system begins to atrophy in the fourth month of gestation and blood flow 
stops in the seventh month (Jakobiec, 1982). The hyaloid system is fully 
developed at 9 WG, then regresses uniformly to completely disappear by 
birth (Saint-Geniez & D'Amore, 2004; Zhu et al., 2000a). 
2 
Introduction 
In general, development of the eye is organised by secreted signalling 
molecules that belong to several gene families. Hedgehog (Shh), wingless 
(Wnt), transforming growth factor-β (TGF-β), bone morphogenetic proteins 
(BMP) and fibroblast growth factor (FGF) families help activate specific 
intracellular cascades that control gene transcription. Growth factors 
modulate the migration, proliferation and differentiation of embryonic cells. 
For example, the generation of the optic stalk and the optic vesicle  is under 
the influence of signals from Shh and TGF-β families (Esteve & Bovolenta, 
2005; Yang, 2004); TGF-β and FGF signalling act antagonistically to 
separate the RPE and neural retina from the optic vesicle; Shh and BMP 
control the dorsal ventral polarity of the optic cup together with Vax and Tbx5 
transcription factors (Yang, 2004; Martinez-Morales et al., 2004; Golz et al., 
2008), and Shh has been implicated in the propagation of retinal 
differentiation in vertebrates (Zhang & Yang, 2001). TGF-β also has a 
specific role in directing the migration and development of cranial neural crest 
cells (Tripathi, 1991) and FGF has been described as part of a ‘signalling 
centre’ that coordinates and initiates retinal differentiation (Martinez-Morales 
et al., 2005). 
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FIGURE 1.1 Early eye development. A. Cranial end of 22 day old embryo 
showing first indication of eye development. Neural folds are not yet fused to 
form the primary brain vesicles. B. Transverse section through an optic 
sulcus. C. Schematic drawing of the forebrain at 28 days, with its covering 
layers of mesoderm and surface ectoderm. D, F and H. Schematic sections 
of the developing eye illustrating successive stages in the development of the 
optic cup and the lens vesicle. E. Lateral view of 32 day embryo showing 
external appearance of the optic cup. G. Transverse section through the optic 
stalk, showing the optic fissure and its contents. The edges of the optic 
fissure grow together and fuse, thereby completing the optic cup and 
enclosing the central artery and vein of the retina in the cup and optic nerve. 
(Adapted from figure 19-1, Moore, 1988). 
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FIGURE 1.2 Sagittal section through the developing eye of a 41 day old 
embryo. The intraretinal space of the optic cup represents the cavity of the 
original optic vesicle (200x magnification). (Adapted from figure 19-3 Moore, 
1988).  
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1.1.1 THE CHOROID 
Structure 
The choroid consists of layers of blood vessels in loose stroma extending 
from the ora serrata anteriorly to the optic nerve posteriorly forming the 
posterior part of the uveal tract that provides a vascular supply to the outer 
retina. The innermost vascular layer of the choroid is the choriocapillaris, 
comprising a highly permeable capillary network. 
The choriocapillaris has an afferent supply from three sources: mainly short 
posterior ciliary vessels that come from around the optic disc, branching as 
they pass anteriorly into the choroid; recurrent branches of long ciliary 
vessels as they pass back from the ora region to supply the choroid up to the 
equator and branches of the anterior ciliary arteries, which pass back from 
the ciliary muscle to enter the choriocapillaris. There are extensive 
anastomoses, with venous return via the vortex veins (Hogan, 1971).  
Development 
Development of the choroid was the subject of several early studies, first 
described by Hovius in 1702 when the term ‘choroid’ was derived from the 
Greek work for “membrane” and “form” (Ryan, 2001). Leber (1903) dissected 
the choroid and Versari (1910) injected Prussian blue into human choroidal 
vessels. Further histological studies were carried out by Mann (1928; 1964), 
Duke-Elder and Cook (1963), Hogan, Alvarado and Weddell (1971) including 
electron microscope (EM) analyses in the chick (Francois et al., 1963) and 
rat (Braekevelt & Hollenberg, 1970; Leeson, 1968). The most detailed light 
microscope (LM) studies of the human choroid were done by Heimann (1970, 
1972, 1974) along with EM observations of the developing choroid in the 
primate Macaca mulatta done by Ozanics (1978); and in the human by Mund 
(1972), Sellheyer and Spitznas (1988) and Sellheyer (1990). 
Recent studies have concentrated on choroidal neovascularisation using 
immunohistochemistry, in situ hybridisation, cell culture, ultrasonography and 
gene therapy. These have shed light on functional choroid development that  
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is observed in diseases such as age related macular degeneration and 
diabetic retinopathy with experiments done in mice (Rousseau et al., 2003; 
Zhao & Overbeek, 1999; Zhao & Overbeek, 2001b; Rousseau et al., 2000; 
Neuhardt et al., 1999), in rats (Steinle et al., 2002; Shi et al., 2004; Yi et al., 
1998), in chicks (Nickla et al., 1998), in bovine (Sakamoto et al., 1995; Morse 
et al., 1989), and in humans (Steinle & Smith, 2002; Steinle et al., 2005).  For 
example, chronic sympathetic denervation of the adult rat results in increased 
thickness of the choroid and vascular luminal area with increased numbers of 
choroidal small venules (Steinle et al., 2002). This suggests that sympathetic 
innervation is important in maintaining ocular vascularity and that chronic loss 
of sympathetic activity may contribute to abnormal vascular proliferation in 
diseases such as age related macular degeneration.  
The mesenchyme surrounding the optic cup forms vascular channels from 29 
days’ gestation that surround the optic vesicle (Ozanics et al., 1978). Other 
choroidal cells, including stromal cells, melanocytes and pericytes are 
derived from neural crest cells (Etchevers et al., 2001). Closed endothelial 
channels first display slit-like lumina and then expand around the optic 
vesicle to form a vascular plexus (Sellheyer, 1990).  
The RPE forms the outer blood-retinal barrier (BRB) between the neural 
retina and the choroid by the second month, and is surrounded by a primitive 
choriocapillaris, fed by branches of short and long posterior ciliary arteries 
(Figure 1.3). By 9WG, numerous fenestrations are seen in the choriocapillaris 
endothelial cells, juxtaposed to Bruch’s membrane (Sellheyer, 1990; 
Sellheyer & Spitznas, 1988). These fenestrations contribute to the 
permeability of the choriocapillaris, with subsequent diffusion of oxygen and 
nutrients to the RPE and outer retina. The RPE is essential for the 
development of the choroid as growth factors released by the RPE such as 
FGF-2, VEGF and FGF-9 are involved in endothelial cell proliferation and 
differentiation (Zhao & Overbeek, 2001b; Sakamoto et al., 1995). The larger, 
outer vessels of the choroid form a predominantly venous layer (Haller’s 
layer) in the fourth month. In the fifth month, Sattler’s layer, mostly medium 
sized arterial vessels, is formed between the choriocapillaris and Haller’s 
layer, but doesn’t reach the ciliary body until the sixth month (Figure 1.4). 
Anastomoses of vessels in the ciliary body are not complete until eight 
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months’ gestation (Heimann, 1972). Pigmentation of the choroid begins at 
the optic disc and extends anteriorly to the ora serrata to be completed by 9 
months (Mund et al., 1972). 
Physiology 
The choroidal circulation has one of the highest rates of blood flow in the 
human body. Per gram of tissue, the choroid has four times more blood flow 
than the renal cortex (Ryan, 2001). The choroidal blood supply, present in all 
mammalian species, is responsible for providing nutrients and oxygen to the 
retina.  
The retinal vasculature has evolved to supply the inner retina in many 
species where the retina is thick (>150µm) and the underlying choroidal 
circulation is unable to meet the metabolic demands (Buttery et al., 1991).  
Early studies claimed that the choriocapillaris was thickest at the submacular 
region even though the macular vessels’ diameter approximates 20µm and 
other choroidal vessels range from 18-50µm diameter (Leber, 1903 cited in 
Hogan, 1971). In the central retina the choroid is thickest, with reduced 
intervascular space to be able to meet higher metabolic demands of the 
retina due to high density of cones present and lack of retinal vasculature 
(Fryczkowski & Sherman, 1988). In central fovea (the foveola), oxygen 
diffuses approximately 100µm from the choriocapillaris to supply inner 
segments of foveal cones. In the rest of the retina, oxygen from the choroid 
diffuses 50-60µm but the presence of deep retinal vessels ensures oxygen 
diffusion from these vessels from 50µm in the periphery to 100µm in the 
parafoveal region (Ahmed et al., 1993). This anatomical specialisation occurs 
early in the choroidal blood supply of this area, differentiating before the 
macula itself as all the temporal short posterior ciliary arteries enter the 
eyeball in the macular region with one of these sending 2-3 branches into the 
submacular zone (Hayreh, 1974). In contrast, no central vessels were found 
when the lobular structure of the choroid was studied, instead lobules were 
identified throughout the eye, except for the area located beneath the macula 
where arterial and venular channels appeared to be freely interconnected. 
This region has an abundant arterial supply with arteriolar openings 
outnumbering venular openings by 3:1 (Fryczkowski et al., 1991). 
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FIGURE 1.3 Choroidal vasculature at 9WG where K: short posterior ciliary 
arteries; L: long posterior ciliary arteries; N: optic nerve; Vo: vortex vein; ZK: 
level of what will become the ciliary body; M: region that will become macular 
zone; C: choriocapillaris; OS: region that will become ora and P: pigment 
epithelium. (Adapted from Heimann, 1972). 
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FIGURE 1.4 Choroidal vasculature at 25WG where K: short posterior ciliary 
arteries; L: long posterior ciliary arteries; ZI: circle of Haller-Zinn; Vo: vortex 
vein; V: anterior ciliary artery; Ci: major arterial circle of the iris; R: recurrent 
branches; M: region that will become macular zone; OS: ora serrata; H: 
Haller’s layer and S: Sattler’s layer. (Adapted from Heimann, 1972). 
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1.1.2 THE RETINA 
Structure 
The neural retina extends from the ora serrata anteriorly to the optic disc 
posteriorly. The posterior primate retina has a 1-2mm yellow depression - the 
macula lutea (Latin “yellow spot”) - with a central area, the fovea centralis 
(Latin “central pit”), that is responsible for maximal visual acuity. It is this 
feature that distinguishes the primate retina from other mammalian retina. 
The retina comprises ten layers: RPE, photoreceptor layer of rods and cones 
(consisting of inner (IS) and outer segments (OS)), external limiting 
membrane (ELM), outer nuclear layer (ONL), outer plexiform layer (OPL), 
inner nuclear layer (INL), inner plexiform layer (IPL), ganglion cell layer 
(GCL), nerve fibre layer (NFL) and internal limiting membrane (ILM) (Figure 
1.5). 
In the fovea, the only layers present are the RPE, the cone photoreceptor 
layer, the external limiting membrane, the outer nuclear layer with cone cell 
nuclei, the inner fibres of the photoreceptors (known as fibres of Henle (FOH) 
in cones) and the internal limiting membrane.  
Outside the fovea, the retina has three neuronal and two synaptic layers. The 
primary neurons, the photoreceptors synapse at the OPL onto bipolar and 
horizontal neurons in the INL, then the bipolar cells and amacrine cells in the 
INL synapse onto the ganglion cells at the IPL (Figure 1.6). Three types of 
non neuronal glial cell are found in the human retina; Müller cells, astrocytes 
and microglia.  
Photoreceptors comprise of cones, responsible for photopic high acuity 
colour vision, and rods, responsible for scotopic vision and detection of 
movement. 
Bipolar cells are second order neurons in the visual circuitry (Kolb et al., 
1992; Boycott & Wassle, 1991) and horizontal cells modulate visual 
information from the photoreceptors via a network of fibres that integrates 
activity of the photoreceptor cells horizontally. The concentration of horizontal  
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FIGURE 1.5 Schematic diagram of architecture of the retina showing its 
layers and corresponding cells. ILM: internal limiting membrane, NFL: nerve 
fibre layer, GCL: ganglion cell layer, IPL: inner plexiform layer, INL: inner 
nuclear layer, OPL: outer plexiform layer, ONL: outer nuclear layer, ELM: 
external limiting membrane and RPE: retinal pigmented epithelium. Adapted 
from www.theness.com. 
 
 
FIGURE 1.6 A. Retinal layers in fovea and parafovea, and B. peripheral 
retina where GCL: ganglion cell layer, IPL: inner plexiform layer, INL: inner 
nuclear layer, OPL: outer plexiform layer, ONL: outer nuclear layer,  
photoreceptor layer of rods and cones (consisting of IS: inner and OS: outer  
segments), RPE: retinal pigmented epithelium. (Adapted from Hendrickson 
and Provis, 2004). 
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cells is highest at the fovea and their number decreases towards the 
periphery (Wassle et al., 2000; Dacey et al., 1996; Kolb et al., 1980; Kolb et 
al., 1994; Polyak, 1941).  
Most amacrine cells produce GABA and glycine which have an inhibitory 
action on the ganglion cells (Kolb et al., 1992; Crooks & Kolb, 1992). 
Ganglion cells are the final output neurons of the retina. Like amacrine cells, 
ganglion cells increase their dendritic tree span with eccentricity from the 
fovea (Kolb et al., 1981; Boycott & Wassle, 1974). Two major types of 
ganglion cells M or parasol and P cells which can be further subdivided into 
P1 or midget and P2 or small bistratified cells are found in the retina (Kolb et 
al., 1992; Rodieck et al., 1985; Polyak, 1941). Parasol cells project to the 
magnocellular layers of the lateral geniculate nucleus (LGN), the midget cells 
project to the parvocellular layers of the LGN (Shapley, 1982) and the 
bistratified cells project to the koniocellular layers of the LGN (Martin & Perry, 
1988). The M pathway is concerned with initial analysis of movement seen 
whereas the P and K pathways are concerned with analysis of fine structure 
and colour vision. 
Müller cell nuclei are located in the INL, with processes extending between 
the two limiting membranes. They are the largest of all cells in the retina and 
have an important role in the orientation, displacement and positioning of the 
developing neurons as well as providing structural alignment of neuronal 
elements in developed retina. They express the neural progenitor marker, 
nestin in both differentiated and undifferentiated human foetal retina, 
suggesting that they are end stage progenitor cells (Walcott & Provis, 2003). 
Glutamate transporters on Müller cells are present by 10WG before synaptic 
vesicle proteins are evident, suggesting a role for Müller cells in shaping 
synaptogenesis in the developing human retina (Diaz et al., 2007). They are 
important producers of proangiogenic (VEGF) and antiangiogenic factors 
(TGF-β, PEDF and TSP-1) that influence blood vessel growth and apoptosis 
(Eichler et al., 2004). They control retinal homeostasis protecting ionic shifts 
in neurons and mopping up neural waste products such as carbon dioxide. 
They also break down glycogen to fuel aerobic metabolism of nerve cells and 
help recycle neurotransmitters such as glutamate (Reichenbach, 1997).  
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Astrocytes are derived embryonically from the cells of the neural crest as 
they migrate into the retina via the optic nerve (Huxlin et al., 1992; Ling & 
Stone, 1988). They can be divided into fibrous and protoplasmic astrocytes. 
Fibrous astrocytes have many cytoplasmic processes and are located in the 
NFL whereas protoplasmic astrocytes have short blunt processes and extend 
to the IPL (Sigelman, 1982). Astrocytes contact the abluminal aspect of blood 
vessels, contributing to the inner blood-retinal barrier and they have been 
shown to accompany the development of the primary retinal plexus in several 
species but do not present in the avascular fovea (Sandercoe et al., 1999; 
Provis et al., 1997; Gariano et al., 1996; Chan-Ling & Stone, 1991; Ling et 
al., 1989; Ling & Stone, 1988; Stone & Dreher, 1987).  
Microglia are the immunocompetent cells of the retina, derived from 
mesodermal invasion of the retina. They are found in the fovea up to 20WG 
and continue to migrate from the optic nerve head to peripheral retina til 
25WG, settling in the mature retina between the NFL and OPL (Provis et al., 
1996; Diaz-Araya et al., 1995). They can be stimulated into a macrophagic 
role by tissue debris which is carried to the vasculature for removal from the 
retina (Matsubara et al., 1999; Penfold et al., 1993). 
Specialisation of the fovea 
The ‘macula’ refers to a region 5-6 mm in diameter at the posterior pole of 
the eye that appears as a yellow spot (macula lutea) due to the presence of 
xanthophyll pigments, lutein and zeaxanthin. These pigments are thought to 
protect the retina from blue light and may even act as antioxidants to protect 
photoreceptors from dying (Provis et al., 1995; Snodderly, 1995; Kirschfeld, 
1982; Wald, 1945). The central 1mm2 of the macula is known as the fovea 
centralis which is surrounded by the adjacent parafovea and outermost 
perifovea (Figure 1.7A). The fovea is characterised by a high density of 
photoreceptors and ganglion cells, an absence of retinal blood vessels and 
unique neuronal connections (Provis et al., 2005).  
The fovea consists of the foveal slope and foveola. The foveal slope at the 
foveal rim is rod dominant and contains the perifoveal capillary plexus, whose 
three  layers  anastomose  at  the  cone  dominant  base  of  the foveal  slope          
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forming a vascular ring surrounding the foveola (Provis et al., 2000; Provis, 
2001; Provis et al., 2005; Snodderly et al., 1992). The neuronal composition 
of the foveal slope has a cone connected to a bipolar cell subsequently linked 
to a midget ganglion cell which supports high visual acuity and colour vision 
(Hendrickson, 1994; Dacey, 1996; Dacey et al., 1996; Wassle et al., 1994; 
Polyak, 1941) (Figure 1.7B). The fovea has virtually only cones in its ONL 
(Hendrickson, 1994; Diaz-Araya & Provis, 1992; Hendrickson & Yuodelis, 
1984). The parafovea has a low density of retinal vessels, high density of 
ganglion cells and below average spatial densities of rods whilst the 
perifovea has a high cone:rod ratio, high density of retinal vessels and above 
average cone and ganglion cell densities (Packer et al., 1989; Curcio et al., 
1990; Provis et al., 2005). 
The significance of the avascular zone is that structures such as vessels and 
blood cells do not deflect incident light, helping to improve visual acuity at this 
region. As a result of a lack in blood supply other than from the 
choriocapillaris, this region dense with photoreceptors in primates appears to 
be associated with the presence of a foveal depression, where the retina is 
thinner and more readily supplied by the choriocapillaris. The lateral 
displacement of cells in the pit may indicate an adaptive advantage to reduce 
metabolic stress by having these cells closer to the retinal blood supply, but 
how the structure evolved is not known (Provis, 2001). 
The fovea is the first part of retina to differentiate where it can be defined as 
early as 11 WG (Provis et al., 1985).  
During the third trimester and continuing until 5-8 years of age, cells within 
and surrounding the fovea rearrange themselves. Initially the retinal ganglion 
cells and inner nuclear layer cells move centrifugally away from the foveal 
centre during the third trimester whilst the cone cells move centripetally 
forming a domed cone mosaic in the adult retina (Sandercoe et al., 2003; 
Springer, 1999; Provis et al., 1998; Mann, 1964). The factors that support 
active migration for these populations of cells are not known. Alternatively, it 
is possible that instead of migrating, the retinal ganglion cells and inner 
nuclear cells die, thus reducing their numbers in the fovea whilst the cone 
cells proliferate thus increasing their population centrally. However, formation 
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FIGURE 1.7 A. Fundus photograph of the human eye showing anatomical 
regions of the fundus: the perifovea, parafovea, fovea and foveola (Polyak, 
1941). B. Transverse section of foveal retina, pit, slope, rim and foveal 
avascular zone (FAZ, within arrows), with foveola matched with fundus 
photograph above. Trace shown of laterally displaced synaptic connection 
made between photoreceptor, bipolar cell and ganglion cell. GCL: ganglion 
cell layer, INL: inner nuclear layer, ONL: outer nuclear layer, RPE: retinal 
pigment epithelium. (Adapted from Hendrickson and Provis, 2004). 
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of the foveal pit occurs without significant evidence of apoptosis or mitosis 
(Georges et al., 1999; Provis, 1987). Cone photoreceptors are unlikely to be 
created postnatally, as retinal histogenesis is finished by the beginning of the 
third trimester (Springer, 1999; La Vail et al., 1991).  
A third hypothesis of foveal morphogenesis is that development itself 
weakens the retinal wall allowing it to stretch and causing passive centrifugal 
movement of inner retinal cells, but the fovea does not appear to stretch 
significantly as in monkeys where the optic disc-fovea distances do not 
appear to increase with age (Springer & Hendrickson, 2005; Springer, 1999; 
Kirby & Steineke, 1996; Robinson, 1991). 
During the first half of gestation much of the retina is avascular and the retina 
derives most of its oxygen by diffusion from the choriocapillaris and hyaloid 
system. The superior and inferior vascular arcades grow from the optic disc 
towards the central retina, curving around the fovea without entering the 
foveal avascular zone (FAZ) (Provis et al., 2000; Gariano et al., 1994). Using 
engineering models, mechanical experiments have shown that as tissue 
within an avascular zone is more elastic than the surrounding vascularised 
retina, if a stretching force is applied, a pit would be formed in the avascular 
zone (Springer & Hendrickson, 2004a). Following measurements of 
developing monkey retinas between 68 days postconception (dpc) and adult, 
it was found that retinal length increased rapidly until 115dpc and then 
remained unchanged between 115dpc-180dpc. After birth, the retina again 
grew rapidly for 3 months and then very slowly into adulthood. The onset of 
pit development overlapped the late foetal stable phase suggesting that the 
main mechanical factor in commencing pit formation was intraocular pressure 
rather than retinal growth induced stretch (Springer & Hendrickson, 2004b). 
After the stable development phase of retinal growth, in the first four months 
after birth, central retinal stretch forces are thought to remodel the pit and 
help in packing cones in the fovea. A stretching of the inner retina may 
generate lift forces as the pit becomes shallower and wider drawing cones 
centripetally (Springer & Hendrickson, 2005). 
The pit may result from hypoxia due to a local absence of retinal vessels, a 
thickened foveal cone mosaic and insufficient oxygenation from the choroidal 
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blood supply as photoreceptors can consume high concentrations of oxygen 
from the choroid-over 90% in the adult (Ahmed et al., 1993; Rodieck, 1988).  
In species where a retinal vasculature develops it has been proposed that 
transient hypoxia in the inner layers of the developing retina is induced by 
increased metabolic activity in maturing retinal neurons and photoreceptors, 
resulting in the proliferation and migration of retinal endothelial cells, 
mediated by growth factors (Stone, 1997; Michaelson, 1948) However, the 
central primate retina – despite being developmentally advanced relative to 
other regions (Georges et al., 2006; Xiao & Hendrickson, 2000; Bumsted & 
Hendrickson, 1999; Bumsted et al., 1997; Linberg & Fisher, 1990; Provis & 
van Driel, 1985) is avascular for a protracted period, and formation of retinal 
vessels in the central retina is delayed (Provis et al., 2000; Engerman, 1976). 
This suggests that other factors are expressed in the central retina which (a) 
guide developing vessels around the future foveal region, resulting in a 
longer growth trajectory for vessels in temporal compared with nasal retina, 
and/or (b) significantly reduce the rates of proliferation and migration of 
retinal endothelial cells (EC) in central retina, resulting in a slower rate of 
vessel formation and/or (c) assist in keeping the avascular zone more elastic 
than the surrounding vascularised retina (Stone et al., 1995; Provis, 2001). 
TGF-β is one such candidate factor. 
Development of the neural retina 
The retina develops from the walls of the optic cup, the outer thinner layer 
forming the RPE and the inner thicker layer forming the neural retina. Retinal 
differentiation commences centrally, at the posterior pole, and proceeds in a 
wave-like manner towards the periphery, so that cell division first ceases and 
differentiation of the retinal laminae first occurs in the central region, at the 
incipient fovea and progressively in more peripheral regions (Provis & van 
Driel, 1985; Rapaport & Stone, 1982). 
Retinal progenitor cells (RPC) have radial processes and nuclei that migrate 
along them between the ventricular layer, where cell division occurs and the 
inner retina where DNA synthesis occurs (Waid & McLoon, 1995). Studies 
relying on incorporation of labelled thymidine during DNA synthesis prior to  
the final cell division have indicated that retinal neurons are born in two  
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phases. The early phase includes ganglion cells, horizontal cells and cone 
photoreceptors whilst the late phase includes amacrine cells, bipolar cells 
and rod photoreceptors (Levine & Green, 2004; Walcott & Provis, 2003; 
Rapaport et al., 1996; Harman & Ferguson, 1994; Harman et al., 1989). 
Müller cells are thought to be the end-stage differentiation of RPC (Walcott & 
Provis, 2003). 
The incipient foveal region differentiates first, with all retinal layers evident by 
11WG (Linberg & Fisher, 1990; Provis & van Driel, 1985). Many of the 
physiological markers of retinal cells are expressed in central neurons by 14-
15 WG including glutamate transporters and S and L/M opsins (Georges et 
al., 2006; Xiao & Hendrickson, 2000). 
Between 14WG and 17WG, the cell population in the ganglion cell layer 
increases rapidly. The nuclei of the ganglion cells are confined to the 
ganglion cell layer and the axons are aligned by the Müller cell processes 
although the precise nature of the signals controlling this have not been 
defined (Bron, 1997). Ganglion cells send axons to synapse with primary 
visual nuclei in the brain when they first differentiate (Rakic, 1977). Initially, 
there is a substantial overproduction of ganglion cells, more than twice the 
number seen in an adult retina, which is then substantially eliminated 
between 18WG and 30WG to reach a population range seen in the adult 
retina (Provis & Penfold, 1988; Provis et al., 1985). The decreased number of 
cells is accounted for by a period of cell loss due to natural cell death or 
apoptosis thought to be due to synaptic competition between the ganglion 
cells for target nuclei (Oppenheim, 1991; Provis et al., 1985). 
Immunolabelling of synaptic proteins (Georges et al., 1999; Okada et al., 
1994) showed that the first synapses formed are in the primate IPL, followed 
by those in the OPL, but controversy exists about whether synapses are 
amacrine or bipolar or both (Crooks et al., 1995; Linberg & Fisher, 1990; van 
Driel et al., 1990; Nishimura & Rakic, 1987). In the OPL, synaptic 
development is first evident in the foveal cones at 11WG as synaptic ribbons 
and clustered vesicles (Linberg & Fisher, 1990). This later spreads across 
the retina, with horizontal cells seeming to make the first contact with ribbon 
synapses (Hendrickson, 1996) and with rods appearing to form synapses 
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later than cones (Okada et al., 1994). At 22WG rod photoreceptors develop 
cell bodies with inner segments that bulge beyond the external limiting 
membrane. 
Amacrine cells are identifiable at the inner border of the outer neuroblastic 
layer by 14WG (Rhodes, 1979). At 18WG, the outer region of the cone 
accumulates mitochondria and polysomes, and the cell membrane involutes 
to envelop the cilium extending a cytoplasmic process toward the apical 
region of the retinal pigment epithelial cells. Photoreceptor outer segments 
differentiate at five months, when multiple infoldings of the plasma membrane 
develop because of the influence of the ciliary filaments, which parallel the 
development of the horizontal cells (Springer & Hendrickson, 2004a; Springer 
& Hendrickson, 2004b; Springer & Hendrickson, 2005; Hendrickson, 1996; 
Dorn et al., 1995). 
Following synaptic formation of the IPL, there is a wave of bipolar cell death 
starting around 15WG that progresses in a centro-peripheral pattern across 
the retina during further development suggesting that bipolar apoptosis is 
associated with onset of synaptogenesis (Georges et al., 1999).  
As gestation progresses the area devoid of mitotic activity increases so that 
by 24WG, dividing cells are present in 62.5% of the retinal surface and are 
confined to the periphery. By 30WG mitotic activity has ceased completely 
but the surface area of the retina increases until 3 weeks post birth which is 
attributed to the growth and maturation of individual cells (Sandercoe et al., 
1999; Provis et al., 1985).  
Development of the retinal vasculature 
a) Mechanisms 
Two processes describe the formation of new blood vessels that results in 
the creation of endothelial lined tubes. When the endothelial cell precursors 
differentiate from mesoderm forming a primary capillary plexus it is termed 
vasculogenesis (Pepper, 1997). When the new vessels are formed by 
sprouting from pre-existing vessels then it is known as angiogenesis (Pepper, 
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1997). The primary vasculature is thought to be established via 
vasculogenesis whilst deep capillaries growing from the primary vasculature 
into the inner layers of the retina or secondary vasculature are formed by 
angiogenesis (Chan-Ling et al., 2004; Provis, 2001; Sandercoe et al., 1999; 
Chan-Ling et al., 1990; Ashton, 1970). Spindle shaped vascular precursor 
cells migrating from the optic disc to the periphery have been thought to be 
associated with establishment of the primary vasculature but whether they 
are astrocyte precursor cells or angioblasts remains controversial. Astrocyte 
precursors may enter the retina ahead of the retinal vessels and be 
stimulated to differentiate into mature GFAP immunoreactive astrocytes in 
the presence of invading endothelial cells that produce leukemia inhibitory 
factor (LIF) (Mi et al., 2001). Astrocytes are associated with the developing 
vessels, leading them by at least a few hundred microns, producing VEGF 
(Provis et al., 1997; Gariano et al., 1996; Ling & Stone, 1988). Differentiated 
astrocytes in advance of the vascular front are sensitive to changes in 
oxygen and respond to hypoxia by upregulating VEGF expression, which 
drives endothelial cell proliferation (Provis et al., 1997; Stone, 1997; Aiello et 
al., 1995; Pierce et al., 1995; Stone et al., 1995). Similarly VEGF expression 
by Müller cells is thought to regulate development of the deep, secondary 
vascular plexus (Stone, 1997). Chan-Ling et al. have suggested that the 
vascular precursor cells may be angioblasts rather than immature astrocytes 
(Chan-Ling et al., 2004). However, an extensive network of astrocytes, that 
are not GFAP+, have been identified and it is possible that the vascular 
precursor cells may be microglia instead. Microglia have been recently found 
to be closely apposed to developing blood vessels (Checchin et al., 2006). 
The depletion of resident microglia in retinal explants was also found to be 
associated with reduced developmental vessel growth and density, restored 
by intravitreal microglial injection (Checchin et al., 2006).  
In addition, when the retinal vascular network in mice was labelled using a 
probe (VEGF receptor 1 and 2) against endothelial cells and angioblasts, this 
probe failed to label the spindle shaped cells in front of it. These spindle cells 
were positively stained with a marker for retinal astrocytes (PDGFRα) 
implying that the immature retinal astrocytes precede the forming retinal 
vasculature and that the vasculature forms by angiogenesis and not by 
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angioblasts in vasculogenesis (Fruttiger, 2002). Similarly when retinal 
astrocytes were blocked, there was a loss of vascular patterning comprising 
endothelial cells with filopodial extensions that would normally follow the 
astrocytic template (Dorrell et al., 2002). 
The importance of the VEGF and VEGF-receptor system in blood vessel 
growth has been demonstrated by: 
A) Spatiotemporal expression of VEGF and its receptors, which 
correlates with phases of vasculogenesis and angiogenesis in the 
embryo and with phases of neovascularisation in the adult (Mandriota 
et al., 1996; Mustonen & Alitalo, 1995). 
B) Mice lacking VEGFR-2, required for endothelial cell differentiation or 
VEGFR-1, needed for correct vascular assembly, die at early stages in 
development (Fong et al., 1995; Shalaby et al., 1995). 
C) VEGF is the major angiogenic factor in an animal model in ischemia 
stimulated retinal neovascularisation which was upregulated in retinal 
endothelial cells, pericytes, RPE cells, ganglion cells and Müller cells 
(Aiello et al., 1995). 
D) VEGF antibodies block tumour angiogenesis and growth (Millauer et 
al., 1994; Kim et al., 1993).  
The regulation of angiogenesis by hypoxia is mediated by the transcriptional 
regulator, hypoxia inducible factor (HIF-1), which stimulates angiogenesis by 
activating VEGF gene transcription (Das & McGuire, 2003; Ozaki et al., 
1999). Incubation of bovine microvascular and large vessels aortic 
endothelial cells which express VEGFR-2 but not VEGFR-1, with TGF-β1, 
results in a marked decrease in VEGFR-2 expression. This down regulation 
induced by TGF-β1 may be responsible for the inhibitory effect on VEGF, 
induced in in vitro angiogenesis (Mandriota et al., 1996; Pepper et al., 1993). 
Negative regulators of vascular growth include TGF-β, pigment-epithelium 
derived factor (PEDF), angiostatin, endostatin, thrombospondin-1 (TSP-1) 
and MMP (matrix metalloproteinase) inhibitors (TIMPs). 
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Contact between endothelial cells and pericytes activates TGF-β, which then 
stabilises vessels by inhibiting endothelial cell proliferation, migration and 
pericyte differentiation (Antonelli-Orlidge et al., 1989). When VEGF is 
downregulated TGF-β has been found to be upregulated (Ogata et al., 2001). 
TGF-β will be described in more detail in Chapter 1.2. 
Hypoxia downregulates expression of PEDF and induces expression of 
VEGF whilst hyperoxia upregulates PEDF whilst downregulating VEGF in a 
retinoblastoma cell line (Dawson et al., 1999). PEDF has also been shown to 
reduce corneal neovascularisation and retinal neovascularisation when 
injected intravitreally (Duh et al., 2002; Dawson et al., 1999). 
Angiostatin and endostatin have been shown to suppress new vessel growth 
(O'Reilly, 1997; O'Reilly et al., 1997; O'Reilly et al., 1994) and TSP-1, 
secreted by endothelial cells and smooth muscle cells inhibits endothelial cell 
proliferation, migration and tumour angiogenesis (Tolsma et al., 1997; Majack 
et al., 1985; McPherson et al., 1981). TIMPs bind the proteinases and inhibit 
their activity, stopping cell migration and tube formation (Moses et al., 1996). 
b) Patterning 
The first retinal vessels form at the optic disc at approximately 14 WG and 
initially grow in a lobular arrangement, each lobule defining the territories of 
one of the quadrantic arteries of the mature retina (Provis, 2001; Sandercoe 
et al., 1999; Provis et al., 1997; Ashton, 1970; Patz, 1966; Mann, 1964; 
Michaelson, 1948; Michaelson et al., 1954). The vessels of the primary 
vasculature form at the NFL/GCL interface and nasal to the optic disc the 
superior and inferior lobes merge along the equator at ~20 WG (Provis, 
2001). Temporally, the superior and inferior vascular lobes skirt around the 
foveal region to meet along the equator, peripheral to the foveal region, at 
~25 WG and establish the FAZ (Provis, 2001; Provis et al., 2000; Gariano et 
al., 1994) (Figure 1.8).  
The secondary vasculature develops by sprouting from the primary layer,  
which then crosses the IPL forming a new vascular layer at the IPL/INL 
interface - the superficial inner nuclear layer plexus (SINL) (Provis, 2001; 
Gariano et al., 1994). Branches of the SINL then penetrate the INL to form a 
24 
Introduction 
layer of vessels at the INL/OPL border - the deep INL plexus (DINL) (Gariano 
et al., 1994). Analysis of retinal wholemounts and sections suggest that the 
lobular vessels that skirt around the fovea first form near the optic disc 
growing on the nasal side first, with the SINL just ahead of the DINL (Provis, 
2001; Gariano et al., 1994). Along the horizontal meridian, approximately 1 
mm from the optic disc, primary vessels leave the NFL, cross the GCL and 
continue to grow towards the incipient fovea at the GCL/IPL interface, 
forming the  ganglion cell layer plexus (GCP) (Provis, 2001; Provis et al., 
2000). Close to the disc SINL and DINL are present; within a few millimetres 
GCP and SINL are present whilst closest to the fovea only GCP capillaries 
are seen (Provis, 2001). The innermost GCP capillaries are established at 
around foetal day (fd) 100 in the macaque which corresponds to around 
24WG in the human but the deep plexus of the perifoveal capillary bed is not 
complete until birth (Provis, 2001; Provis et al., 2000). At fd105~25WG a ring 
of vessels and astrocytes surrounds the avascular area where blind ending 
capillary sprouts are seen (Provis, 2001; Provis et al., 2000). A foveal 
depression surrounded by the GCP is then noted within the avascular zone 
with no deep plexus within a millimetre of the fovea until fd142~32WG 
(Provis, 2001; Provis et al., 2000). Then GCP capillaries contribute to the 
deep plexus establishing the DINL before the SINL getting as close as 
250µm from the foveal centre at fd155~35WG. Anastomosis of the deep 
plexus with the GCP capillaries occurs in the perinatal period (Provis, 2001; 
Provis et al., 2000) (Figure 1.9). Astrocytes leading the GCP vessels towards 
the incipient fovea retreat from it upon formation of the foveal avascular zone 
(Provis et al., 2000). 
The long trajectory of the temporal vessels, combined with a slow growth rate  
results in the central retina remaining avascular for a much longer period 
than other parts of the retina (Engerman, 1976). The central fovea is not 
normally vascularized at any stage of development (Provis et al., 2000; 
Gariano et al., 1994). This occurs despite the central retina being the most 
developmentally advanced and having the highest density of cells when 
compared to other parts of the retina (Provis, 2001; Hendrickson & Yuodelis, 
1984) . The slow growth of temporal vessels contrasts with the usual   
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FIGURE 1.8 Retinal wholemounts showing growth patterns of the primary 
retinal vasculature at various stages of gestation. A. The earliest vessels 
(thick arrows) form four lobes corresponding with each retinal artery. B. The 
temporal lobes skirt around the incipient fovea with small branches from the 
lobular vessels establishing the ganglion cell layer plexus (GCP small 
arrows). C. GCP vessels anastomose around the fovea defining the foveal 
avascular zone. (Adapted from Provis, 2001). 
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mechanism of retinal vascularisation, where endothelial cell growth is thought 
to be mediated by hypoxia produced by high metabolic demand, such as 
increased numbers of active photoreceptors, which in turn increase VEGF 
expression and stimulate angiogenic and vasculogenic vessel development 
(Provis, 2001; Stone et al., 1999; Stone et al., 1995). Cell proliferation in the 
vascular complex increases with retinal maturation except when retinas are 
older than 20WG, where cell proliferation is found to be lowest near the fovea 
before the time the deep plexus forms (Sandercoe et al., 1999). The diameter 
of the foetal FAZ is similar to the adult avascular zone, suggesting that 
remodelling occurs in a dynamic fashion as the foveal pit develops. Because 
the adult avascular zone outlines the foveal slope, and vessel growth near 
the fovea is retarded together with reduced cell proliferation, an inhibitory 
molecule within the foetal fovea potentially marks out the future foveal zone 
repelling astrocytes, blood vessels and ganglion cell axons from this region 
(Provis, 2001; Provis et al., 2000). 
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FIGURE 1.9 Stages of formation of the perifoveal capillary plexus in monkey 
(fd: foetal day and P: postnatal). A. GCP vessels (red) define the avascular 
area lead by astrocytes (green) followed by formation of the foveal 
depression. B. DINL then SINL capillaries approach the developing foveal 
depression about six weeks after the GCP. C. SINL capillaries form in the 
deep plexus in the perinatal period. D. Anastomosis of GCP and deep plexus 
around the foveal depression in early postnatal period (Provis, 2001). 
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1.2 THE ROLE OF TRANSFORMING GROWTH FACTOR-β IN 
RETINAL DEVELOPMENT 
Primate retinal development is a highly complex and controlled process that 
involves expression of several families of growth factors, acting in a tightly 
regulated spatial and temporal sequence. Earlier studies from this laboratory 
demonstrated the importance of FGF and VEGF in normal development of 
cone photoreceptors and retinal vasculature (Cornish et al., 2004c; Cornish 
et al., 2004b; Cornish et al., 2004a; Cornish et al., 2005; Sandercoe et al., 
2003). 
As discussed previously (Chapter 1.1), as blood vessels approach the 
incipient primate fovea, proliferation of endothelial cells and astrocytes is 
reduced in this region and along the horizontal meridian; the FAZ is also 
clearly defined before formation of the foveal depression. Taken together with 
the observation that endothelial cells and astrocytes do not enter the 
developing fovea at any time during development, these findings suggest that 
a factor(s) with anti-proliferative, anti-migratory and/or anti-angiogenic 
properties may be expressed in the incipient foveal region, prior to physical 
marking of the FAZ by astrocytes and endothelial cells (before 23 to 25WG in 
humans, and before ~fd100 in monkey).  
Previous studies indicate that one potential factor is Transforming Growth 
Factor-β (TGF-β), and the following section discusses in detail the structure 
and properties of TGF-β and its receptors in the context of its potential role in 
the developing human fovea.  
The Transforming Growth Factor (TGF)–β family are multifunctional, naturally 
occurring proteins that regulate cell growth, differentiation, migration and 
extracellular matrix (ECM) production and play important roles in embryonic 
development, wound healing, immune responses and vascular development 
in species from flies and worms to mammals (Duenker, 2005; Shi & 
Massague, 2003; Govinden & Bhoola, 2003; Schuster & Krieglstein, 2002; 
Ten Dijke et al., 2002; Mummery, 2001; Zhao and Overbeek, 2001; Bottner 
et al., 2000; Dunker & Krieglstein, 2000; Patterson & Padgett, 2000; 
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Massague et al., 2000; Clark & Coker, 1998; Massague, 1998; Lawrence, 
1996; Saltis, 1996; Nishida et al., 1995; Cox, 1995; Pasquale et al., 1993). 
TGF-β is the prototype of a growing superfamily of peptide growth factors, 
containing TGF-β isoforms, activin/inhibin family, bone morphogenetic 
protein (BMP) family, Müllerian inhibiting substance, glial cell derived 
neurotrophic factor (GDNF), and other factors that are characterised by 
structural similarities and similar signalling cascades but with functional 
diversity (Duenker, 2005; Itoh et al., 2000; Massague, 2000; Massague et al., 
1990; Roberts & Sporn, 1989). There are seven genetically distinct TGF-β 
isoforms TGF-β1, TGF-β1.2, TGF-β2, TGF-β2.3, TGF-β3, TGF-β4 and TGF-
β5 (Clark & Coker, 1998; Lutty et al., 1991; Roberts et al., 1990a; Rizzino, 
1988). Only three isoforms TGF-β1, TGF-β2 and TGF-β3 have been 
detected in mammals (Pasquale et al., 1993; Roberts et al., 1990a). 
The TGF-β isoforms have been widely recognised as a prototype of 
multifunctional growth factors and master switches in the regulation of key 
events in development, disease and repair (Bottner et al., 2000; Kingsley, 
1994; Wahl, 1992; Roberts et al., 1990a).  
The essential role of the TGF-β family in normal development has been 
demonstrated in studies of TGF-β isoform knockout mice.   
In TGF-β1 knockout mice, 50% of animals die in utero and the remainder 
succumb to uncontrolled inflammation by 3 to 6 weeks post birth (Javelaud & 
Mauviel, 2004; Clark & Coker, 1998). TGF-β2 deficient mice reveal obvious 
ocular malformations, including cell migration into the posterior chamber of 
the eye, hyperplastic retinas and decreased thickness of the corneal stroma 
(Sanford et al., 1997). TGF-β3 knockout mice do not reveal an eye 
phenotype, but show defects in palate fusion, heart and lung development 
(Duenker, 2005; Kaartinen et al., 1997; Cox, 1995; Proetzel et al., 1995). 
Interestingly, overexpression of TGF-β1 in TGF-β2 null mice rescues the 
abnormalities in ocular development caused by the deletion of TGF-β2 
(Saika, 2005; Zhao & Overbeek, 2001a; Proetzel et al., 1995; Shull & 
Doetschman, 1994; Kaartinen et al., 1995). These studies clearly 
demonstrate that all TGF-β isoforms display overlapping spatial and temporal 
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expression patterns in most tissues, and that ablation of one TGF-β isoform 
may be compensated for by another isoform resulting in a lack of an obvious 
phenotype (Duenker, 2005). 
1.2.1 STRUCTURE OF TRANSFORMING GROWTH FACTOR-β 
TGF-β is part of a growth factor superfamily comprising more than 50 
members, which have been grouped according to sequence similarities. This 
encompasses activins, glial cell line-derived neurotrophic factor (GDNF) sub-
family and bone morphogenic proteins (BMP) including the decepentaplegic 
(Dpp) and the vegetal-1 related group (DVR) (Bottner et al., 2000) (Figure 
1.10).  
The three mammalian isoforms encoded by the three distinct genes are 
structurally nearly identical with nine conserved cysteine residues and 76-
80% amino acid homology. These are synthesised by many cell types 
including platelets, macrophages, fibroblasts and tumour cells (Javelaud & 
Mauviel, 2004), and secreted as latent precursor molecules which need to be 
activated by changing into the mature form for receptor binding and activation 
of signalling pathways (Javelaud & Mauviel, 2004; Barcellos-Hoff, 1996). In 
humans TGF-β1, TGF-β2 and TGF-β3 are located on three different 
chromosomes, 19q13, 1q41, 14q24 respectively (Govinden & Bhoola, 2003; 
Roberts, 1998; Cox, 1995; ten Dijke et al., 1988). 
The TGF-β molecules consist of 390 to 414 amino acids, and  contain an 
amino-terminal hydrophobic signal peptide region, the 249 residue latency-
associated-peptide (LAP) region and the C-terminal, bioactive region that has 
112 amino acids per monomer (Javelaud & Mauviel, 2004) (Figure 1.11A). 
They are characterised by a knot composed of six cysteines that form three 
intramolecular disulfide bonds - two of which form an eight membered ring, 
which is traversed by the third cysteine bond that helps stabilise several β-
sheet bands (Figure 1.11B). A seventh cysteine makes an intermolecular 
cysteine bridge that links the two monomers into a functional dimer, providing 
additional stabilisation due to hydrogen bonds between the monomers 
(Javelaud & Mauviel, 2004; Bottner et al., 2000; McDonald & Hendrickson, 
1993) (Figure 1.11B).  
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FIGURE 1.10 Dendrogram showing members of the TGF-β superfamily 
where amino acid sequences of the carboxy terminal domains of various 
mammalian members of the TGF-β superfamily were compared unless 
indicated otherwise with (C) C. elegans; (Ch), chicken; (D), Drosophila; (S), 
Sea urchin; (X), Xenopus; (Z), Zebrafish. (Adapted from figure 1, Bottner et 
al., 2000). 
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FIGURE 1.11 A. Simplified diagram of the TGF-β molecule. The total protein 
consists of 412 amino acids (aa) where the aminoterminal prodomain = 
Signal peptide and latency associated protein (LAP), with 4 nitrogen 
glycosylation sites and the potential fibronectin/vitronectin recognition site 
RGD. The prodomain is proteolytically cleaved at an RKKR site to release a 
mature carboxyterminal subunit of 112aa. (Arrows refer to cleavage sites). 
(Adapted from Cox, 1995).      B. Structure of representative TGF-β ligand, 
TGF-β3 (Mittl et al., 1996). The two ligands are coloured blue and green, 
cysteine side chains and disulfide bonds are represented by the red lines. 
The two monomers are linked by a disulfide bond. (Adapted from Figure 3A, 
Shi and Massague, 2003). 
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The LAP and signal peptide are important in disulfide bond formation, folding 
and exporting the mature protein (Cox, 1995).The three mammalian isoforms 
are regulated at the transcriptional level (Govinden & Bhoola, 2003; Roberts, 
1998). They are transcribed as TGF-β precursor mRNA, with the 3’ region 
corresponding to the mature TGF-β region and the 5’ region corresponding to 
the latency associated peptide LAP (Nishida et al., 1995; Miyazono et al., 
1988).  
Mature TGF-β is a 24kDa homodimer that is noncovalently associated with 
the 80kDa LAP, which together are known as latent TGF-β (LTGF-β). The 
LAP is required for efficient secretion, preventing binding to ubiquitous cell 
surface receptors. 
 The LTGF-β complex may be stored in granules in platelets or secreted by 
all cells, and can bind to a cell membrane associated mannose-6-phosphate 
receptor, circulate or bind to the ECM (Govinden & Bhoola, 2003; Clark & 
Coker, 1998; Munger et al., 1997; Gleizes et al., 1996). Latent TGF-β is 
usually secreted as a large latent complex (LLC) covalently bound via the 
LAP region to latent TGF-β binding protein (LTBP) or as a small latent 
complex (SLC) without LTBP. Newly synthesised TGF-β is released from 
most cells as the LLC (Govinden & Bhoola, 2003; Munger et al., 1997; 
Gleizes et al., 1996; Nishida et al., 1995; Olofsson et al., 1992) (Figure 1.12). 
LTBP1 is involved in the sequestration of LTGF-β in the ECM and in the 
regulation of its activation in the extracellular environment by ensuring the 
correct folding, secretion and target of TGF-β (Figure 1.13) (Govinden & 
Bhoola, 2003; Saharinen & Keski-Oja, 2000; Munger et al., 1997; Gleizes et 
al., 1996). The LAP confers latency to the complex whereas LTBP1 serves to 
bind TGF-β to the ECM and enable its proteolytic activation (Govinden & 
Bhoola, 2003; Gualandris et al., 2000).  
Conformational changes of the LTGF-β complex as a result of LAP cleavage 
by plasmin, thrombin, plasma transglutinases or endoglycosylases, or 
physical interactions of the LAP with other proteins such as TSP-1, leads to 
the release and activation of TGF-β (Javelaud & Mauviel, 2004; Zhao & 
Overbeek, 2001a; Khalil, 1999; Nishida et al., 1995; Lutty et al., 1993; 
Lyonset al., 1988). 
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The biological half life of TGF-β is short, ~1hour, and it is rapidly cleared via 
the action of scavenger molecules such as α-2-macroglobulin (Dennler et al., 
2002; Vaughan & Vale, 1993; Wakefield et al., 1990). 
1.2.2 TRANSFORMING GROWTH FACTOR-β RECEPTORS 
 
Members of the TGF-β superfamily signal through a family of transmembrane 
receptor-linked serine/threonine kinases that have a short cysteine-rich 
extracellular domain, a single transmembrane domain and an intracellular 
serine/threonine kinase domain via mediators of TGF-β signalling known as 
Smads (Duenker et al., 2005; Govinden & Bhoola, 2003; Padgett, 1999b; 
Padgett, 1999a; Heldin et al., 1997; Attisano & Wrana, 1996; Massague, 
1996; Massague & Weis-Garcia, 1996; Miyazono et al., 1994). The biological 
effects of TGF-β are exerted via specific binding interactions involving two 
distinct membrane bound receptors, types I and II (TβRI and TβRII) (Figure 
1.14). A third receptor, type III (TβRIII), has also been identified, with no 
known signalling function.  
The dimeric arrangement of the ligands suggests the formation of a 
tetrameric complex with TβRI and TβRII (Bottner et al., 2000; Yamashita et 
al., 1994). The receptor serine/threonine kinase family in the human genome 
comprises 12 members: 7 type I and 5 type II receptors all dedicated to TGF-
β signalling (Shi & Massague, 2003; Manning et al., 2002). TGF-β displays a 
high affinity for type II receptors and does not interact with the individual type 
I receptors (Shi & Massague, 2003; Massague, 1998). Initially, the ligand 
binds tightly to the ectodomain of the type II receptor, which  allows 
subsequent incorporation of the type I receptor, forming a large ligand-
receptor complex involving a ligand dimer and four receptor molecules 
(Duenker, 2005; de Caestecker, 2004; Shi & Massague, 2003; Itoh et al., 
2000; Miyazono, 2000; Wrana & Attisano, 2000; Heldin et al., 1997; Cox, 
1995; Wrana et al., 1994; Wrana et al., 1992). Structural analysis reveals that 
binding occurs at the far ends of the elongated ligand dimer where each 
receptor binds to one monomer of the dimeric TGF-β (Shi & Massague, 
2003; Hart et al., 2002). Binding to the extracellular domains of both types of 
receptors by the dimeric ligand induces close proximity and productive 
conformation for the intracellular kinase domains of the receptors, facilitating 
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FIGURE 1.12 Synthesis and secretion of TGF-β1 – from gene to released 
product. Process for TGF-β2 and TGF-β3 isoforms is similar. (Adapted from 
Clark and Coker, 1998). 
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FIGURE 1.13 Diagram showing the extracellular pathway for TGF-β, which is 
released in the latent form, acts on receptors and is subsequently 
catabolised. (Adapted from Clark and Coker, 1998). 
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the phosphorylation and subsequent activation of the type I receptor 
(Govinden & Bhoola, 2003; Wrana, 1998) (Figure 1.14 and Figure 1.15). 
TβRI has a highly conserved sequence known as the “GS” domain, which 
contains a repetitive glycine-serine motif between transmembrane and kinase 
domains. TβRII has more distantly related kinase domains (Bottner et al., 
2000; Franzen et al., 1995; Wieser et al., 1995). The GS region in TβRI is 
phosphorylated by TβRII leading to its activation, and is an important 
regulatory domain for TGF-β signalling (Shi & Massague, 2003; Massague, 
1998). TβRII has a large C terminal extension that is rich in serine and 
threonine (Govinden & Bhoola, 2003; Liu et al., 1995). The membrane-
anchored proteoglycan, betaglycan or endoglin, also known as TGF-β type III 
receptor (TβRIII), has a large extracellular domain, a single transmembrane 
domain and a short cytoplasmic region lacking apparent signalling function 
(Gomes et al., 2005; Massague, 1998; Lopez-Casillas et al., 1991; Cheifetz 
et al., 1988).  
The steps leading to receptor activation are tightly controlled by two classes 
of molecules with opposing function. One class acts as ligand binding traps, 
binding to TGF-β and stopping access to membrane receptors, as seen for 
example with the LAP, which is the pro-region of the TGF-β precursor. The 
other class includes membrane anchored proteins that act as co-receptors, 
promoting ligand binding to the signalling receptors. TβRIII mediates TGF-β 
binding to TβRII, which is particularly important for TGF-β2, but so far there is 
no evidence of it being able to transduce the signal (Javelaud & Mauviel, 
2004; Shi & Massague, 2003; Brown et al., 1999; Massague, 1998).  
Once TGF-β binds to TβRII, it forms a heteromeric complex with TβRI, with 
subsequent phosphorylation and activation of TβRI (Govinden & Bhoola, 
2003; Attisano & Wrana, 2000; Padgett, 1999a; Massague, 1998; Heldin et 
al., 1997; Wrana et al., 1994). The activated TβRI interacts with an adaptor 
protein, Smad anchor for receptor activation (SARA) (Duenker, 2005; Shi & 
Massague, 2003; Tsukazaki et al., 1998), which transfers signals to 
intracellular mediators known as Smads (ten Dijke & Hill, 2004; Govinden & 
Bhoola, 2003; Attisano & Wrana, 2000; Derynck et al., 1998; Massague, 
1998; Heldin et al., 1997). 
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FIGURE 1.14 Simplified diagram of TGF-β ligand (red square) binding to 
TβRII, recruiting TβRI with subsequent phosphorylation resulting in signal 
transduction. 
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FIGURE 1.15 Structure of the extracellular ligand binding domain of TβRII 
bound to TGF-β3 (Hart et al., 2002). The predicted TβRI binding sites are 
shown by red circles. Disulfide bond is marked by a red line. (Adapted from 
figure 4C, Shi and Massague, 2003). 
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Although each Smad has a specific role, all have conserved amino (N-
terminal) and carboxyl terminal Mad-homology (MH) domains known as MH1 
and MH2 respectively (Javelaud & Mauviel, 2004; Govinden & Bhoola, 2003). 
There are eight Smad proteins constituting three functional classes:  receptor 
regulated Smads (R-Smad), Co-mediator Smads (Co-Smad) and inhibitory 
Smads (I-Smad) (Bottner et al., 2000).  
R-Smads (Smad 1,2,3,5 and 8) are directly phosphorylated and activated by 
the TβRI kinases and undergo homotrimerisation and formation of 
heteromeric complexes with Co-Smad, Smad 4 (Bottner et al., 2000; Heldin 
et al., 1997; Chen et al., 1996; Lagna et al., 1996; Zhang et al., 1996). The 
activated Smad complexes are translocated into the nucleus and together 
with other nuclear cofactors, activate specific target genes via interactions 
with DNA and DNA-binding proteins (Govinden & Bhoola, 2003; Zhang et al., 
1998). Smad 4 only translocates to the nucleus when complexed with R-
Smads, whereas ligand-activated Smad 2 and Smad 3 may translocate into 
the nucleus in a Smad 4 independent fashion. In the absence of Smad 4, 
neither Smad 2 nor Smad 3 is capable of transcriptional activity, suggesting 
that the principal function of Smad 4 is to regulate transcription rather than to 
transmit signals from the cytoplasm to the nucleus (Javelaud & Mauviel, 
2004; Massague & Chen, 2000).  
I-Smads, Smad 6 and Smad 7, negatively regulate TGF-β signalling by 
competing with R-Smads for receptor or Co-Smad interaction, and by 
targeting the receptors for degradation (Duenker, 2005; ten Dijke & Hill, 
2004; Shi & Massague, 2003; Bottner et al., 2000; Hill, 1999).  
Aside from the Smads that are highly specific substrates for the TGF-β 
receptor kinases, other signalling pathways may also be activated by TGF-β 
in a context and cell type specific manner. These include the mitogen 
activated protein kinase (MAPK) cascades (p38, ERK, JNK), phosphatidyl-
inositol-3-kinase, and PP2A/p70s6K, though the molecular details of these 
couplings are obscure (Javelaud & Mauviel, 2004; de Caestecker et al., 
2000; Mulder, 2000). 
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1.2.3 TRANSFORMING GROWTH FACTOR-β FUNCTION 
The biological activity of TGF-β is multifunctional and TGF-β is involved in 
cell-cycle control, regulation of early development, differentiation, ECM 
formation, hematopoiesis, angiogenesis, chemotaxis, and immune functions 
(Bottner et al., 2000; Cox, 1995). 
TGF-βs are contextually acting molecules that can either stimulate or repress 
cell proliferation depending on cell type, differentiation status, cellular 
environment, and the presence or absence of other growth factors, cytokines 
and ECM components (Duenker, 2005; Unsicker & Krieglstein, 2000; Combs 
et al., 2000; Gold, 1999; Ashley et al., 1998; Roberts et al., 1990a; Roberts et 
al., 1990b), are neurotrophic (Duenker, 2005; Krieglstein et al., 1998a; 
Krieglstein et al., 1998b; Krieglstein et al., 1998c) or induce cell death 
(Duenker, 2005; Krieglstein et al., 2000; Hata et al., 1998; de Luca et al., 
1996). They are important mediators of normal developmental and repair 
processes in the embryo, neonate and adult, with roles in tissue 
morphogenesis and differentiation, regulating cell proliferation, differentiation 
and expression of ECM proteins that may induce fibrosis and angiogenesis 
(Cox, 1995; Kingsley, 1994; Roberts et al., 1990a; Roberts & Sporn, 1993; 
Sporn & Roberts, 1992; Pasquale et al., 1993; Lutty et al., 1991; Mustoe et 
al., 1987; Ignotz & Massague, 1986; Laiho et al., 1986; Roberts et al., 1986; 
Sporn et al., 1983). 
TGF-β can enhance or antagonise the action of other growth factors on cells.  
For example, TGF-β can stimulate proliferation of osteoblasts, chondroblasts 
and mesothelial cells but inhibit proliferation of hepatocytes, haematopoietic 
stem cells, lymphocytes, endothelial cells and epithelial cells (Pfeffer et al., 
1994; Hunter et al., 1993; Roberts et al., 1990a; Roberts et al., 1990b; 
Leschey et al., 1990; Silberstein & Daniel, 1987; Jetten et al., 1986). TGF-β1 
enhances mitogenic effects of acidic fibroblast growth factor (aFGF, now 
known as FGF-1) and basic fibroblast growth factor (bFGF, now known as 
FGF-2) on osteoblasts (Pfeffer et al., 1994; Hunter et al., 1993; Flaumenhaft 
et al., 1992; Globus et al., 1988) but inhibits mitogenic effects of FGF-1 and 
FGF-2 on endothelial cells (Hunter et al., 1993; Baird & Durkin, 1986).  
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Function of TGF-β in Brain and Nervous System 
TGF-β expression starts early in the development of the nervous system and 
even though TGF-β1, TGF-β2 and TGF-β3 are often co-expressed, they 
have distinct spatiotemporal patterns. Each of the isoforms act as 
coordinated mediators of mesenchymal epithelial interactions, via their 
effects on the synthesis and composition of the ECM (Duenker, 2005). 
The reported distribution and roles of TGF-βs in the developing and adult 
CNS are summarised in Table 1.1. 
TABLE 1.1 TGF-β actions in the nervous system 
 
GROWTH 
FACTOR 
FUNCTION 
TGF-β1 Neuroprotection against glutamate toxicity  
(Prehn et al., 1993; Prehn & Krieglstein, 1994; Bruno et al., 
1998; Buisson et al., 1998; Docagne et al., 2002) 
 Survival of neurons  
(Krieglstein & Unsicker, 1994; Prehn & Krieglstein, 1994; 
Krieglstein et al., 1998a; Krieglstein et al., 1998b; Krieglstein et 
al., 1998c; Schober et al., 1999; Zhu et al., 2000b; Roussa et al., 
2004; Roussa & Krieglstein, 2004; Gomes et al., 2005) 
 Neuronal differentiation  
(Ishihara et al., 1994; Abe et al., 1996; Gomes et al., 2005) 
 Control of neuronal death and microgliosis  
(de Luca et al., 1996; Brionne et al., 2003) 
 Control of astrocytic cytoskeleton, morphology and motility 
(Labourdette et al., 1990; Toru-Delbauffe et al., 1990; Morganti-
Kossmann et al., 1992; Baghdassarian et al., 1993; Gagelin et 
al., 1995; Laping et al., 1994; Bottner et al., 2000) 
 Astrocyte differentiation  
(Rich et al., 1999; Perillan et al., 2002; de Sampaio e Spohr et 
al., 2002; Sousa Vde et al., 2004; Gomes et al., 2005) 
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 Inhibition of astrocyte proliferation  
(Johns et al., 1992; Lindholm et al., 1992; Morganti-Kossmann et 
al., 1992; Baghdassarian et al., 1993; Hunter et al., 1993; Vergeli 
et al., 1995; Rich et al., 1999) 
 Extracellular matrix production  
(Liesi, 1985; Sanes, 1989; Wujek et al., 1990; Baghdassarian et 
al., 1993; Wyss-Coray et al., 1995; Buisson et al., 1998; 
Docagne et al., 1999; Docagne et al., 2002; Brionne et al., 2003) 
 Wound healing and immunosuppression  
(Pratt & McPherson, 1997) 
 Cell migration in the cerebral cortex  
(Siegenthaler & Miller, 2004) 
 Influence MHC expression  
(Schluesener, 1990; Johns et al., 1992; Bottner et al., 2000) 
 Apoptosis in microglia  
(Xiao et al., 1997; Bottner et al., 2000) 
 Inhibition of microglia proliferation  
(Bottner et al., 2000) 
 Inhibition of oligondendroglia migration  
(Fok-Seang et al., 1998) 
 Organisation of a glial scar  
(da Cunha et al., 1993; Pratt & McPherson, 1997; Flanders et al., 
1998; Moon & Fawcett, 2001) 
 Induction of blood brain barrier characteristics in endothelial cells 
(Garcia et al., 2004) 
TGF-β2 Neuroprotection against glutamate toxicity  
(Bruno et al., 1998) 
 Neuronal differentiation  
(Flanders et al., 1991; Ishihara et al., 1994; Unsicker et al., 1996; 
Miller, 2003) 
 Inhibition of mitogen-induced neuronal proliferation 
(Constam et al., 1994) 
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 Neuronal migration 
(Flanders et al., 1991; Miller, 2003) 
 Survival of neurons  
(Poulsen et al., 1994; Krieglstein & Unsicker, 1994; Krieglstein et 
al., 1998a; Krieglstein et al., 1998b; Krieglstein et al., 1998c; 
Schober et al., 1999; Farkas et al., 2003; Roussa et al., 2004; 
Roussa & Krieglstein, 2004) 
 Apoptosis of cerebellar neurons  
(de Luca et al., 1996) 
 Inhibition of mitogen-induced astrocyte proliferation  
(Hunter et al., 1993) 
 Induction of microglia proliferation  
(Flanders et al., 1991; Dobbertin et al., 1997; Miller, 2003) 
 Influence MHC expression  
(Schluesener, 1990; Johns et al., 1992; Bottner et al., 2000) 
TGF-β3 Neuroprotection against glutamate toxicity  
(Prehn et al., 1993; Prehn & Krieglstein, 1994) 
 Neuronal differentiation 
(Flanders et al., 1991; Unsicker et al., 1996) 
 Neuronal migration 
(Flanders et al., 1991) 
 Survival of neurons  
(Krieglstein & Unsicker, 1994; Poulsen et al., 1994; Krieglstein et 
al., 1998a; Krieglstein et al., 1998b; Krieglstein et al., 1998c; 
Schober et al., 1999; Farkas et al., 2003; Roussa et al., 2004; 
Roussa & Krieglstein, 2004) 
 Apoptosis of cerebellar neurons  
(de Luca et al., 1996) 
 Induction of midbrain dopaminergic phenotype  
(Farkas et al., 2003) 
 Inhibition of mitogen-induced astrocyte proliferation  
(Hunter et al., 1993) 
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TGF-β and its Role in the Eye 
All three TGF-β isoforms and type I and II receptors are present in 
developing and adult human eyes (Zhao & Overbeek, 2001a). TGF-βs are 
present in the cytoplasm of  cells  in the retina-RPE-choroid complex, 
including photoreceptors, ganglion cells, Müller cells, RPE and vascular cells 
(choroidal and retinal) as well as in the cornea, lens, tears, aqueous and 
vitreous humour (Duenker, 2005; Hu et al., 1998; Majima, 1997; Kokawa et 
al., 1996; Anderson et al., 1995; Pfeffer et al., 1994; Tripathi et al., 1994b; 
Tanihara et al., 1993; Helbig et al., 1991; Knisely et al., 1991; Jampel et al., 
1990). The primary ligand in the postnatal retina is TGF-β2, mainly 
expressed by inner retinal neurons. TGF-β receptors have been found in 
cornea, ciliary body, iris, lens, retinal cells, RPE and brain (Duenker, 2005; 
Gomes et al., 2005; Dunker & Krieglstein, 2003; Miller, 2003; MacConell et 
al., 2002; Yamanaka et al., 2002; Bottner et al., 2000; Galter et al., 1999; 
Obata et al., 1999; Bottner et al., 1996). 
TGF-β And Eye Growth 
TGF-β isoforms play an important role in normal eye development and 
growth, and during pathology (Table 1.2).  
For example, TGF-β1 and TGF-β3 deficient mice have no ocular 
abnormalities but TGF-β2 deficient mice display several ocular defects 
including a thinned cornea with loss of corneal endothelium, a shallow 
anterior chamber, an immature retina and persistent vitreous vessels (Saika, 
2005; Proetzel et al., 1995; Shull & Doetschman, 1994; Kaartinen et al., 
1995; Sanford et al., 1997). Overexpression of TGF-β1 in TGF-β2 null mice 
rescues the abnormalities in ocular development caused by the deletion of 
TGF-β2 (Saika, 2005; Zhao & Overbeek, 2001a). 
Transgenic mice expressing a self-activating form of TGF-β1 exhibit anterior 
subcapsular cataracts by 3 weeks postnatal, with corneal opacities and 
defects in the iris and ciliary body and retinal vascular deficiency, with 
subsequent retinal degeneration (Zhao & Overbeek, 2001a; Srinivasan et al., 
1998). Retinal thickness is reduced in this model, due to an absence of blood 
vessels in some areas of the retina (Zhao & Overbeek, 2001a). Corneal 
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stromal growth is stimulated, reversing the corneal phenotype found in TGF-
β2-null embryos (Zhao & Overbeek, 2001a). 
As mentioned above, TGF-β2 deficient mice revealed ocular malformations, 
including hyperplastic retinas and decreased corneal stromal thickness, 
suggesting that these defects did not overlap with other TGF-β knockout 
mice defects (Sanford et al., 1997). TGF-β3 knockout mice do not reveal an 
eye phenotype, only defects in palate fusion and lung development (Duenker, 
2005; Kaartinen et al., 1997; Proetzel et al., 1995). However when TGF-β2 
and TGF-β3 knockout mice were studied, the neural retina was consistently 
detached from the underlying RPE, with a thickened inner retina and a 
vascularised accumulation of cells in the posterior chamber of the eye 
(Dunker & Krieglstein, 2003). The retinal detachment being probably due to 
the fact that TGF-βs are regulators of mesenchymal-epithelial interactions 
and ECM assembly (Duenker, 2005; Roberts & Sporn, 1992; Heine et al., 
1987). Increased retinal thickness may be due to decreased programmed cell 
death, rather than an increase in proliferation, mediated by TGF-β signalling 
(Dunker & Krieglstein, 2003). 
TGF-β3 exhibits unique antiscarring properties in knockout animals in which 
embryonic wound healing is not scarless, as opposed to embryos expressing 
TGF-β3 (Javelaud & Mauviel, 2004; O'Kane & Ferguson, 1997). Manipulation 
of the ratios of TGF-β, especially by raising the levels of TGF-β3 relative to 
TGF-β1 and TGF-β2 reduces scarring and fibrosis (O'Kane & Ferguson, 
1997; Giri et al., 1993). 
The loss of Smad-3 does not produce ocular abnormalities, indicating that 
multiple signalling pathways are involved in ocular tissue morphogenesis 
(Saika, 2005).  
Even in the postnatal eye the control of ocular growth is important in order to 
ensure high visual acuity with the correct relationship between axial eye 
length and the optical power of the eye. In the chicken embryo it was found 
that TGF-β1 and FGF-2 act in a push-pull fashion to control the release of 
matrix degrading proteases from capillary endothelial cells to regulate scleral 
thickness (Anderson et al., 1995; Rohrer & Stell, 1994; Hageman et al., 1991; 
Edwards et al., 1987; Presta et al., 1986; Ignotz & Massague, 1986). 
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TABLE 1.2 Effects of TGF-β in the Eye 
GROWTH 
FACTOR 
 
FUNCTION 
TGF-β 
overall 
Inhibition of progenitor proliferation in the retina  
(Close et al., 2005) 
 Induction of apoptosis in the retina 
(Duenker, 2005; Duenker et al., 2005; Siegel & Massague, 2003; 
Schuster et al., 2003; Schuster et al., 2002; Valderrama-Carvajal 
et al., 2002; Dunker et al., 2001; Buenemann et al., 2001; 
Larisch et al., 2000; Frade & Barde, 1999) 
 Enhancement of corneal epithelium migration and matrix 
deposition in wound repair  
(Kim et al., 2004; Saika, 2004; Nishimura et al., 1998; Mita et al., 
1998; Honma et al., 1997; Wilson et al., 1994; Mishima et al., 
1992) 
 Inhibition of corneal epithelium proliferation 
(Nishida et al., 1995) 
 Promotion of lens fibre differentiation 
(Saika, 2005; Beebe et al., 2004; Saika et al., 2000; Pasquale et 
al., 1993; Pelton et al., 1991) 
 Induction of cataract formation  
(Wormstone et al., 2002; de Iongh et al., 2001; Gordon-Thomson 
et al., 1998) 
 Inhibition of endothelial cell proliferation in vitreous 
(Zhao & Overbeek, 2001a; Spranger et al., 1999; Lutty et al., 
1993; Connor et al., 1989; Lutty et al., 1985; Lutty et al., 1983; 
Patz et al., 1978; Jacobson et al., 1984) 
TGF-β1 TGF-β1 in the chick retina in vitro was found to inhibit DNA 
synthesis and induce an increase in the number of ECM 
molecules  
(Carri, 2003; Calvaruso et al., 1997) 
 Possible regulation of metabolism or healthy maintenance of 
photoreceptor or interphotoreceptor matrix (IPM) production in 
rod outer segments of adult eyes 
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(Anderson et al., 1995; Pfeffer et al., 1994; Lutty et al., 1991; 
Lutty et al., 1993; Sporn et al., 1987; Polans et al., 1986) 
 Stimulation of conjunctival scarring  
(Cordeiro et al., 1999) 
  Upregulation of ECM production in monkey eyes with 
experimentally induced glaucoma to aid remodelling of the 
lamina cribrosa of the optic nerve head  
(Fukuchi et al., 2001) 
 Upregulation of matrix degrading proteases to regulate scleral 
thickness in eye growth  
(Anderson et al., 1995; Rohrer & Stell, 1994; Hageman et al., 
1991; Edwards et al., 1987; Presta et al., 1986; Ignotz & 
Massague, 1986) 
TGF-β2 Inhibition of Müller cell proliferation 
(Close et al., 2005; Ikeda & Puro, 1995) 
 Possible regulation of metabolism or healthy maintenance of 
photoreceptor or IPM production in rod outer segments of adult 
eyes 
(Anderson et al., 1995; Pfeffer et al., 1994; Lutty et al., 1991; 
Lutty et al., 1993; Sporn et al., 1987; Polans et al., 1986) 
 Stimulation of conjunctival scarring  
(Cordeiro et al., 1999; Connor et al., 1989) 
 Transdifferentiation of conjunctival epithelium to corneal 
epithelium in wound repair 
(Pasquale et al., 1993) 
 Prevent apoptosis in the region of the optic nerve head assisting 
development  
(Duenker, 2005; Pena et al., 1999) 
 Related to intraocular pressure with increased TGF-β2 levels in 
aqueous humour in eyes with glaucoma 
(Lutjen-Drecoll, 2005; Gottanka et al., 2004; Picht et al., 2001; 
Tripathi et al., 1994b; Cousins et al., 1991; Jampel et al., 1990) 
 Upregulation of ECM production in eyes with glaucoma to aid 
remodelling of the lamina cribrosa of the optic nerve head 
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(Fukuchi et al., 2001; Pena et al., 1999) 
 Inhibition of endothelial cell proliferation by RPE 
(Anderson et al., 1995; Pfeffer et al., 1994) 
TGF-β3 Possible regulation of metabolism or healthy maintenance of 
photoreceptor or IPM production in rod inner segments of adult 
eyes 
(Anderson et al., 1995; Pfeffer et al., 1994; Lutty et al., 1991; 
Lutty et al., 1993; Sporn et al., 1987; Polans et al., 1986) 
 Stimulation of conjunctival scarring  
(Cordeiro et al., 1999) 
 Reduction in scarring and fibrosis by raising the levels of TGF-β3 
relative to TGF-β1 and TGF-β2  
(O'Kane & Ferguson, 1997; Giri et al., 1993) 
 Prevent apoptosis in the region of the optic nerve head during 
development  
(Duenker, 2005) 
 
Effect of TGF-β on Neurons and Müller Cells  
Retinal progenitor proliferation is regulated by extrinsic and intrinsic factors, it 
peaks around the day of birth and declines until approximately the end of the 
first postnatal week (Close et al., 2005; Young, 1985). After this time there 
seems to be no renewed proliferation of either progenitors or Müller glia in 
the mammalian retina except under abnormal conditions (Close et al., 2005; 
Fariss et al., 2000; Sueishi et al., 1996; Nork et al., 1987). TGF-β has been 
implicated in the inhibition of proliferation in the nervous system as the 
postnatal decline in cerebellar precursor proliferation is paralleled by an 
increase in neuronal TGF-β2 expression, and TGF-β2 inhibits precursor 
proliferation in culture (Close et al., 2005; Constam et al., 1994). 
Retinal neurons appear to provide both mitogenic and cytostatic factors. 
TGF-β signalling has an antiproliferative effect on cells of the postnatal rat 
retina, and inhibiting this endogenous signal with a TGF-β receptor blocker 
maintains proliferation of the progenitors past the developmental period in 
which the retina would normally become mitotically quiescent. Hence TGF-β 
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is an important inhibitor of progenitor proliferation in the postnatal retina 
(Close et al., 2005). Mitogenic and growth inhibitory signals from one source  
might finely tune the numbers and ratios of cells as they are born or as 
neurons die, resulting in properly functioning circuits (Close et al., 2005; 
Alexiades & Cepko, 1996). 
Müller cells express type I and II TGF-β receptors and TGF-β1 and TGF-β3 
is localised to the cytoplasm in Müller cells which are uniquely positioned to 
deliver factors to retinal neurons as they span the entire retina (Anderson et 
al., 1995). TGF-β receptors I and II are located in nestin positive progenitors 
early in development (P4) and Glast positive Müller glia later in development 
(P10) (Close et al., 2005). They secrete TGF-β after stimulation with 
mitogens and scavenge debris in diabetic retinas (Close et al., 2005; Ikeda et 
al., 1998; Lutty et al., 1991; Assoian et al., 1987; Bloodworth & Molitor, 
1965). Normally mammalian Müller glia do not proliferate after retinal 
development is complete. Even in disease states, such as diabetic 
retinopathy and retinitis pigmentosa few Müller glia enter mitosis (Close et 
al., 2005; Fariss et al., 2000; Sueishi et al., 1996; Robison et al., 1990; Nork 
et al., 1987). A retina derived TGF-β signal may be responsible for the 
developmental decline in retinal proliferation without affecting cell death and 
Müller glial quiescence (Close et al., 2005; Ikeda & Puro, 1995).  
Inhibition of TGF-β signalling potentiates epidermal growth factor (EGF) 
stimulated Müller glial proliferation in vivo, enhancing the ability of Müller glia 
to re-enter the cell cycle in response to EGF so that TGF-β negatively 
regulates the proliferation of retinal progenitors and Müller glia in the 
developing retina (Close et al., 2005; Milenkovic et al., 2003; Ikeda & Puro, 
1995; Scherer & Schnitzer, 1994; Roque et al., 1992; Mascarelli et al., 1991). 
The antagonistic interaction between the EGF and TGF-β pathways 
intracellularly may allow EGF to play a mitogenic role in the presence of anti-
mitogenic TGF-β signals in the postnatal retina (Close et al., 2005; ten Dijke 
et al., 2000). The response to EGF and TGF-β signals received by a given 
cell are determined by the expression pattern of factors such as the Fox 
proteins, which are transcription factors that regulate Smad mediated 
transcription. Foxo-1 is more abundant centrally compared to the periphery, 
where it might facilitate TGF-β signalling in the central retina (Close et al., 
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2005; Seoane et al., 2004). The response to mitotic inhibitors such as TGF-β 
as well as the availability of mitogens shifts from conditions favouring 
proliferation to conditions that maintain quiescence at the termination of 
neurogenesis (Close et al., 2005). 
Role of TGF-β on Photoreceptors 
The immunohistochemical localisation of TGF-β1 and TGF-β2 to 
photoreceptors in human donor eyes was the first suggestion of a retinal site 
of TGF-β although its function is speculative (Anderson et al., 1995; Pfeffer et 
al., 1994; Lutty et al., 1991; Lutty et al., 1993). Extracellular TGF-β1 was 
observed in cytoplasmic membrane of photoreceptor inner and outer 
segments whilst intracellular TGF-β2 was found in outer segments almost 
exclusively in rods as opposed to cone photoreceptors (Lutty et al., 1993; 
Polans et al., 1986). TGF-β1 and TGF-β2 are distributed more or less 
uniformly throughout the rod outer segment cytoplasm – maybe to regulate 
photoreceptor metabolism or to help in maintenance of healthy outer 
segments (Anderson et al., 1995; Lutty et al., 1991). In monkey retina, TGF-
β1 and less intensely, TGF-β2 antibodies reacted with photoreceptor outer 
segments particularly rod outer segments with no difference between central 
and peripheral retina. TGF-β2 immunolabelling viewed with electron 
micrographs showed it to be intracellular, in outer segments, and not in the 
interphotoreceptor matrix (IPM-extracellular compartment between the 
photoreceptor outer segments and the RPE) (Pfeffer et al., 1994). TGF-β3 is 
absent in photoreceptor outer segments but is compartmentalised in inner 
segments, within mitochondria concentrated in the rod and cone ellipsoids-
possibly to regulate mitochondrial function. Moderate levels of TGF-β3 
antibody labelling could be detected in the RPE cytoplasm within the 
mitochondrial rich zone of the photoreceptor inner segments (ellipsoid) and in 
the cytoplasm of the various cell types that form the retinal vasculature 
(Anderson et al., 1995).  
TGF-β function may affect secretion of extracellular protein constituents (eg 
IPM) associated with and synthesised by photoreceptors that do not  
accumulate in outer segments, but are secreted from the inner segment 
portion of the cell where protein synthesis occurs and where the cellular 
machinery for processing and release is located (Pfeffer et al., 1994; Bok, 
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1985; Hollyfield et al., 1985; Feeney, 1973). TGF-β is known to stimulate 
production of basement membrane components like collagen and fibronectin 
in several cells, so it could stimulate production of IPM components (Lutty et 
al., 1991; Sporn et al., 1987). 
TGF-β in the Lens 
Much of our understanding of the effects of TGF-β has come from studies 
done in the lens (McAvoy et al., 2000). Heterogenous expression of all TGF-
β isoforms is found in developing and adult human and animal crystalline 
lens (Saika, 2005; Saika et al., 2000; Pasquale et al., 1993; Pelton et al., 
1991). 
Lens fibre differentiation is controlled by FGF, BMP and TGF-β (Saika, 2005; 
Tanaka et al., 2004; Beebe et al., 2004; McAvoy et al., 2000). However, 
studies have shown that TGF-β can disrupt normal lens architecture and 
induce changes in lens cells that are similar to those described in human 
subcapsular cataracts (de Iongh et al., 2005; Lovicu et al., 2002; Hales et al., 
1995; Hales et al., 1999; Schulz et al., 1996). TGF-β induces the formation of 
spindle shaped cells containing α-smooth muscle actin, capsule wrinkling, 
apoptotic cell death and accumulation of ECM proteins such as laminin and 
fibronectin (de Iongh et al., 2001). All isoforms can induce cataractous 
changes but TGF-β2 and TGF-β3 are around ten times more potent than 
TGF-β1 (de Iongh et al., 2001; Wormstone et al., 2002; Gordon-Thomson et 
al., 1998). 
TGF-β in the Vitreous 
TGF-β is also found in the posterior chamber of the eye where all its isoforms 
were localised to hyalocytes (amoeboid and ovoid) in cortical vitreous (Lutty 
et al., 1993). Hyalocytes were the only cells in the posterior segment of the 
eye that were immunoreactive for TGF-β1, TGF-β2 and TGF-β3 (Lutty et al., 
1993; Balazs, 1984). Most TGF-β activity in the vitreous is from TGF-β2, 84-
100% whilst 10-21% is due to TGF-β1 (Dieudonne et al., 2004; Connor et al., 
1989). 
In this case, the main role for TGF-β appears to be anti-angiogenic. 
Production of a vitreous inhibitor of endothelial cells by hyalocytes has been 
53 
Introduction 
demonstrated (Jacobson et al., 1984). It is thought that TGF-β in the vitreous 
inhibits endothelial cell proliferation in vitro, and inhibits neovascularisation in 
vivo in the chick chorioallantoic membrane assay and in the rabbit corneal 
assay to maintain the avascularity of this gel (Zhao & Overbeek, 2001a; 
Spranger et al., 1999; Lutty et al., 1993; Lutty et al., 1985; Lutty et al., 1983; 
Patz et al., 1978). 
TGF-β in the Choroid and RPE 
TGF-β1 and TGF-β2 are found in the capillary endothelium, and within 
connective tissue of large choroidal arterial walls and in choroidal stroma 
respectively (Anderson et al., 1995; Pfeffer et al., 1994; Lutty et al., 1993; 
Kane et al., 1991). TGF-β3 immunoreactivity was seen in intravascular 
leukocytes and in a few choroidal interstitial cells, possibly histiocytes (Lutty 
et al., 1993). 
 RPE cells have been shown to express TGF-β and its receptors and 
respond to many growth factors from the TGF-β superfamily (Mitsuhiro et al., 
2003; Guerin et al., 2001; Anderson et al., 1995; Pfeffer et al., 1994; Hiscott 
et al., 1985). Resemblance between secretory granules and anti-TGF-β2 
positive granules identified in monkey RPE cells supports the view that the 
RPE synthesises and secretes TGF-β2 into the choroid or apically into the 
interphotoreceptor space (Anderson et al., 1995). The antiangiogenic effects 
of TGF-β are again noted as photocoagulated RPE cells containing TGF-β2 
inhibit proliferation of bovine aortic endothelial cells and bovine retinal 
endothelial cells (Yoshimura et al., 1995). 
Effects of TGF-β on Astrocytes and Endothelial Cells 
A number of studies in astrocytes, identify these cells as a source of TGF-β1, 
TGF-β2, and TGF-β3 with all TGF-β receptors expressed (Anderson et al., 
1995; Constam et al., 1992; Morganti-Kossmann et al., 1992). 
Retinal astrocytes emerge from precursor cells that express Pax 2 and the 
platelet derived growth factor receptor α (PDGFRα) in the optic nerve head 
and migrate just ahead of the developing vascular network to form a template 
for the developing retinal vasculature (West et al., 2005; Fruttiger, 2002; 
Sandercoe et al., 1999; Zhang & Stone, 1997; Fruttiger et al., 1996; Jiang et 
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al., 1995; Huxlin et al., 1992; Ling et al., 1989; Watanabe & Raff, 1988; Stone 
& Dreher, 1987).  Astrocytes invade the retina from around 14WG in humans, 
and begin to express low levels of GFAP, which increases during 
development and into maturity (Gariano, 2003). 
Little is known about the guidance mechanisms that determine the pattern of 
the vascular template. Only species with vascularised retinas are known to 
have retinal astrocytes (Gariano et al., 1996; Schnitzer, 1987), and 
disturbances to the astrocytic network strongly affect vascular patterning 
(Fruttiger et al., 1996). Once astrocytes migrate beyond the retinal 
vasculature where it is hypoxic, they differentiate, altering their shape and 
increasing their branching, known as stellation, to attach to blood vessels, 
where they end their migration (Zhang et al., 1999). 
Hypoxia induces retinal astrocytes to express VEGF which causes astrocytes 
to undergo stellation and promotes endothelial cell proliferation and migration 
(Zhang et al., 1999; Provis et al., 1997; Pierce et al., 1996; Stone et al., 1995; 
Laterra et al., 1990). The endothelial cells at the leading edge of 
vascularisation possess filopodia that follow the accompanying astrocytic 
template and appear directly influenced by VEGF (Gerhardt et al., 2003). As 
the hypoxic front moves to the new edge of retinal vessels, migrating 
astrocytes repeat this process until the entire retina is covered by astrocytes 
(Zhang et al., 1999).  
Astrocytes may therefore direct endothelial cell growth and guidance during 
retinal developmental angiogenesis by secretion of VEGF and also the 
expression of adhesion molecules such as R-cadherin (Dorrell et al., 2002). 
In the mouse retina, superficial and deep vascular layers were shown to use 
filopodial extensions and R-cadherin cell adhesion molecules as guidance 
cues (Dorrell et al., 2002). Co-staining for GFAP (astrocytes) and collagen IV 
(endothelial cells) showed a strong correlation between the pattern of retinal 
vessels and retinal astrocytes. Endothelial cells were never observed in 
regions without underlying astrocytes in the superficial vascular plexus. 
During the initial formation of the deeper vascular plexus no GFAP+ cells 
were observed. However, in the later stages, GFAP+ cells resembling Müller 
cells were seen between the inner nuclear and outer plexiform layers where 
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the deep vascular plexus had formed. In association with astrocytes, 
filopodial processes were noted extending from endothelial cells at the 
developing vascular front and at the tips of migrating endothelial cells as 
vessels branched to form the interconnections with the deep vasculature. 
Antibodies to R-cadherin found in astrocytes and in filopodial extensions of 
endothelial cells resulted in incomplete retinal vascularisation with an 
unaffected astrocytic template (Dorrell et al., 2002).  
Astrocyte proliferation and migration across the retina is also thought to be 
due to platelet derived growth factor (PDGFa) produced by retinal neurons 
(Fruttiger et al., 1996; Mudhar et al., 1993). However, it is not clear whether 
hypoxia induces PDGFa upregulation (Zhang et al., 1999). When transgenic 
mice contained astrocytes which produced PDGFa themselves there was an 
initial hyperproliferation of astrocytes and blood vessels, but cell proliferation 
still stopped within a week after birth as seen in normal mice, suggesting that 
other factors limit retinal astrocyte proliferation even when PDGFa is in 
excess, raising the possibility of TGF-β being one such factor (West et al., 
2005). 
When the astrocyte number is greatly increased by overexpression of 
PDGFa, there is a proportional overgrowth of retinal vessels (Fruttiger et al., 
1996). Furthermore, when rats are subjected to a cyclic hyperoxic 
environment, there is a depletion of superficial retinal vessels followed by 
neovascularisation with death of astrocytes and defects in the glia limitans of 
retinal vessels resulting in microaneurysms (Zhang & Stone, 1997).  In a 
hypoxic environment, retinal vessels hypertrophy beyond the astrocytic 
template, astrocytes degenerate and breaches in the glia limitans of large 
veins occur with subsequent bleeding into the vitreous (Zhang & Stone, 
1997). Astrocytes clearly play an important role in constraining newly formed 
retinal vessels to the retina and maintaining vascular structural integrity 
(Zhang & Stone, 1997).  
Factors that stimulate astrocyte proliferation in vitro are: PDGF, EGF, FGF-2 
and IL-1 which is consistent with findings that PDGF, EGF and interleukin 1 
(IL1) are found in developing CNS (Hunter et al., 1993; Yeh et al., 1991; Huff 
& Schreier, 1989; Giulian et al., 1988; Kniss & Burry, 1988; Richardson et al., 
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1988; Walicke & Baird, 1988; Giulian & Lachman, 1985; Fallon et al., 1984; 
Leutz & Schachner, 1981). 
Mitogenic (induces mitosis) response of astrocytes to PDGF, EGF, FGF-2 
and IL1 is inhibited by each of the isoforms TGF-β1, TGF-β2 and TGF-β3 
without TGF-β itself directly affecting the rate of astrocyte proliferation (Close 
et al., 2005; Sousa Vde et al., 2004; Bachoo et al., 2002; Doetsch et al., 
2002; Rabchevsky et al., 1998; Hunter et al., 1993; Huff & Schreier, 1990; 
Leutz & Schachner, 1981). A small reduction in the rate of proliferation in 
astrocytes with TGF-β alone may be due to inhibiting the small amounts of 
PDGF and EGF that astrocytes produce in culture so that TGF-β may 
modulate response of astrocytes to growth factors and thereby control the 
rate of astrocyte proliferation in vivo (Hunter et al., 1993; Richardson et al., 
1988). For example, in cultured astrocytes, exogenous TGF-β1 inhibits 
proliferation and modulates the expression of cytoskeletal and ECM proteins 
such as fibronectin and laminin (Anderson et al., 1995; Laping et al., 1994; 
Baghdassarian et al., 1993; Hunter et al., 1993; Gallo & Bertolotto, 1990). 
TGF-β mostly inhibits growth of astrocytes (Bottner et al., 2000; Flanders et 
al., 1998; Hunter et al., 1993; Koontz & Hendrickson, 1993). The anti-
mitogenic effect of TGF-β is particularly noted with the presence of FGF-2, 
where FGF-2 would otherwise be a mitogen for astroglial cells (Bottner et al., 
2000); Flanders et al., 1993). Region specific responses of astrocytes to 
TGF-β1 have been reported where astroglial cell proliferation of brainstem 
but not forebrain is stimulated by TGF-β1 (Bottner et al., 2000; Johns et al., 
1992). TGF-β1 best suppressed proliferation induced by PDGF, and TGF-β3 
best suppressed FGF induced proliferation (Gomes et al., 2005; Hunter et al., 
1993).  
Early studies suggested  that TGF-β was not associated with retinal 
vasculature in human eyes (Lutty et al., 1991), however  intracellular TGF-β1 
and TGF-β2 were subsequently found in smooth muscle cells (SMC- 
associated with arteries, arterioles and large veins), in pericytes (abluminal 
on capillaries and small venules) and also in adventitia of large arteries (Lutty 
et al., 1993). Extracellular TGF-β1 was observed in pericytes, SMC, EC and 
their basement membrane (Lutty et al., 1993).  
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Vascular endothelial cell proliferation is regulated by TGF-β and interestingly 
TGF-β can be either antiangiogenic or angiogenic (Zhao & Overbeek, 2001a; 
Pepper, 1997). Although TGF-β induces growth inhibition and apoptosis of 
cultured EC (Siegel & Massague, 2003; Hyman et al., 2002; Goumans et al., 
2002; Hogg et al., 1999; Choi & Ballermann, 1995; Pepper et al., 1993; 
RayChaudhury & D'Amore, 1991) and an injection of TGF-β elicits an 
angiogenic response in vivo (Siegel & Massague, 2003; Yang & Moses, 
1990; Roberts et al., 1986) TGF-β is vital for vasculogenesis and 
angiogenesis during development (Siegel & Massague, 2003; Larsson et al., 
2001; Oshima et al., 1996; Dickson et al., 1995).  
In vitro studies have shown that TGF-β can inhibit proliferation of vascular 
endothelial cells and smooth muscle cells induced by FGF-1 and FGF-2 in 
both small and large vessels (Zhao & Overbeek, 2001a; Beck & D'Amore, 
1997; Pepper, 1997; Pasquale et al., 1993; Passaniti et al., 1992; Lutty et al., 
1991; Sato et al., 1990; Bensaid et al., 1989; Orlidge & D'Amore, 1987; Baird 
& Durkin, 1986; Eichler et al., 2004).  
TGF-β1 also inhibits chemotaxis of EC, tube formation and vascular tumour 
growth without inflammatory reactions (Zhao & Overbeek, 2001a; Dong et al., 
1996; Pepper et al., 1990; Pepper et al., 1991; Pepper et al., 1993; Mignatti 
et al., 1989; Muller et al., 1987).  
However, in inflammation, TGF-β has been shown to be angiogenic when 
administered subcutaneously to mice or rats, (Zhao & Overbeek, 2001a; 
Frank et al., 1994; Rubbia-Brandt et al., 1991; Sprugel et al., 1987; Roberts 
et al., 1986) when applied to the chick chorioallantoic membrane, (Zhao & 
Overbeek, 2001a;  Yang & Moses, 1990)  the  rabbit  cornea (Zhao & 
Overbeek, 2001a; Phillips et al., 1992; Phillips et al., 1993) or in the disc 
angiogenesis system (Zhao & Overbeek, 2001a; Fajardo et al., 1996). TGF-
β1 has been shown to promote the organisation of single EC embedded in 
three dimensional collagen gels into tube-like structures (Pepper et al., 1993; 
Merwin et al., 1990; Madri et al., 1988) playing an important function in 
vascular remodelling (Govinden & Bhoola, 2003; Pepper, 1997; Risau, 1997). 
All three isoforms have an effect on angiogenesis (Cox, 1995; Merwin et al., 
1991a; Merwin et al., 1991b). TGF-β3 is more potent than TGF-β1 and TGF-
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β2 in chicken chorioallantoic membrane assay in stimulating 
neovascularisation and in vascular rearrangements in vivo to help restore 
damaged vessels and increase blood flow in injured areas (Cox, 1995). This 
suggests that angiogenesis may be stimulated by VEGF and other 
angiogenic factors released by the chemoattractant effect on inflammatory 
cells and therefore a secondary effect (Govinden & Bhoola, 2003; Zhao & 
Overbeek, 2001a; Pasquale et al., 1993; Roberts & Sporn, 1989; Wahl et al., 
1987). 
TGF-β1 has a dose-dependent effect on angiogenesis, where low 
concentrations of TGF-β enhance, whereas high concentrations reduce, the 
invasiveness of cultured EC following treatment with angiogenic factors such 
as VEGF and FGF-2 (Govinden & Bhoola, 2003; Gajdusek et al., 1993; 
Pepper et al., 1993). The nature of the angiogenic response to TGF-β also 
depends on the presence of other cytokines in the endothelial 
microenvironment (Pepper et al., 1993). Overall, the response of cells to 
growth factors can be considered to be on the presence and concentration of 
other cytokines in surrounding environment, interactions between cells, 
cytokines and the ECM, and the organisation of the cells (Pepper, 1997).  
Recent studies may explain the contradictory effects of TGF-β on EC. EC 
express two TGF-β type I receptors activin receptor-like kinase 1 (ALK-1) 
and ALK-5 (TβRI). ALK-1 signalling via Smad-1 increases proliferation and 
migration of endothelial cells, whereas ALK-5 signalling via Smad-2 and 
Smad-3 inhibits these actions. These two effects may occur at different TGF-
β concentrations, providing a possible basis for the opposing responses 
depending on the amount of TGF-β (Siegel & Massague, 2003; Goumans et 
al., 2002; Oh et al., 2000). 
Astrocytes, as described above, express VEGF and TGF-β that blocks 
endothelial cell growth and induces their apoptosis in vitro (Eichler et al., 
2004; Eichler et al., 2001; Eichler et al., 2000; Behzadian et al., 1998; 
Behzadian et al., 1995; Ikeda et al., 1998; Pierce et al., 1995; Stone et al., 
1995). Although hypoxia is probably a cause of pathologic angiogenesis, it is 
not clear whether endothelial cells respond to the low oxygen directly or they 
react to signals via an autocrine/paracrine method. Pathological 
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angiogenesis secondary to conditions of ischemia and hypoxia is 
accompanied by expression of factors including TGF-β and VEGF 
(Behzadian et al., 1998; Damert et al., 1997; Dvorak et al., 1995; Ijichi et al., 
1995; Khaliq et al., 1995; Nomura et al., 1995; Pierce et al., 1995; Shima et 
al., 1995; Stone et al., 1995; D'Amore, 1994; Breier et al., 1992; Shweiki et 
al., 1992; Leung et al., 1989).  
Müller cell conditioned medium (MCM) from normoxic and hypoxic cultures, 
can stimulate or inhibit bovine retinal capillary endothelial cell proliferation 
respectively (Behzadian et al., 1998). Hypoxia activates the TGF-β released 
by Müller cells, and VEGF expression is enhanced by exogenous TGF-β and 
by hypoxia, supporting a primary role for glial cell-derived TGF-β in hypoxia 
induced angiogenesis (Behzadian et al., 1998).  
At low MCM concentrations the VEGF effect predominates over the TGF-β 
effect resulting in increased cell number but at high MCM concentrations the 
effect is reversed, as perhaps a threshold is reached at which the VEGF 
effect does not increase further and the TGF-β inhibiting activity begins. In 
the in vitro model, TGF-β at low concentrations is angiogenic (0.2-0.5ng/ml) 
but angiostatic at high concentrations (5-10ng/ml) (Behzadian et al., 1998; 
Pepper et al., 1993). This is also supported by the observation that 
overexpression of TGF-β in transgenic mice does not induce angiogenesis 
(Zhao & Overbeek, 2001a; Zhou et al., 1996; Lee et al., 1995; Sanderson et 
al., 1995; Wyss-Coray et al., 1995; Jhappan et al., 1993; Nabel et al., 1993; 
Pierce et al., 1993). 
Similarly, cultured Müller cells in a hypoxic environment release not only the 
proangiogenic cytokine VEGF but the antiangiogenic factors TGF-β2, PEDF 
and TSP-1 (Eichler et al., 2004). The proliferation of bovine retinal endothelial 
cells (BREC) was stimulated by elevated concentrations of VEGF alone but 
not if the Müller cell derived antiangiogenic factors; TGF-β2, PEDF or TSP-1 
were present. The PEDF levels in the Müller cell cultures were lower than 
those necessary to inhibit endothelial cell migration but sufficient to inhibit the 
growth of retinal endothelial cells (Eichler et al., 2004). Müller cells are 
thought to help control the onset of endothelial activation and 
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neovascularisation largely by releasing anti-angiogenic cytokines (Eichler et 
al., 2004). 
Since vascular cells express both type I and II receptors (Zhao & Overbeek, 
2001a; Obata et al., 1999; Srinivasan et al., 1998) TGF-β probably 
modulates retinal vascular development by directly acting upon vascular 
endothelial cells and/or pericytes promoting differentiation and physical 
interactions between them which leads to maturation of blood vessels 
(Antonelli-Orlidge et al., 1989). A subset of pericytes producing TGF-β is 
exclusively associated with stable vessels as exogenous TGF-β1 protects 
retinal capillaries against oxygen-induced loss through the induction of 
VEGFR-1 which provides protection against vessel degeneration (Shih et al., 
2003). Overexpression of TGF-β1 in endothelial cells causes hyperplasia 
(Shih et al., 2003; Schulick et al., 1998) and gene studies have shown that in 
embryos lacking TGF-β1 or TβRII receptor, contacts between vascular 
endothelial cells do not form or are disrupted in the yolk sac (Zhao & 
Overbeek, 2001a; Oshima et al., 1996; Dickson et al., 1995). Capillary like 
tubes are absent so that TGF-β1 deficiency markedly affects the 
establishment and maintenance of vessel wall integrity.   
Angiogenesis plays a major role in many blinding ocular diseases including 
retinopathy of prematurity (ROP), diabetic retinopathy (DR) and in “wet” 
(exudative) age-related macular degeneration (Zhao & Overbeek, 2001a; 
Campochiaro, 2000; Maslim et al., 1997). Proteins that counterbalance the 
effects of VEGF and modulate ocular angiogenesis, such as TGF-β have 
implications for treatment of ocular diseases caused by abnormal 
angiogenesis.  
In normal development, TGF-β may inhibit astrocyte proliferation within the 
central retina, retarding blood vessel growth and maintaining an avascular 
fovea. 
1.3 THESIS PROPOSAL 
Despite considerable evidence showing that the developing primate fovea 
‘needs’ a vascular supply, and expresses growth factors and conditions 
conducive for endothelial cells and accompanying astrocytes to grow into this 
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region, at no time during development is the incipient or developing fovea 
vascularised. In fact, as blood vessels approach the incipient primate fovea, 
proliferation of endothelial cells and astrocytes decreases in this region and 
along the horizontal meridian, with the FAZ defined prior to formation of the 
foveal depression. Furthermore, the incipient fovea with its impending 
metabolic demands is supplied predominantly by diffusion from the 
underlying choriocapillaris. 
Taken together, these observations suggest that a factor(s) with anti-
proliferative, anti-migratory and/or anti-angiogenic properties may be 
expressed in the incipient foveal region, prior to physical marking of the FAZ 
by astrocytes and endothelial cells (before 23 to 25WG in humans, and 
before ~fd100 in monkey). One candidate growth factor that may display 
these properties given appropriate conditions and cell types is Transforming 
Growth Factor- β (TGF-β).  
This thesis aimed to investigate the relationship between the metabolic 
demands of the primate retina, particularly the fovea, and its vascular supply 
during development. Further, the possible role of TGF-β in regulating the 
patterning of blood vessel growth during development, particularly in the 
incipient fovea, is investigated.  Specifically the thesis addressed the 
following questions:  
1. Does differentiation of the developing human retina, with onset of 
synaptic activity and associated increased metabolic demand, affect 
development of the human choriocapillaris? (Chapter 3) 
2. Does the incipient (avascular) human fovea express higher levels of 
TGF-β mRNA than peripheral retina, and how does this compare with 
adult retina? (Chapter 4) 
3. Is there a distinct spatial and temporal distribution of TGF-β and 
receptors (gene and protein) in the developing human and primate 
retina and does this reflect a relationship to the distinct pattern of 
blood vessel growth observed during development? (Chapter 5)
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2.1 SPECIMENS 
Human foetal eyes (13-19WG) were obtained from terminations of pregnancy 
with informed maternal consent, following approval from the Human Ethics 
Committee, University of Sydney. The gestational age was determined by 
preoperative obstetric ultrasound and dimensions of eyes including corneal 
diameter, equator and central cornea-to-foveal distance were recorded to 
compare size with age. Specimens that were appropriate for size and age 
were selected for RNA extraction or either frozen or paraffin sectioning 
depending on the experiment.  
Human adult eyes (10-40 years) were obtained from the NSW Lions Eye 
Bank with ethical approval from the Human Ethics Committee, University of 
Sydney. All these specimens had post mortem times less than 16 hours, and 
were used for RNA extraction.  
Macaque (Macaca fascicularis) eyes (Fd64-P11y) were obtained from Bogor 
Agriculture University, Indonesia with approval from the Ethics Committee of 
The University of Washington, Seattle, USA. Foetuses were delivered by 
caesarean section and euthanased by administration of intravenous 
barbiturate. Eyes were enucleated, fixed in methyl Carnoy’s and prepared for 
paraffin embedding. 
2.2 FIXATION AND FROZEN SECTIONING 
Following removal of the anterior segment and vitreous, eyecups were fixed 
for 2 hours in 2% paraformaldehyde in 0.1M phosphate buffered saline (PBS; 
pH 7.4), washed in PBS, and then placed in 30% sucrose in PBS at 4ºC for 3 
hours for cryoprotection. Eyecups were embedded in TissueTek OCT 
Compound (Sakura Finetek, Torrance, CA, USA), snap frozen in liquid 
nitrogen-cooled isopentane (BDH, Sydney, NSW, Australia) and stored at -
80ºC. Transverse frozen sections of 20µm thickness were cut on a Leitz 
1720 Kryostat (Leitz, Stuttgart, Germany) and collected onto poly-L-lysine 
(Sigma-Aldrich, Sydney, NSW, Australia) and gelatin coated slides (BDH). 
Four sections were collected per slide, and only sections passing through the 
incipient fovea and the optic disc were used for analysis. 
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2.3 FIXATION AND PARAFFIN SECTIONING 
The superior margin of the eye/s were marked using a fine suture. Methyl 
Carnoy’s fixative was prepared immediately before use as follows: 6ml 
methanol (4˚C), 3ml chloroform (4˚C), 1ml glacial acetic acid (room 
temperature - RT). Approximately 20-50µl fixative was injected into the 
vitreous chamber, via the pars plana, to gently 'inflate' the globe. The eye 
was then immersed in fixative and left overnight at 4˚C, then placed in 100% 
methanol. A scalpel blade was used to remove the superior calotte in the 
horizontal plane, approximately at the level of the superior border of the iris 
(Figure 2.1), and the eye was then stored in 70% alcohol. For eyes that were 
fixed in 2% paraformaldehyde, both superior and inferior calottes were 
removed.  
For sectioning, eyes were washed in several changes of 100% methanol and 
then processed for paraffin embedding (Leica ASP 200 Automated Tissue 
Processor). Specimens were embedded with the superior cut edge facing 
down and sectioned in the horizontal plane at 10µm (Finesse 325). Only 
sections through the optic disc and fovea were analysed.  
2.4 RNA EXTRACTION 
Whole retinas were used for RNA extraction, except for analysis of TGF-β 
using quantitative PCR (QPCR) (Chapter 4). For QPCR experiments, a 5 mm 
trephine of retina from the central retina including the incipient fovea, and 5 
mm trephine from the nasal retina was used; RNA was extracted from each 
sample separately.  
To extract RNA, retinas were carefully placed in a sterile 1.7ml eppendorf 
tube, and homogenised in 200µl of Trizol (Invitrogen) using a tissue pestle. A 
further 600µl of Trizol was added, followed by incubation at RT for 7 minutes. 
Then, 200µl of cold chloroform was added and tubes were shaken vigorously 
for no more than 20 seconds, and centrifuged at 13000 rpm at 4˚C for 15 
minutes. 
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FIGURE 2.1 Diagram showing the position of the horizontal incision 
(dashed line-superior calotte, dotted line-inferior calotte). The location of 
the suture is shown in orange. s: superior; n: nasal; i: inferior; t: temporal; 
a: anterior; p: posterior.  
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The aqueous layer (containing about 600µl RNA) was removed to clean 
tubes, mixed gently with 400µl of cold isopropyl alcohol, and RNA 
precipitated by incubating at -20˚C for 20 minutes to increase the yield of 
extracted RNA. RNA was pelleted by centrifugation at 13000 rpm, 4˚C for 15 
minutes, the supernatant discarded and the pellet washed in 1ml 75% 
ethanol, at 7500 rpm, 4˚C for 15 minutes, and air dried at RT for 
approximately 10 minutes. The RNA was dissolved in 25µl RNAse free 
water, incubated at 42˚C for 10 minutes and then stored at -80˚C. RNA 
quantity and purity was determined by spectrophotometer (Biorad 
SmartSpecTM3000), and samples with an absorbance ratio of A260/A280 > 
1.8 were used for analysis. 
2.5 POLYMERASE CHAIN REACTION (PCR)                                             
Target nucleotides for TGF-β1, TGF-β2 and TGF-β3 were identified from the 
National Centre for Biotechnology Information (NCBI) GenBank. PCR 
primers with sequences complementary to the known sequences flanking the 
target DNA were designed for TGF-β1, TGF-β2 and TGF-β3, and primers 
were synthesised by Sigma Genosys Australia. Forward and reverse primers 
used are shown in Tables 2.1 and 2.2.  
For QPCR, the amplicon length (between the forward and reverse primers) 
was less than 150bp and the primers themselves were around 20 bases to 
optimise the efficiency of real time QPCR.  
For riboprobe design, the amplicon length was longer, 200-400 bp for TGF-
β1 (267 base pairs (bp)), TGF-β2 (225 bp) and TGF-β3 (367 bp) so as to 
improve visualisation of target mRNA.  
Protein Accession number 
Forward primer  
Sequence 5’ to 3’ 
Reverse primer  
Sequence 5’ to 3’ 
Amplicon 
size (bp)
TGF-β1 X02812 GCAACAATTCCTGGCGATAC CTAAGGCGAAAGCCCTCAA 136 
TGF-β2 NM03238 CATCCCGCCCACTTTCTAC AATCCGTTGTTCAGGCACTC 148 
TGF-β3 X14149 CGAGTGGCTGTTGAGGAGAG CATTGGGCTGAAAGGTGTG 80 
TABLE 2.1 Primers used for QPCR 
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Protein Accession number 
Forward primer  
Sequence 5’ to 3’ 
Reverse primer  
Sequence 5’ to 3’ 
Amplicon 
size (bp)
TGF-β1 X02812 AACCCACAACGAAATCTATGAC ACTCCGGTGACATCAAAAGATA 267 
TGF-β2 NM03238 AAGCAGAGTTCAGAGTCTTTCG AATCCCAGGTTCCTGTCTTTAT 225 
TGF-β3 X14149 AGTCGGAATACTATGCCAAAGA GTTGGACTCTCTTCTCAACAGC 367 
TABLE 2.2 Primers used for reverse transcriptase PCR 
(RTPCR) and Riboprobe Design 
RNA (1-5µg) was reverse transcribed to cDNA using the Superscript TM II 
Firststrand Synthesis System for Reverse Transcriptase PCR (Invitrogen, Ca, 
USA). The following RNA/Primer mixture was prepared: 1µg RNA, 1µl 10nM 
DNTP mix, 1µl Oligo (dT) (0.5µg/µl) with remaining volume up to 10µl 
provided by DEPC treated water.  
Samples were incubated for 5 minutes at 65˚C and then placed on ice for 1 
minute. The following reaction mixture was prepared: 2µl 10x RT-Buffer 
(PCR buffer), 4µl 25mM MgCl2, 2µl 0.1M DTT and 1µl RNAse Out (RNAse 
inhibitor) and 9µl of reaction mixture was added to each tube, mixed gently 
and collected by centrifugation, then incubated at 42˚C for 2 minutes. Finally, 
1µl of Superscript II RT was then added to each tube (except for the negative 
controls), mixed and incubated at 42˚C for a further 50 minutes.  
The reaction was terminated by increasing the temperature to 70˚C for 15 
minutes, followed by chilling on ice. The reactions were collected by brief 
centrifugation and 1µl of RNAse H was added all samples to remove any 
remaining RNA, with a further incubation of 20 minutes at 37˚C. cDNA was 
stored at –20˚C for a maximum of 2-3  months. 
PCR was performed using Biotaq Red DNA polymerase kit (Bioline, stored at 
-20˚C) and the following reaction mixture: 2.5µl 10x NH4 buffer, 1.25µl MgCl2 
50mM solution, 2.5µl 100mM dNTP mix, 0.5µl BIOTAQ red enzyme, 14.75µl 
RNAse free water, 1µl ss cDNA template (see above), 1.25µl TGF-β Forward 
& 1.25µl TGF-β Reverse primer (10µM). The final program for RTPCR was 
as follows: denaturating at 94˚C for 3min, and amplified through 40 cycles 
with denaturing at  94˚C for 25s, annealing at 58˚C for  25s, followed by 
extension at 72˚C for 25s, with a final extension of 72˚C for 5min 
(PCRExpress, Hybaid Sciences). PCR products and DNA ladder were run at 
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100V on 1% agarose gels using TBE buffer and 0.2ng/ml ethidium bromide. 
Gels were viewed under UV light using a GelDoc system (UVitech) and 
images taken using WinFast Software. 
Spectrophotometry (Biorad SmartSpecTM3000) was used to measure the 
concentration of dsDNA as follows:  
concentration 
dsDNA (µg/ml) = 
absorbance 
@ 260nm x 
dilution factor 
(mL) x 
dsDNA constant 
(50µg/ml)* 
*absorbance of 1 at A260=50µg/ml 
2.6 QUANTITATIVE PCR  
The Superscript II Synthesis System was used with the Platinum SYBR 
Green qPCR Supermix UDG kit (Invitrogen, USA) to detect quantitative 
changes in RNA expression. SYBR Green is a fluorescent dye that binds 
directly to double stranded DNA (dsDNA); as the dsDNA accumulates, the 
dye generates a signal proportional to the concentration of DNA, that can be 
detected by a real-time PCR machine.  
The following components per sample were prepared on ice as a master mix: 
12.5µl Platinum SYBR Green qPCR SuperMix-UDG, 0.5µl TGF-β Forward 
primer (10mM), 0.5µl TGF-β Reverse primer (10mM) and 6.5µl of RNAse 
free water. Forward and reverse primers for housekeeping genes including 
for β-actin, GAPDH and 18sRNA were used to determine an endogenous 
standard. A total of 0.5µl of cDNA was used per reaction.  
A two-step cycling program was carried out in the Rotorgene 3000 thermal 
cycler (Corbett Research, Australia) (Table 2.3). Rotorgene version 6.0 
(Corbett Research, Australia) was used to interpret the intensity of the 
fluorescent signal and thus DNA synthesis in real time, by providing a 
platform to analyse comparative quantitation and melt curves through graphs 
and tables. The tables were then converted into Excel spreadsheets and 
analysed (see Chapter 4).  
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Number of 
cycles 
Reaction temperature 
(C˚) 
Time per 
cycle 
1 50 2 min 
1 95 2 min 
40 95 15 s 
40 60 30 s 
TABLE 2.3 Cycling program for QPCR 
2.7 RIBOPROBE PREPARATION 
As described in Section 2.4, RNA isolated from human foetal retinas was 
reverse transcribed to cDNA and amplified by PCR amplification using 
specific primers.  
PCR products were purified by gel extraction and inserted into a pGemT 
Easy DNA vector (Promega), cloned in heat-shocked competent cells 
(JM109, Promega), purified, further grown up in E. coli cells and further 
purified using Miniprep (QIAprep Miniprep) and  Midiprep (Jet Star) kits. DNA 
was used as a template for preparing digoxigenin (DIG)-labelled riboprobes 
for in situ hybridisation. 
Following PCR amplification, DNA was run on 2% agarose gels, and 
extracted and purified from using QIAquick Gel Extraction Kit (Qiagen). The 
purity was checked on UV spectrophotometer (Biorad SmartSpecTM3000, 
A260/A280=1.7-2.1) and stored at -20ºC until used.   
The PCR product was ligated using a pGEM-T vector kit (Promega) with a 
vector: insert ratio of 1:1 (50ng:50ng). The product was cloned in JM109 
competent cells using the pGEM-T vector system protocol. Briefly, cells were 
heat shocked for 30 seconds in a water bath at 42ºC without shaking, and 
returned to ice immediately for 2 minutes. Cells were plated and incubated 
overnight at 37ºC. A single white colony containing the insert was selected 
and grown overnight in LB/ampicillin (50mg/ml) at 37ºC in a shaking 
incubator. (NB: Blue colonies contain β-galactosidase activity coded by the 
Lac Z gene and rarely contain the insert). The QIAprep Spin Miniprep Kit 
Protocol was used to purify high-copy plasmid DNA, which was run on 1% 
agarose gels and measured by spectrophotometry. 
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Samples were subsequently sent for sequencing to Supamac (University of 
Sydney). Once sequencing was done and orientation of fragment sequence 
was confirmed as correct, the bulk plasmid was grown in E. coli cells. 
Purification was then performed using Jet Star Midi Prep columns. Briefly, 
cells were pelleted by centrifugation, resuspended and lysed before loading 
on equilibrated columns; plasmid DNA was eluted and precipitated, then 
washed and recentrifuged in ethanol. The DNA plasmid pellets were dried 
and redissolved in 50µl TE and quantified using the spectrophotometer (2µl 
DNA solution in 98µl TE).  
Plasmid DNA was linearised to produce the sense and anti-sense templates 
which constituted the riboprobes. To linearise plasmid DNA, reactions were 
set up as follows: 10µl plasmid (4000µg/ml), 10µl of 10x restriction buffer, 
0.7µl BSA, 4µl restriction enzyme of choice (e.g. Sal-1, Nco-1 (GE 
Healthcare) and 45.3µl RNA free water was combined for 3 hours at 37ºC. 
The presence of linearised plasmid DNA was confirmed on a 1% agarose 
gel, and plasmids stored at -20ºC. 
Plasmid template DNA was purified using phenol:chloroform: isoanylalcohol 
(25:24:1) with centrifugation at 13000 rpm for 5 minutes at 4ºC. The aqueous 
layer  was collected in clean eppendorf tube, and mixed with 3M Na-Acetate 
and 100% cold ethanol by inversion. The DNA was stored at -20ºC overnight, 
then spun at 13000 rpm for 15 minutes at 4ºC and the supernatant 
discarded. The DNA pellet was dislodged and washed in 70% cold ethanol, 
then centrifuged at 10000 rpm for 10 minutes at 4ºC. The supernatant was 
discarded and the DNA pellet was air dried before resuspending in 20-30µl of 
DEPC-treated water. The purified plasmid template DNA was assessed by 
spectrophotometer and run on a 1% agarose gel. 
Riboprobes were prepared by adding 1µg of DNA template (e.g. TGF-β1 nco, 
TGF-β1 sal) to DEPC-treated water to a final volume of 13µl. On ice, 2µl 10x 
NTP labelling mixture, 2µl 10x Transcription buffer, 1µl RNAse inhibitor and 
2µl RNA polymerase (SP6 or T7, Roche) were added, so that TGF-β1 sal-I 
T7, TGF-β2 sal-I T7 and  TGF-β3 nco-I SP6 made “sense” strands and TGF-
β1 nco-I SP6, TGF-β2 nco-I SP6 and TGF-β3 sal-I T7 made “antisense” 
strands. After gentle mixing, this mixture was incubated at 37ºC for 2 hours, 
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then 2µl of DNAse I was added to remove the DNA template, followed by a 
further incubation at 37ºC for 15 mins. The reaction was stopped by adding 
2µl of 0.2M EDTA pH 8.0. 
Probes were purified by adding 2.5µl 4M LiCl (to prevent DNA precipitation) 
and 60µl ice-cold 100% ethanol to the final reaction product. After mixing, 
probes were left at -20ºC overnight to precipitate RNA. Riboprobes were 
centrifuged at 13000 rpm for 15 mins at 4ºC, the supernatant removed and 
the pellet washed in 100µl of ice-cold 70% ethanol. After further 
centrifugation at 13000 rpm for 5 mins at 4ºC, the supernatant was again 
discarded and the pellet air dried. The pellet was finally resuspended in 50µl 
of DEPC-treated water. The riboprobes were run on a 1% agarose gel to 
confirm their presence. 
A dot-blot dilution method on dry nylon positively-charged membrane 
(BIODYNE B 0.45µm – Pall, Gelman Sciences) was used to quantify the 
probes. Serial dilutions (1µl) of RNA standards or ribroprobes (unknown 
concentration) were blotted and subsequently fixed to the dry membrane with 
1 min UV exposure.  The membrane was subsequently washed in a Washing 
Buffer (0.1mM maleic acid, 0.15mM NaCl and 0.3% Tween 20) for 1 min and 
incubated in Blocking Buffer (Blocking Reagent (Roche) dissolved in maleic 
acid) for 30 mins. The membrane was then incubated in 1:5000 anti-DIG-AP 
(Fab fragments) antibody (Roche) for 30 mins, and washed twice in Washing 
Buffer for 15 mins. The membrane was then rinsed in Detection Buffer 
(0.1MTris-HCl, 0.1M NaCl, 10mM MgCl2, pH 8.0) for 2 mins. Dots were 
visualised using NBT/BCIP colour substrate (Roche; 200µl in 10ml Detection 
Buffer) added in the dark. The colour reaction was stopped in RNase-free 
water when the most dilute control dot was just visible. The RNA 
concentration was estimated by comparison with dilutions of the RNA 
standards. 
2.8 IN SITU HYBRIDISATION 
Paraffin sections were dewaxed in xylene and hydrated through a graded 
series of alcohols. Following an initial rinse in PBS for 5 minutes, frozen or 
dewaxed paraffin sections were fixed in 10% Neutral Buffer Formalin (NBF) 
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for 20 mins, then washed twice in PBS for 5 mins. Sections were incubated in 
20µg/ml Proteinease K for 7 mins at 37ºC, rinsed in PBS for 5 mins, then re-
fixed in 10% NBF for 20 mins, followed by incubation in 0.1M triethanolamine 
(TEA, pH 8.0) supplemented with 630µl of acetic anhydride for 10 mins. 
Slides were then washed in PBS for 5 mins, then 0.9% NaCl for 5 mins, 
dehydrated through graded ethanols and air dried.  
The pre-hybridisation solution without probe was pre-heated to 65 ºC before 
being applied to the sections under a coverslip. The hybridisation mixture 
with probe was heated at 55 ºC for at least 2 mins, then 100-150µl added; 
slides were then placed in a hybridisation chamber (containing 50ml of 50% 
formamide, 25ml of 20x SCC, 25ml of milliq water) and incubated at 55 ºC for 
90 mins. Optimal temperatures were determined on several preliminary 
experiments. 
Sections were washed in posthybridisation washes as follows; twice in 4x 
SSC (saline sodium citrate pH7.4) at 60 ºC for 30 min, twice in 2x SSC at 60 
ºC for 45 min, once in 1.0x SSC at 60 ºC for 30 min, twice in 0.1x SSC at 60 
ºC for 30 min and once in 0.1x SSC at RT for 5 min. 
For DIG detection, slides were rinsed in Washing Buffer and blocked in 
Blocking Buffer for 30 min, then incubated for 1 hour in anti-DIG-AP antibody 
diluted 1:2000 in Blocking Buffer. Slides were washed twice in Washing 
Buffer for 15min, then rinsed in detection buffer (0.1M Tris HCl, 0.1M NaCl, 
10mM MgCl2 pH8.0) for 5 min. Sections were incubated in colour substrate 
(10µl HNPP solution (Roche), 10µl solution Fast Red (Roche, 2.5mg 
/0.0025g powder dissolved in 100µl RNAfree water), 980µl detection buffer) 
for 1 hour at 37°C to produce a red fluorescence. The reaction was stopped 
in water for 10 min. Sections were rinsed twice in PBS for 5 min, then 
coverslipped or prepared for immunohistochemistry (see Section 2.9). For 
immunohistochemistry, sections were blocked in 10% normal goat serum for 
30 min, incubated with appropriate primary antibody overnight at 4˚C, 
followed by secondary antibody for 30 min. After a final rinse in PBS, 
sections were coverslipped with Universal mounting medium (Open 
Biosystems). 
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2.9 IMMUNOHISTOCHEMISTRY 
Paraffin sections were dewaxed in xylene and hydrated through graded 
alcohols. Following an initial rinse in PBS for 5 minutes, frozen or dewaxed 
paraffin sections were placed in 0.01M citrate buffer (pH 6.0) with 0.4% 
saponin at 80ºC for 5 minutes to enhance antigen detection. After cooling to 
room temperature and further rinsing in PBS for 10 minutes, slides were 
incubated in 10% normal serum (species in which the secondary antibody/ies 
was raised) in PBS for 60 minutes, to reduce non-specific immunolabelling. 
Sections were incubated in either one or two primary antibodies (Table 2.4) 
at 4ºC overnight. After rinsing in PBS for 10 minutes, sections were 
incubated for 60 minutes at RT in secondary antibody fluorochrome/s 
conjugates (Table 2.5, 1:1000; Molecular Probes) in a light proof slide box. 
After rinsing in PBS for 10 minutes, sections were coverslipped with 
glycerol/PBS/DABCO (Triethylenediamine; Sigma) and sealed with nail 
varnish or Universal mounting medium. Negative controls, omitting the 
primary antibody, and using non-specific isotype control antibody or 
immunoglobulins were included in each experiment. 
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TABLE 2.4 Primary antibodies - Species, dilution, manufacturer and 
labelling site. 
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Secondary antibody 
Species Dilution Manufacturer 
Alexa 594 
Goat anti-rabbit 1:1000 Molecular Probes 
Alexa 488 
Goat anti-mouse 1:1000 Molecular Probes 
TABLE 2.5 Secondary antibodies - species, dilution and manufacturer 
2.10 CONFOCAL MICROSCOPY, IMAGING AND DATA 
ANALYSIS 
Image analysis aims to provide quantitative data from images including 
number of immunoreactive structures or intensity of immunolabelling. In 
Chapter 3, a Leica laser scanning confocal microscope using Leica TCSNT 
software version 1.6.587 (Leica Microsystems, Germany) was used to 
capture images as z-series. These were combined to measure the number of 
Ki-67 immunolabelled mitotic endothelial cells and the area of the CD34 
immunolabelled choriocapillaris. Adobe Photoshop version 5.0.2 was used in 
preparing the images for measurement and NIH software (version 1.62 
http://rsb.info.nih.gov/nih-image/) macros were used to quantify relevant 
parameters (area and proliferation). Measurements were recorded and 
analysed in Excel.  
In Chapter 5, the intensity of mRNA expression was quantified by preparing 
montages of confocal images captured with LSM 5 Pascal (Carl Zeiss) 
software in Adobe Photoshop version 7.0. The montages were then re-
imported into the LSM 5 Pascal software, and measurement tools were used 
to measure the intensity across each montage. Results were compiled in an 
Excel database and presented graphically. 
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CHAPTER 3 – ENDOTHELIAL CELL PROLIFERATION 
IN CHORIOCAPILLARIS 
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The study described in this chapter has been published in the following 
paper:  
Allende A, Madigan MC and Provis JM (2006) Endothelial Cell Proliferation in 
the Choriocapillaris During Human Retinal Differentiation. Br J Ophthalmol. 
90:1046-1051. 
3.1 INTRODUCTION 
The choroid develops early, with primitive endothelium-lined elements 
present in the mesenchyme surrounding the anterior optic cup as early as 29 
days’ gestation, and its development into a loosely stratified aggregation of 
vessels being largely complete by 24 weeks’ gestation (WG) (Heimann, 
1972; Ozanics et al., 1978). The choriocapillaris is the innermost capillary 
layer of the choroid. It comprises a close, thin-walled, highly permeable 
network of endothelial cells (EC) with little or no basement membrane 
material, and supplies the neural retina by diffusion across the retinal 
pigmented epithelium (RPE) and Bruch’s membrane. Little is known about 
mechanisms that regulate choroidal growth as only recently groups have 
began to look at mechanisms of development in the choroid (Steinle et al., 
2005; Saint-Geniez et al., 2006; Hasegawa et al., 2007). 
In contrast, development of the retinal vasculature is better understood and 
the mechanisms regulating its growth and development are well documented. 
The retinal vessels form later than those in the choroid, the first vessels 
forming at the optic disc at approximately 14WG, the final stage of 
development being formation of the perifoveal capillary plexus just after birth 
(Michaelson, 1948; Nilhausen, 1958; Mann, 1964; Ashton, 1970; Provis et 
al., 1997; Provis, 2001). Initially the retinal vessels grow in a lobular 
arrangement, each lobule defining the territories of one of the quadrantic 
arteries of the mature retina (Michaelson, 1954; Patz, 1966; Provis et al., 
1997; Sandercoe et al., 1999). Nasal to the optic disc the superior and 
inferior lobes merge along the equator at ~20WG. Temporally, the superior 
and inferior lobes of vasculature skirt around the foveal region to meet along 
the equator, peripheral to the foveal region, at ~25WG (Gariano et al., 1994; 
Provis et al., 2000; Provis, 2001). The long trajectory of temporal vessels,  
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combined with a slow growth rate (Engerman, 1976), results in the central 
retina remaining avascular for a much longer period than other parts of the 
retina. The central fovea itself is not normally vascularized at any stage of 
development (Gariano et al., 1994; Provis et al., 2000). 
It has been argued that development of the retinal circulation is determined 
by the ability/inability of the choroid to deliver nutrients to the retina (Chase, 
1982; Stone, 2006). Indeed, it is widely accepted that formation of the retinal 
vasculature is induced by a transient hypoxia associated with increased 
metabolic activity in maturing retinal neurons and photoreceptors, resulting in 
the proliferation and migration of retinal endothelial cells, mediated by growth 
factors including HIF1-α and VEGF (Stone et al., 1995; Stone, 1997; Ozaki et 
al., 1999; Semenza, 2000; Morita et al., 2003). Because the retina matures 
from centre (fovea) to periphery, the differentiation patterns of the neural 
retina and its retinal vasculature are not well matched. In humans, all of the 
retinal layers are evident and there is a full complement of cells at the 
incipient fovea by 11WG (Provis & van Driel, 1985; Linberg & Fisher, 1990), 
but the perifoveal capillary bed does not begin to form until 25WG and is not 
complete until after birth. This delay in central retinal vascularization means 
that the metabolic demands of rapidly maturing central neurons are supplied 
by diffusion from the choroid, along with some diffusion from the hyaloid 
vessels via the vitreal body, until relatively late in development (Michaelson, 
1954; Bernstein & Hollenberg, 1965). 
In this study, it was hypothesized that during the period when the central 
retina is largely avascular, metabolic activity in central retinal neurons might 
be supported by increased capacity in the choriocapillaris, reflected by 
increased proliferation of choriocapillaris EC. Consistent with the accepted 
mechanism of retinal vascularization (Michaelson, 1948; Stone et al., 1995), 
it was predicted that maturation of neurons at the incipient fovea and 
adjacent retina might drive EC proliferation in the adjacent choriocapillaris 
during the early phases of retinal vascular development. The results, 
however, indicate that proliferation of choroidal EC is not regulated by 
maturation of retinal neurons. 
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3.2 MATERIALS AND METHODS 
Please refer to Chapter 2 for a more detailed explanation of methods. 
SPECIMENS 
Five human foetal eyes aged 14, 15, 17, 17.5 and 18.5WG were obtained 
from terminations of pregnancy with informed maternal consent, following 
approval from the Human Ethics Committee, University of Sydney. 
Gestational age was determined by preoperative obstetric ultrasound and 
post mortem ocular morphometry. Following removal of the anterior segment 
and vitreous, eyecups were fixed for 2 hours in 2% paraformaldehyde/0.1M 
phosphate buffered saline (PBS; pH7.4), washed in PBS, and then placed in 
30% sucrose/PBS at 4ºC for 3 hours for cryoprotection. Eyecups were 
embedded in TissueTek OCT (Sakura Finetek, Torrance, CA, USA), snap 
frozen in liquid nitrogen-cooled isopentane (BDH, Sydney, Australia) and 
stored at -80ºC. Transverse frozen sections (20µm) were cut on a Leitz-
1720-cryostat and collected onto poly-L-lysine (Sigma-Aldrich, Sydney, 
Australia) and gelatin coated slides (BDH). Only sections passing through the 
incipient fovea and the optic disc were used for analysis. 
IMMUNOHISTOCHEMISTRY 
After rinsing in PBS, sections were placed in 0.01M citrate buffer (pH 6.0) 
with 0.4% saponin at 80ºC for 5 minutes to enhance antigen detection. They 
were cooled to room temperature, rinsed, then blocked in 10% normal goat 
serum (NGS) in PBS for 60 minutes. Sections were incubated in polyclonal 
rabbit anti-human Ki-67 antibody (1:50) to label proliferating cells, and 
monoclonal mouse anti-human CD34 antibody (1:100) to label the vascular 
endothelium (Sandercoe et al., 1999), at 4ºC overnight. After rinsing in PBS, 
sections were incubated for 60 minutes in goat anti-rabbit Alexa-488 (1:1000; 
Molecular Probes) to detect bound anti-Ki-67 and goat anti-mouse Alexa-594 
(1:1000; Molecular Probes) to detect bound anti-CD34. Sections were then 
rinsed in PBS, mounted in glycerol/DABCO (Triethylenediamine; Sigma) and 
coverslipped. A negative control, omitting the primary antibody, was included 
in each experiment. 
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CONFOCAL MICROSCOPY 
For each specimen, three sections from three different slides were analysed. 
Fifteen areas/section were sampled (135 sample areas/specimen) and 
subsequently grouped into five chorioretinal regions – incipient fovea (foveal, 
F), peripheral (nasal, N; temporal, T) and transitional/intermediate regions 
(nasofoveal, NF; temporofoveal, TF) - using morphological criteria (Figure 
3.1A). The incipient fovea was identified by (1) the absence of proliferating 
cells, (2) the presence of cone photoreceptors only (no rods), and (3) the 
presence of all characteristic layers of the neural retina (Provis et al., 1985). 
The peripheral regions (T and N) were identified as having only a 
differentiated ganglion cell layer (GCL), the deeper retina having no layers 
and comprising a maximum density of Ki-67 immunoreactive (IR) cells 
(Walcott & Provis, 2003). The intermediate regions (TF and NF), like the 
peripheral ones, had a fully differentiated GCL and partially differentiated 
outer retina containing relatively few (<15) Ki-67-IR cells. 
Sections were imaged using a Leica upright scanning laser confocal 
microscope (Leica TCSNT software, version 1.6.587). An argon-krypton laser 
with dual filters for maximum excitation (488nm and 594nm) was used to 
visualise anti-Ki-67-IR (Alexa-488) proliferating cells and anti-CD34-IR 
(Alexa-594) vascular endothelium respectively. Each sample area 
(250µmx250µm) was viewed using a 40x oil immersion objective. Ten optical 
z-sections at 1µm intervals were collected from each sample location (total of 
1350 images/specimen). Photomultiplier gain, offset, aperture and laser 
power settings were standardised and maintained for all measurements for 
comparisons between specimens. 
IMAGE ANALYSIS 
Counting Proliferating cells 
Immunolabelled confocal images were opened in Adobe Photoshop 5.0.2 
(Figure 3.1B) with z-sections of each field comprising different layers of each 
image. Proliferating cells were counted in each layer and identified as cells 
with a green-labelled (Ki-67-IR) nucleus within the red-stained (CD34-IR) 
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FIGURE 3.1 
A: Diagrammatic representation of sample areas analysed; inset showing 
central region (fovea shaded in blue). B: Adobe Photoshop image (250µm x 
250µm; 512 pixels x 512 pixels) of a chorioretinal sample showing Ki-67-IR 
proliferating cells (green) and the CD34-IR choriocapillaris endothelium (red). 
C: Single red channel, after blue and green channels are filled with black. 
The choriocapillaris is selected as shown by the white outline. D: Cropped 
image of the selected choriocapillaris. E: The inverted cropped image is 
imported into NIH Image in greyscale. F: Thresholding of the image into 
binary form, where red pixels above background are changed into black 
pixels. Measurement macros were then used to calculate the vascular area 
of the choriocapillaris.  
ONZ, outer neuroblastic zone; CC, choriocapillaris; RPE, retinal pigmented 
epithelium; BV, blood vessel 
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blood vessel wall, present in at least three adjacent layers. Each double-
labelled cell was counted only once. 
Estimating Choriocapillaris Area 
Layers were flattened and the green and blue channels filled with black to 
allow visualisation of the single red channel (Figure 3.1C). The length of 
choriocapillaris was a constant of 250µm (Figure 3.1D). The choriocapillaris 
was identified as the part of the choroid lying immediately adjacent to Bruch’s 
Membrane and containing no large vessels. The identified region of 
choriocapillaris was copied, pasted into a new Photoshop document, colour-
inverted, saved in TIFF format and imported into NIH Image software 
(version 1.62 http://rsb.info.nih.gov/nih-image/) with the units set to pixels 
(Figure 3.1E). Three estimates of area, which varied by no more than 4%, 
were taken from each flattened image and the average area recorded in 
pixels, and converted to microns (µm2).  
The amount of red in the background of each image was determined by 
sampling at least three vessel-free areas. After thresholding, each image was 
converted into binary form, (Figure 3.1F) and measurement macros used to 
calculate the vascular area using the “Compute Percent Black and White” 
command. All sections were processed in this way. Counts of proliferating 
cells versus CD34-IR choriocapillaris area were recorded in Microsoft Excel 
according to gestational age and chorioretinal region. The rate of cell 
proliferation in the choriocapillaris was calculated: (number of proliferating 
cells in a sample region)/(area of the choriocapillaris). 
STATISTICAL ANALYSIS 
After normalizing the data we used ANOVA to compare the fovea with other 
locations (NF, N, TF and T) at each age for (a) mean choriocapillaris area 
and (b) mean rates of choriocapillaris proliferation. To elucidate trends in 
choriocapillaris development we grouped the data based on degree of retinal 
differentiation. Prior to 16WG only a very small area of central retina is 
differentiated; after this age the differentiated region grows rapidly in size, 
beyond the incipient macular region. We use ‘<16WG’ and ‘>16WG’ to 
indicate these groups, respectively. Grouped data was tested for significance 
84 
Endothelial Cell Proliferation in Choriocapillaris 
using the Kruskal-Wallis and the Conover Inman post hoc tests (StatsDirect, 
p<0.05). 
3.3 RESULTS 
IMMUNOLABELLING 
The antibody to CD34 (red) consistently labelled cells in the choroid and 
choriocapillaris (Figure 3.2A and B). Few retinal blood vessels were identified 
at 14 and 15WG. In the 17 to 18.5WG specimens, endothelial cell labelling 
was evident at the nerve fibre layer/GCL interface, temporal to the optic disc. 
No labelling was present in control sections when primary antibody was 
omitted. 
Ki-67-IR (green), indicative of proliferating cells, was seen consistently 
throughout the choroid within the vascular endothelium and stroma (Figures 
3.2A and B, Figure 3.3) and in the nuclei of neuroblasts in undifferentiated 
retina of all specimens (Figure 3.2B, Figure 3.3).  In the choriocapillaris, the 
proliferating cells were most commonly seen on the sclerad aspect of vessel 
walls, away from the RPE. 
Proliferating cells were also seen in the optic nerve, in presumed endothelial 
cells in inner retina of some specimens, but rarely in the RPE. No labelling 
was present in control sections with the primary antibody omitted.  
Choriocapillaris Area  
The choriocapillaris endothelium appeared as CD34-IR, small-calibre profiles 
oriented parallel to the RPE (Figure 3.1). Vessels outside the choriocapillaris 
could be identified travelling obliquely over several sections, were generally 
larger in diameter, but not readily identifiable as belonging to either Sattler’s 
or Haller’s layer (Figure 1.4). 
Choriocapillaris area by location and age is illustrated in Figure 3.4. 
Measurements from the transitional areas (NF and TF) are omitted from 
Figure 3.4A for clarity. When choriocapillaris area at the foveal location is 
compared with nasal and temporal locations the differences are statistically 
significant (p<0.001, ANOVA), except for the foveal vs nasal samples at  
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FIGURE 3.2 Cell proliferation in 18.5WG human chorioretinal locations. 
A: In the incipient fovea (‘Foveal’ location), no Ki-67-IR proliferating cells 
(green, arrowheads) are present in the retina but are seen in the CD34-IR 
choriocapillaris (red). 
B: Numerous Ki-67-IR proliferating cells (green, arrows) are seen in the outer 
neuroblastic zone in a peripheral sample. In the choriocapillaris, proliferating 
cell nuclei are generally seen in vessel walls away from the retina 
(arrowhead).  
CC, choriocapillaris; INL, inner nuclear layer; ONL, outer nuclear layer; ONZ, 
outer neuroblastic zone; OPL, outer plexiform layer; RPE, retinal pigmented 
epithelium. 
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FIGURE 3.3 Comparison of cell proliferation between young (14-15WG) and 
old (17-18.5WG) human chorioretinal locations. Ki-67-IR proliferating cells 
(green) are seen in the outer neuroblastic zone (arrows) of the retina and in 
choroidal endothelial cells (arrowheads). No proliferation is observed in the 
foveal region of the retina. 
CC, choriocapillaris; INL, inner nuclear layer; ONL, outer nuclear layer; ONZ, 
outer neuroblastic zone; OPL, outer plexiform layer; RPE, retinal pigmented 
epithelium. 
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FIGURE 3.4 Analysis of choriocapillaris endothelial area, by location and by 
age.  
A: Graphs showing the area of CD34 immunolabelling in the choriocapillaris 
(±standard error), shown at three of the five locations analyzed – nasal, 
temporal and foveal - for clarity. The graphs show that (a) there is a steady 
increase in choriocapillaris area over the age range studied and (b) the area 
of choriocapillaris at the incipient fovea is greater than in the peripheral 
locations at all the ages analyzed. 
Foveal choriocapillaris area is significantly different from the other locations 
by ANOVA (p<0.001) at each age except one sample at 17.5WG (F vs N). 
B: Data from all five locations in which measurements from the two youngest 
retinas (14 and 15WG) are grouped and compared with data from the three 
older retinas (17-18.5WG) (±standard error). The data shows that in the 
transitional locations (NF and TF) choriocapillaris area is greater than in the 
periphery, but not as high as in the fovea, in both age-groups. Thus, the data 
indicates a progressive decrease in choriocapillaris area from central to 
peripheral locations. * denotes significant differences, p<0.05 (Kruskal-Wallis 
test and Conover Inman post hoc test). 
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17.5WG (Figure 3.4A). The grouped data also indicate a significant increase 
in choriocapillaris area with age at all locations (p<0.05, Kruskal-Wallis test 
and Conover Inman post hoc test) (Figure 3.4B). 
EC Proliferation 
In general, fewer proliferating cells were observed in the choriocapillaris 
underlying the foveal region compared with other locations (Figure 3.5). In 
the <16WG group peak numbers of proliferating cells were observed at NF 
and TF locations (2.33 cells/field ±0.33SE; 1.67 ±0.21SE) but in the >16WG 
group peak numbers were in the peripheral chorioretinal locations (N, 1.67 
±0.24SE; T, 2.22 ±0.15SE). This suggests a proliferation gradient in the 
choroid, but did not reach statistical significance, probably due to the 
relatively small sample size. 
The rate of cell proliferation was calculated as the number of proliferating 
cells/unit of choriocapillaris EC area. The highest mean rate of 
choriocapillaris EC proliferation occurred at 14WG, and declined as a 
function of age (Figure 3.6A). Analysis by age and location indicated that the 
lowest rates of proliferation were in central locations compared with 
peripheral (N and T) locations at all ages (Figure 3.6B), reaching statistical 
significance in samples at 14WG (F vs N; F vs T), 17.5WG (F vs T) and 
18.5WG (F vs N; F vs T) (ANOVA, p<0.001).  
3.4 DISCUSSION 
These data support three new findings. First, the area of the choriocapillaris 
endothelium is greater in the foveal region at all ages studied, and declines 
toward the periphery. Choriocapillaris area also increases, at all locations 
analyzed, as development progresses (Figure 3.4). Second, the rate of 
choriocapillaris EC proliferation declines dramatically over the period studied 
(14–18.5WG, Figure 3.6A). Third, when the rate of EC proliferation is 
calculated (number of proliferating cells/unit area of choriocapillaris), the 
lowest rates of EC proliferation are at the incipient fovea for all ages (Figure 
3.6B). 
91 
Endothelial Cell Proliferation in Choriocapillaris 
 
 
 
 
 
 
 
 
FIGURE 3.5 Numbers of Ki-67-IR cells in choriocapillaris endothelium in two 
groups (14 and 15WG, compared with 17, 17.5 and 18.5WG) at five 
chorioretinal locations. In the younger specimens, the peak numbers of 
proliferating cells are in the transitional regions (naso-foveal and temporo-
foveal), subjacent to areas nearing retinal differentiation. In the older group 
the peak numbers of proliferating cells are in the more peripheral nasal and 
temporal regions. Error bars show standard error. 
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FIGURE 3.6 Rates of choriocapillaris EC proliferation (±standard error) 
per unit area of choriocapillaris. 
A: The mean rate of EC proliferation in the choriocapillaris (all locations) 
is shown for each age. The data indicate a reduction in the proliferation 
rate, with increasing age. 
B: Graphs showing the rate of EC proliferation at three locations at each 
age. Naso- and temporo-foveal locations are omitted for clarity. The data 
suggest that (a) there is a decline in the rate of proliferation with age at 
the foveal and peripheral locations, and (b) rates of proliferation at the 
fovea are less than in the periphery at all ages studied. Proliferation rates at 
the foveal locations are significantly different from the other locations at 
14WG (F vs N; F vs T), 17.5WG (F vs T) and 18.5WG (F vs N; F vs T) by 
ANOVA (p<0.001). 
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The increase in choriocapillaris endothelium area in the foveal region at all 
ages studied is consistent with other observations of specialization of the 
choriocapillaris underlying the foveal region of the adult retina.  
This specialization may allow for a higher rate of oxygen and nutrient delivery 
to central photoreceptors/unit time, compared with other parts of the retina 
(Fryczkowski & Sherman, 1988; Provis et al., 1998). While the data suggests 
that choriocapillaris area increases as development progresses neither the 
full timecourse of this expansion, nor at what stage choriocapillaris area 
stabilizes, is established. Analysis of proliferating EC by location suggests 
that there may be a wave of proliferation passing towards the periphery over 
the timecourse of the present study (NF/TF <16WG cf N/T >16WG). Although 
not statistically significant, this is an unexpected finding worthy of further 
investigation. One possible explanation for the larger areas of choriocapillaris 
at foveal locations earlier in development is that at <14WG peak EC 
proliferation occurs centrally, establishing a substantial choriocapillaris that is 
added to by subsequent EC proliferation. However suitable specimens are 
not available to validate this suggestion at this stage. 
Most significantly, this study indicates that EC proliferation in the 
choriocapillaris does not appear to be promoted by increased metabolic 
activity in central retinal neurons. Such a mechanism is widely thought to 
regulate development of the retinal vasculature (Stone, 1997). If retinal 
maturation regulated choriocapillaris EC proliferation, peak EC proliferation 
would be expected at foveal locations, and to increase with increasing age – 
at least until there is a significant retinal vasculature in temporal retina. 
However, reduced EC proliferation is found at foveal locations for all ages 
studied. Furthermore, the rate of EC proliferation at foveal locations is stable 
between 14 and 18.5WG (0.6 – 1.2 x10-3 proliferating cells/µm2 
choriocapillaris), when the central retina is undergoing rapid maturation (Xiao 
& Hendrickson, 2000; Georges et al., 2006), suggesting no dynamic 
relationship between the differentiating retina and choroid during this period. 
Earlier studies in this laboratory suggest that a factor/s expressed in central 
retina inhibit the growth of retinal vessels in the foveal region (Provis et al.,  
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2000; Sandercoe et al., 2003) and may reduce rates of EC proliferation in 
central retina (Stone, 2006). Such factors may also act on the adjacent 
choriocapillaris, resulting in the reduced rates of EC proliferation in the 
‘foveal’ chorioretinal location described here. While such an effect cannot be 
discounted, other evidence regarding EC growth, origins and phenotypes 
need to be considered. 
In very early human ocular development (<10WG) both VEGF and the KDR 
receptor are reported to be expressed at relatively high levels in the choroid, 
while at stages comparable with those investigated here, very little VEGF or 
KDR is detected (Gogat et al., 2004). Consistent with this, little VEGF mRNA 
expression is seen in the choroid of human and monkey eyes at equivalent 
ages of ≥14WG (Provis et al., 1997; Sandercoe et al., 2003), although VEGF 
mRNA is detected in the RPE (Provis et al., 1997). Although conditional 
inactivation of VEGF expression in the RPE results in absence of the 
choriocapillaris and microphthalmia in mice (Marneros et al., 2005), in vitro 
studies show that VEGF has only mild effects on choroidal EC proliferation 
compared with strong effects for FGF-2 (Zubilewicz et al., 2001; Geisen et 
al., 2006). Furthermore, choroidal EC, in contrast to retinal EC, display 
increased proliferation and migration when stimulated with nerve growth 
factor (NGF) (Steinle & Granger, 2003). 
Other evidence indicates divergent lineages of EC with different response 
characteristics. Lineage negative haematopoietic, bone-marrow derived stem 
cells give rise to endothelial precursor cells that can integrate into peripheral 
vasculature (Asahara et al., 1997; Kalka et al., 2000a; Kalka et al., 2000b; 
Isner et al., 2001; Csaky et al., 2004) and, when injected intravitreally, 
selectively seek out astrocytes and are incorporated into retinal vessels 
(Otani et al., 2002; Otani et al., 2004). Bone marrow stromal cells (BMSC) - 
non-haematopoietic pluripotent cells – can give rise to a variety of 
mesenchymal phenotypes, including EC (Prockop, 1997; Reyes et al., 2002). 
BMSC-derived EC are more responsive to FGF-2 than VEGF, proliferating at 
double the rate (Annabi et al., 2004). Studies with DNA microarrays have 
shown that EC from different blood vessels such as arteries and veins, as 
well as large and small vessels, and EC from different tissues have distinct  
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gene expression profiles (Ho et al., 2003). A very recent study using DNA 
microarrays and quantitative PCR has shown that there are marked 
differences in the gene expression profile (up to 263 fold) between EC from 
the retina and the choroid in up to 9% of genes supporting the notion of 
retinal and choroidal vascular endothelium each having a unique molecular 
phenotype (Smith et al., 2007). 
Given the time lag of at least 10 weeks between initial formation of the 
choroid and vascularization of the retina, and that formation of a retinal 
vasculature is not a constant feature of vertebrate eye development, the 
possibility that choriocapillaris EC and retinal EC derive from different 
lineages appears strong. This may explain some of the differences in 
response characteristics of retinal and choroidal EC, including the lack of 
response of choriocapillaris EC to the metabolic demands of the 
differentiating retina described here. 
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CHAPTER 4 – TRANSFORMING GROWTH FACTOR-β 
mRNA IN CENTRAL AND PERIPHERAL HUMAN 
RETINA  
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4.1 INTRODUCTION 
Previous studies in this laboratory suggested that a factor(s) expressed in the 
central retina could define the region of the incipient fovea, subsequently 
inhibiting the growth/migration of retinal vessels and astrocytes into the 
foveal region (Provis et al., 2000; Sandercoe et al., 2003) and reducing rates 
of endothelial cell proliferation in central retina (Stone, 2006).  
In Chapter 3, I have described reduced rates of endothelial cell proliferation 
in the choriocapillaris between 14WG and 18.5WG in choroid sampled at the 
‘foveal’ chorioretinal location. Thus, increased metabolic demands of central 
retina resulting from dark current and neuronal maturation appear not to 
promote proliferation of endothelial cells in the choriocapillaris supplying the 
central region. As discussed in Chapter 3, this may reflect different 
endothelial lineages and thus responses to growth factors. It may also be 
possible that anti-angiogenic/proliferative growth factors within the retina in 
the incipient foveal region also influence choriocapillaris endothelium. 
Further evidence for inhibitory factor(s) in central retina include presence of 
blind-ended capillaries directed towards, but not entering, the foveal region 
(Provis, 2001); reduced cell proliferation in retinal vessels on the horizontal 
meridian (Provis et al., 1998); and, exclusion of astrocytes and endothelial 
cells from the fovea during development (Provis et al., 2000; Provis, 2001). 
Not only are astrocytes excluded from the incipient fovea but they retreat 
once the perifoveal plexus has been formed (Provis et al., 2000).  
It is important to note that such a factor(s) would be required to be expressed 
within the incipient fovea prior to any physical marking of the FAZ by the 
developing vasculature and astrocytes (before 23-25WG, or fd100). TGF-β is 
such a candidate molecule (Chapter 1.2).  
In this chapter, the expression of TGF-β mRNA is examined in developing 
and adult human retina. Reverse transcription polymerase chain reaction 
(RTPCR) and quantitative PCR (QPCR) are used to detect and quantify 
mRNA of TGF-β isoforms in the central and peripheral retina. According to 
the proposed hypothesis (Chapter 1.3), TGF-β mRNA is expected to be 
preferentially expressed at the incipient fovea, prior to definition of the FAZ. 
99 
Transforming Growth Factor β mRNA in Central and Peripheral Human Retina 
4.2 MATERIALS AND METHODS 
SPECIMENS 
Seven human foetal eyes aged 16, 16, 17.5, 18, 18, 18.5 and 19WG were 
obtained from terminations of pregnancy with informed maternal consent, 
following approval from the Human Ethics Committee, University of Sydney. 
Gestational age was determined by preoperative obstetric ultrasound and 
post mortem ocular morphometry. Two human eyes from a 10 year old 
juvenile and a 20 year old man were obtained with ethical approval from the 
NSW Lions Eye Bank. Following removal of the anterior segment and 
vitreous, retinas were carefully removed from the choroid and placed into a 
separate sterile 1.5ml eppendorf tube. 
RNA EXTRACTION 
In some cases RNA was extracted from whole retinas (one 16WG and one 
18WG eye) for RTPCR; for other retinas, a 5mm trephine was used to excise 
samples from central retina (including the incipient fovea) and nasal retina, to 
compare transcript levels for each of the TGF-β isoforms. 
RNA was extracted using Trizol (Invitrogen) according to manufacturer’s 
instructions. Briefly, tissue was homogenised in Trizol and incubated at room 
temperature for 7 minutes. Chloroform was added, the tube shaken 
vigorously, centrifuged, and the aqueous layer collected into a clean 
eppendorf tube. RNA was precipitated using isopropyl alcohol, and incubated 
at -20˚C for 20 minutes, then centrifuged. The pellet was washed in 75% 
ethanol, centrifuged and allowed to air dry for approximately 10 minutes. The 
RNA was then dissolved in 25µl RNAse free water, incubated at 42˚C for 10 
minutes and stored at -80˚C for later use. Purity was determined by 
spectrophotometery (Biorad SmartSpecTM3000). Only samples with an 
absorbance ratio A260/A280 greater than 1.8 were utilised in these 
experiments (see Chapter 2.4). 
REVERSE TRANSCRIPTION PCR (RTPCR) 
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National Centre for Biotechnology Information (NCBI) GenBank. PCR 
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primers with sequences complementary to the known sequences flanking the 
target DNA were designed for TGF-β1, TGF-β2 and TGF-β3, and primers 
were synthesised by Sigma Genosys Australia. Forward and reverse primers 
used are shown in Table 4.1.  
TABLE 4.1 Primers used for QPCR 
Protein Accession number 
Forward primer  
Sequence 5’ to 3’ 
Reverse primer  
Sequence 5’ to 3’ 
Amplicon 
size (bp) 
TGF-β1 X02812  GCAACAATTCCTGGCGATAC CTAAGGCGAAAGCCCTCAA 136 
TGF-β2 NM03238  CATCCCGCCCACTTTCTAC AATCCGTTGTTCAGGCACTC 148 
TGF-β3 X14149 CGAGTGGCTGTTGAGGAGAG CATTGGGCTGAAAGGTGTG 80 
RNA (1-5µg) was reverse transcribed to cDNA using the Superscript TM II 
Firststrand Synthesis System for Reverse Transcriptase PCR (Invitrogen, Ca, 
USA). PCR was performed using Biotaq Red DNA polymerase kit (Bioline) 
using the cycle shown in Table 4.2. Presence and concentration of DNA was 
assessed on a 1% agarose gel and by spectrophotometry (Biorad 
SmartSpecTM3000) (Chapter 2.5). Isoform identities were confirmed by 
sequencing. 
TABLE 4.2 Cycling program for RTPCR 
Number of cycles Reaction temperature (C˚) Time 
1 94 3 min 
40 94 25s 
40 58 25s 
40 72 25s 
1 72 5 min 
QUANTITATIVE PCR 
The Superscript II Synthesis System was used with the Platinum SYBR 
Green qPCR Supermix UDG kit (Invitrogen, USA) to detect quantitative 
changes in RNA expression by means of a fluorescent signal. Forward and 
reverse primers for housekeeping genes including β-actin, GAPDH and 
18sRNA were used to determine an endogenous standard. Triplicates of 
each sample with a total of 0.5µl of cDNA per reaction were used. A two-step 
cycling program was carried out in the Rotorgene 3000 thermal cycler 
(Corbett Research, Australia) (Table 4.3) to interpret the intensity of the 
fluorescent signal and thus DNA synthesis in real time. Melt curve analysis 
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was done to verify specificity of the reaction after cycling finished (Chapter 
2.6). 
TABLE 4.3 Cycling program for QPCR 
Number of cycles Reaction temperature (C˚) Time per cycle 
1 50 2 min 
1 95 2 min 
40 95 15 s 
40 60 30 s 
PFAFFL ANALYSIS 
Relative quantification of target genes in comparison to reference house 
keeping genes is done using a mathematical model (See Appendix A). In this 
mathematical model it is necessary to determine the “crossing points” (CP) or 
replicate “takeoff points” for each transcript. CP is defined as the point at 
which the fluorescence rises appreciably above the background fluorescence 
(Pfaffl, 2001). The “takeoff point”, is calculated from the second derivative of 
the raw data and is the point determined where the reaction is increasing 
most rapidly. This is the “peak” of the exponential reaction and occurs shortly 
after the “takeoff” of the reaction. The “takeoff” point is estimated as 80% 
below the peak level (Rotorgene version 6.0, Corbett Research).  
Relative quantification of target and reference genes was done by using the 
Pfaffl mathematical equation which despite different cDNA input 
concentrations to mimic different RT efficiencies, all target transcripts as well 
as reference transcripts are affected in parallel (Pfaffl, 2001) (see Appendix 
A). Results were tabulated and graphed on an Excel spreadsheet. 
4.3 RESULTS 
REVERSE TRANSCRIPTION PCR (RTPCR) 
In the 17.5WG foetal retina, all TGF-β isoforms were present, although the 
TGF-β3 band appeared weaker than the other two isoforms (Figure 4.1A). 
When expression was compared in central versus nasal samples from an 
18.5WG foetal eye, no difference was seen in the appearance of the bands 
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between sample locations (Figure 4.1B); TGF-β2 was clearly the most 
abundant isoform present (Figure 4.1B). Comparison of results obtained from 
a 19WG and a 10yo retina showed more intense bands in the foetal 
compared to juvenile retina for all three isoforms (Figure 4.1C).  
QUANTITATIVE PCR 
House Keeping Genes 
After comparing GAPDH, β-actin and 18sRNA house keeping genes, the 
least variability in “average amplification” and “replication take off” between 
adult and foetal eyes as well as between central and peripheral retina was 
found for GAPDH (variability of 0.4 compared with 0.7 for β-actin and >1 for 
18sRNA). Therefore, GAPDH was used as the endogenous standard in all 
analyses.
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FIGURE 4.1 
A: All TGF-β isoforms were present at 17.5WG, with amplicon sizes of 
267bp- TGF-β1; 225bp- TGF-β2; 367bp - TGF-β3. 
B: Peripheral (per) versus central (cen) expression for all three TGF-β 
isoforms in an 18.5WG eye shows more intense bands for TGF-β2 but little 
difference between peripheral and central expression.  
C: Less TGF-β expression of all isoforms was noted in a 10 year old eye 
when compared to 19WG foetal eye. 
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TGF-β1 isoform  
The take off point for TGF-β1 occurred late in the course of the quantitative 
PCR amplification cycles, suggesting very low amounts of mRNA in the 
retina source tissue. Using the Pfaffl equation, the highest amounts of TGF-
β1 were found in the central retina at 18WG and in the peripheral retina for 
the 20yo retina (Figure 4.2). The lowest amounts were seen in the 16-18WG 
peripheral retina. When central and nasal retinas were compared at each 
age, TGF-β1 expression was highest in the central retina at 16WG, 18WG, 
but in the peripheral retina in the 20yo samples (Figure 4.2). Amplification 
specificity was confirmed when PCR products were subjected to a melting 
curve analysis and showed a single predominant product. 
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FIGURE 4.2 Ratio of TGF-β-1 gene expression relative to GAPDH. Error 
bars are standard error measurements (SEM). Ratios >1 indicate higher 
TGF-β1 gene expression in the central sample, whilst ratios <1 show lower 
gene expression in the central sample. 
A. Central versus nasal expression of TGF-β1 at three ages. Ratios are 
calculated using replication take off values for TGF-β1 and GAPDH in the 
Pfaffl equation. The graphs show values for 16WG, 18WG and 20yo central 
(c) and nasal (n) retina indicating that higher levels for TGF-β1 expression 
are found in the central foetal retina when compared to the periphery. In the 
adult retina TGF-β1 expression is higher in the nasal retina when compared 
to the central retina.  
B. TGF-β1 expression in central retina at different ages. The findings indicate 
that the adult central retina has the highest levels of TGF-β1 expression, 
followed by the 18WG central retina.  
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TGF-β2 isoform 
The replication take off points for TGF-β2 were the earliest in the 
amplification cycles for all samples, suggesting a relative abundance of TGF-
β2 isoform in the retina. Using the Pfaffl equation, the highest amounts of 
TGF-β2 were found in the central retina at all ages when compared to the 
corresponding nasal retina (Figure 4.3A). When central retina was compared 
between ages, little difference was observed between the 16WG-18WG and 
the 20yo retina, however that slight difference showed TGF-β2 expression 
was highest at 16WG and lowest in the 20yo retina (Figure 4.3B). When 
nasal retina was compared between ages, TGF-β2 expression was found to 
be highest in the 20yo retina and lowest in the 18WG retina. 
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FIGURE 4.3 Ratio of TGF-β-2 gene expression relative to GAPDH. Error 
bars are SEM. 
A. Central versus nasal TGF-β2 expression comparison. A ratio>1 indicates 
higher levels of TGF-β2 expression in the central retina compared with 
peripheral retina at all ages. 
B. Central retina TGF-β2 expression versus age comparison indicates that 
levels of TGF-β2 in central retina do not change significantly between 16-
18WG and adulthood. The mildly increased levels of TGF-β2 are seen in the 
central retina at 16WG and the lowest levels at adulthood. 
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TGF-β3 isoform 
An almost identical pattern to TGF-β2 expression is seen for TGF-β3 in the 
foetal retinas. TGF-β3 is predominantly expressed in the central retina 
compared with nasal retina in the youngest retinas (Figure 4.4A) and does 
not change over time (16-18WG compared to 20yo) (Figure 4.4B). When 
both central and nasal retinas are compared between ages, although the 
difference is small, TGF-β3 expression is highest centrally at 16WG and 
lowest in the 20yo nasal retina. Amplification specificity was confirmed when 
PCR products were subjected to a melting curve analysis and showed a 
single predominant product. 
 
 
These quantitative analyses indicate that in foetal retinas higher levels of all 
TGF-β isoforms are expressed in the central retina when compared to the 
peripheral retina (Figure 4.5). TGF-β2 and TGF-β3 are most highly 
expressed in the youngest retina at 16WG with only low levels of TGF-β1 
detected at all ages. In the adult, TGF-β2 is preferentially expressed in the 
central retina. Also TGF-β1 levels expressed in the adult nasal retina exceed 
those observed in the developing retina.  Overall the quantitative analyses 
indicate that higher levels of all TGF-β isoforms are found in the developing 
retina compared to adult human retina. TGF-β2 is the most abundant of the 
isoforms, followed by TGF-β3, and TGF-β1. 
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FIGURE 4.4 Ratio of TGF-β-3 gene expression relative to GAPDH. Error 
bars are SEM. 
A. Central versus nasal TGF-β3 expression comparison, indicating central 
retina TGF-β3 expression is greater than in the peripheral retina in foetal 
retinas, but not in adult retina.   
B. Central retina TGF-β3 expression versus age comparison showing TGF-
β3 expression in central retina is mildly increased when the developing 
central retina is compared to the adult retina, with higher TGF-β3 levels seen  
in 16WG-18WG and lowest levels in the 20yo retina. 
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FIGURE 4.5 Relative levels of expression of A. TGF-β1, B. TGF-β2 and C. 
TGF-β3 in central compared with nasal retina at 16WG, 18WG and at 20 
years. All TGF-β isoforms are present at higher levels in central compared 
with nasal retina in the samples from foetal retinas. TGF-β1 and TGF-β3 
were more abundant in nasal retina in the 20yo sample.  
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4.4 DISCUSSION 
RTPCR followed by QPCR is the most powerful method for analysing mRNA 
expression from small samples. For quantitative purposes traditional 
methods rely on endpoint analyses which are not very accurate due to 
variations in amplification efficiency in the later stages of the PCR reaction 
(Simpson et al., 2000). The use of fluorescent hybridisation probes has 
enabled real-time monitoring of the amplification reaction (Simpson et al., 
2000). The high affinity double-stranded (ds) DNA binding dye SYBR green 
has negligible fluorescence in the absence of dsDNA, but high fluorescence 
upon binding to dsDNA. It can be used with any primer pair provided no non-
specific PCR products are amplified (Lee et al., 1993; Wittwer et al., 1997; 
Morrison et al., 1998; Simpson et al., 2000). Monitoring each PCR reaction 
by means of fibre optic fluoroimetry results in a curve of fluorescence which 
can be used to quantify the product of interest. 
In this study RTPCR confirmed the presence of all three TGF-β isoforms in 
the human retina and suggested that TGF-β2 is the predominant isoform in 
developing and adult human retina. QPCR confirmed those findings, also 
indicating that TGF-β2 is the predominant isoform expressed in the retina 
(Figure 4.3A compared to Figure 4.2A, 4.4A). The developing and adult 
human retina showed lower levels of TGF-β3, with very little evidence of 
TGF-β1 detectable. These results are consistent with previous investigations 
of TGF-β isoforms in the normal primate vitreous and ocular tissues (Pfeffer 
et al., 1994; Connor et al., 1989). In the Pfeffer study, high levels of TGF-β2 
expression were reported in the vitreous humour, neural retina and RPE-
choroid using enzyme linked immunosorbent assay (ELISA) (Pfeffer et al., 
1994). Growth factors in the vitreous are generally agreed to originate from 
the retina, and it has been reported that most TGF-β activity in the vitreous is 
from TGF-β2 (84-100%), and only 10-21% from TGF-β1 (Connor et al., 
1989). No quantitative information is available on TGF-β3 expression from 
those studies for comparison. 
The significance of the TGF-β1/ TGF-β2 isoforms in retinal development is 
emphasized in TGF-β2 deficient mice, which show ocular malformations  
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including hyperplastic retinas (Sanford et al., 1997). Overexpression of TGF-
β1 in TGF-β2 null mice rescues the abnormalities in ocular development 
caused by the deletion of TGF-β2 (Saika, 2005).  
The present data also indicate higher levels of expression of TGF-β during 
retinal development compared to adult retina, with higher levels in developing 
central retina compared to peripheral retina. In this chapter, the expression of 
TGF-β in the developing central retina adds support to the idea that the 
antiproliferative effects of this factor may be responsible for helping to define 
the FAZ by suppressing astrocyte and endothelial cell proliferation and/or 
migration during retinal development (see also Chapter 1). 
While the present data indicate differences in the levels of expression of 
TGF-β isoforms in central versus peripheral retina; and in developing versus 
adult retina, they provide no details concerning the precise distributions of 
mRNA and protein. Such information is critical in understanding the 
processes involved in the spatial and temporal development of the human 
retina, particularly the fovea. Further investigations of the distribution of the 
TGF-β isoforms and receptors in developing human and primate retinal 
retina, using in situ hybridization and immunohistochemistry, are the subject 
of Chapter 5. 
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CHAPTER 5 – TRANSFORMING GROWTH FACTOR-β 
DISTRIBUTION IN CENTRAL AND PERIPHERAL 
RETINA 
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5.1 INTRODUCTION 
Evidence for expression of an antiproliferative factor in central retina includes 
the presence of blind-ended capillaries directed towards the incipient fovea 
but not entering it (Provis, 2001); reduced cell proliferation in macaque fovea 
along the horizontal meridian (Stone, 2006) and exclusion of astrocytes and 
endothelial cells from the fovea during development (Provis et al., 2000). 
When the ganglion cell vascular plexus - comprising new endothelial cells 
and astrocytes - forms at the foveal edge at fd105 in the macaque, both cell 
types appear to be blocked from entering this region even though there are 
no structural boundaries. Furthermore both astrocytes and ganglion cells in 
the vicinity express the endothelial proliferation factor, VEGF (Provis et al., 
2000; Provis, 2001). Astrocytes are not only excluded from the incipient 
fovea, but retreat once the perifoveal plexus has formed (Provis et al., 2000; 
Distler et al., 1993; Distler & Kirby, 1996; Distler et al., 2000).  
In Chapter 4, I reported on the quantitative analysis of TGF-β expression in 
developing and adult human retina, using reverse transcription polymerase 
chain reaction (RTPCR) and real time quantitative PCR (QPCR). According 
to the proposed hypothesis (Chapter 1.3), TGF-β was expected to be 
preferentially expressed at the incipient fovea. Indeed, for all the foetal 
retinas examined, there was relatively higher expression of all TGF-β 
isoforms in the central compared with peripheral retina, although level of 
expression varied for the different isoforms. The lower levels of TGF-β1 
found using QPCR suggests potential difficulties in accurately quantifying this 
isoform in the retina when using relatively less sensitive techniques such as 
in situ hybridisation (Nuovo, 1996).  
In order to clarify the RTPCR and QPCR results described in chapter 4, I 
further investigated the expression and distribution of mRNA and protein for 
the different TGF-β isoforms, in sections of human and macaque retina, 
during development and in the postnatal period. The development of the 
visual pathways and retinas in humans and macaques is similar as they 
share not only a common developmental timetable but the same retinal cell 
types and connections (Dreher & Robinson, 1988; Kolb et al., 1992). As 
such, a comprehensive developmental profile for TGF-β1, TGF-β2 and TGF-
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β3 mRNA and protein expression and distribution as well as localisation of 
TβRI and TβRII proteins was possible for both human and macaque retinas. 
5.2 MATERIALS AND METHODS 
SPECIMENS 
Fourteen human foetal eyes between 11 and 19 WG were obtained from 
terminations of pregnancy with informed maternal consent, following approval 
from the Human Ethics Committee, University of Sydney (Chapter 2.1). 
Gestational age was determined by preoperative obstetric ultrasound and 
post mortem ocular morphometry. Fifteen macaque (Macaca fascicularis) 
eyes aged foetal day (fd) 64, fd73, fd85, fd95, fd105, fd115, fd130, fd155, 
fd169, postnatal day 6 (p6d), postnatal week 12 (p12wk), postnatal month 4 
(p4mo), postnatal month 6 (p6mo), postnatal 2.5 years (p2.5y) and postnatal 
11 years (p11y) were obtained from Bogor Agriculture University, Indonesia 
following approval from the Ethics Committee of the University of 
Washington, Seattle, USA. Sections from macaque retina were processed in 
paraffin, human sections frozen, as described in Chapter 2. Only sections 
through the optic disc and fovea were analysed quantitatively.  
IMMUNOHISTOCHEMISTRY 
Details of Immunohistochemistry methods are described in detail in Chapter 
2.9. Briefly, sections were incubated at 4ºC overnight in polyclonal rabbit anti-
human TGF-β1, TGF-β2, TGF-β3, TβRI or TβRII antibodies (1:200) and 
either antibodies to TAU (ganglion cells, 1:200), vimentin (Müller cell 
intermediate filaments, 1:100), GFAP (astrocytes , 1:1000), calbindin 
(amacrine and horizontal cells, 1:50), S-opsin (short wavelength opsin in 
cones, 1:10000), RG-opsin (medium-long wavelength opsin in cones, 
1:1000) or rhodopsin (rods, 1:500) (see also Table 2.4). After rinsing in PBS, 
sections were incubated for 60 minutes in goat anti-rabbit Alexa-488 (1:1000; 
Molecular Probes) to visualise bound anti-TGF-β or TβR and/or goat anti-
mouse Alexa-594 (1:1000; Molecular Probes) to visualise the remaining 
antibodies. For some antibodies raised in the same species as the TGF-β 
and TβR antibodies, adjacent retinal sections of tissue were immunolabelled 
with a single antibody.  
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RNA EXTRACTION 
As described in Chapter 2.4, retinas were carefully removed from the choroid 
and the Trizol-extracted RNA was dissolved in 25µl RNAse free water, 
incubated at 42˚C for 10 minutes and then stored at -80˚C until used. Purity 
was determined by using spectrophotometer (Biorad SmartSpecTM3000) 
where samples having absorbance ratio A260/A280 greater than 1.8 were 
used for analysis. 
POLYMERASE CHAIN REACTION (PCR)  
PCR primers with base sequences complementary to the known sequences 
flanking the target DNA were designed for TGF-β1, TGF-β2 and TGF-β3 
(Table 5.1, Chapter 2.5). The three forward and three reverse primers were 
synthesised by Sigma Genosys Australia. For probe design, the amplicon 
length was longer compared with QPCR products, that is, 200-400 base pairs 
(bp), so that more labelling molecules would bind to the probe improving 
visualisation of target mRNA. 
TABLE 5.1 Primer sequences used for riboprobe construction. 
Protein Accession 
number 
Forward primer 
Sequence 5’ to 3’ 
Reverse primer 
Sequence 5’ to 3’ 
Amplicon 
size (bp)
TGF-β1 X02812 AACCCACAACGAAATCTATGAC ACTCCGGTGACATCAAAAGATA 267 
TGF-β2 NM03238 AAGCAGAGTTCAGAGTCTTTCG AATCCCAGGTTCCTGTCTTTAT 225 
TGF-β3 X14149 AGTCGGAATACTATGCCAAAGA GTTGGACTCTCTTCTCAACAGC 367 
 
Using Superscript TMII Firststrand Synthesis System for Reverse 
Transcriptase-PCR (Invitrogen, Ca, USA) cDNA was produced and stored at 
–20˚C for a maximum of 2-3 months. 
A standard PCR was performed using Platinum Taq (Invitrogen), and a 
Hybaid PCR Express thermocycler, where amplification of dsDNA occurred.  
A 1% agarose gel and spectrophotometry (Biorad SmartSpecTM3000) were 
used to assess dsDNA size and concentration respectively. 
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RIBOPROBE PREPARATION 
RNA isolated from foetal retinas was reverse transcribed to cDNA and 
amplified by PCR amplification using specific primers (see Chapter 2.5). PCR 
products were purified by gel extraction and inserted into pGemT Easy DNA 
vector (Promega), cloned in heat shocked competent cells (JM109, 
Promega), further grown up in E. coli cells and purified using Miniprep 
(QIAprep Miniprep) and  Midiprep (Jet Star) kits. DNA was used as a 
template for preparing digoxigenin (DIG)-labelled riboprobes for in situ 
hybridisation (see Chapter 2.7). 
IN SITU HYBRIDISATION 
Frozen and dewaxed paraffin sections were incubated in the hybridisation 
mix, which was combined with 1µl DIG RNA transcript (Sense or Antisense) 
and finally incubated with anti-DIG AP (Fab fragments) antibody (see 
Chapter 2.8). After the reaction was stopped, selected slides were 
subsequently immunolabelled (see Chapter 2.9). 
CONFOCAL MICROSCOPY 
A retinal montage of a section from a 16WG eye was used to assess the 
validity of analysing retinal regions as representative of TGF-β distribution 
across the whole retina. Six retinal regions; the incipient/established fovea 
(foveal, F), peripheral (nasal, N; temporal, T) and transitional regions (nasal 
parafoveal, PFN; temporal parafoveal, PFT; nasal to optic disc, ND) were 
selected using morphological criteria (discussed in Chapter 3). 
Sections were imaged using a Carl Zeiss upright scanning laser confocal 
microscope (Carl Zeiss LSM5 Pascal software). An argon-krypton laser with 
dual filters for maximum excitation (488nm and 594nm) was used to visualise 
green Alexa-488 labelled cells/structures and/or red anti-TGFβ or anti-TβR 
(Alexa-594/Fast Red) labelled structures respectively. Photomultiplier gain, 
offset, aperture and laser power settings were standardised and maintained 
for all measurements for comparisons between specimens.  
All confocal image sample areas (230µmx230µm) were acquired using a 40x 
water immersion objective and processed in one of two ways. A 16WG 
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human retinal montage was compiled from 77 samples images adjacent to 
each other (Figure 5.1, Appendix B). All remaining human and macaque 
specimens of varying ages were compiled into a representative minimontage 
by combining a sample area from each of the six retinal regions described 
above (Figure 5.2, Appendix B).  
IMAGE ANALYSIS - Quantifying distribution of TGF-β 
Confocal images were opened in Adobe Photoshop 7.0 and organised into 
either (1) a 77 image montage for the whole 16 WG retina specimen or (2) 
several six image montages, with each image corresponding to a particular 
retinal location for all other remaining specimens (Figure 5.1 and 5.2, 
Appendix B). All montages were saved in TIFF format and then reimported 
into LSM5 Pascal software (Carl Zeiss). Protein or mRNA expression 
distribution intensity was recorded using the Pascal measurement tool. 
Optical density recordings were made at 1µm intervals across the ganglion 
cell layer (GCL), outer neuroblastic zone (ONZ) and superior, middle and 
inferior aspects of the photoreceptor (PR) layer and were tabulated (Figure 
5.3). Optical density recordings from undifferentiated peripheral 
photoreceptor regions were not recorded. Finally, the optical density values 
were compiled and graphed using an Excel spreadsheet.  
VALIDATION OF SAMPLING 
As described above and in Appendix B, representative regions across the 
retinas, (T, PFT, F, PFN, ND and N) were assembled as minimontages. To 
validate that the distribution of optical density values obtained from sampling 
of the six retinal regions was representative of optical density values obtained 
when measurements were made across a whole retinal section, the data 
corresponding to the optical densities across the GCL and the ONZ were 
compared. Median optical density values (MD) and standard deviations (SD) 
were not significantly different in the minimontage samples compared with 
the whole eye section. Comparison of graphs showing the optical densities 
across the photoreceptor layer in both the whole eye and minimontage also 
showed little variation between corresponding retinal regions. Further details 
of this analysis are given in Appendix B. 
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FIGURE 5.1 Montage of 16WG human retina demonstrating TGF-β2 mRNA 
expression in ganglion cell layer (GCL) and photoreceptor (PR) layer. The 
representative sample areas used for the minimontages are also shown 
(white boxes) - T: temporal, PFT: temporal parafoveal, F: foveal, PFN: nasal 
parafoveal, ND: nasal to disc and N: nasal. Optic nerve (ON) is also shown. 
Bar= 500µm. 
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FIGURE 5.2 Representative example of six retinal regions in a minimontage, 
showing TGF-β2 mRNA expression in a 16WG retina. (GCL: ganglion cell layer; 
INL: inner nuclear layer; ONZ: outer neuroblastic zone; PR: photoreceptor layer; 
CC: choriocapillaris). Bar = 100µm. 
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FIGURE 5.3 Representative example of the 5 tracks (coloured lines) within 
the retina along which optical density measurements were made at 1µm 
intervals. GCL (Measurement 1: green); ONZ/INL (2: blue); PR top (3: 
yellow); PR middle (4: orange); PR bottom (5: pink).  In the younger 
specimens where photoreceptors have not differentiated in the peripheral 
retina optical density measurements were not recorded. Bar = 100µm. 
 
 
 
 
121 
Transforming Growth Factor β Distribution in Central and Peripheral Retina 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     T               PFT                F                PFN              ND                   N 
 
FIGURE 5.4 3D colour diagram of optical density in a minimontage of a 
16WG human retina. Optical density is proportional to colour. The highest 
optical density for TGF-β2 protein is shown as red peaks in the GCL (top 
row) and in the photoreceptor layer (bottom row), particularly in the foveal 
region. 
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5.3 RESULTS 
A rabbit IgG negative control also showing specificity was included in each 
set of experiments (Figure 5.5) 
TGF-β1 PROTEIN  
Location 
Cytoplasmic TGF-β1 protein is seen in the photoreceptors and ganglion cells 
of developing retina (Figures 5.6, 5.7). At 13WG minimal immunolabelling is 
seen in the photoreceptors. Older retinas have more prominent 
immunolabelling that initially involves the outer segments (Figure 5.6 PFT 
and PFN) and progresses to include entire photoreceptors by 16-17WG 
(Figure 5.6 F). Higher intensity immunolabelling is also seen in the central 
photoreceptors compared to the periphery from 14WG onwards. The variable 
labelling in the ganglion cell layer shows no central to peripheral variation 
and is seen for all ages studied. Vessels in the choriocapillaris are 
inconsistently immunolabelled. Positive labelling in the macaque is seen only 
in the postnatal retina, in both photoreceptors and ganglion cells (Figure 5.8). 
Distribution 
Optical densitometry analysis of immunolabelled sections was used to 
observe the relative levels of TGF-β1 protein in the photoreceptor, ganglion 
cell and ONZ layers. A centro-peripheral gradient of optical densities is seen 
in the photoreceptor layer with peak relative levels of TGF-β1 protein in the 
central retina including the parafoveal regions for all ages examined (Figure 
5.9). In the macaque, levels of TGF-β1 protein are low in foetal retinas 
(Figure 5.10A, 5.10B, 5.10C), although a centroperipheral gradient of TGF-
β1 immunoreactivity is evident in the postnatal specimens (Figure 5.10D). 
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FIGURE 5.5 A Sample of rabbit IgG negative control for TGF-β in 14WG 
retina B-D Positive labelling with TGF-β (red) and vimentin (green) with B 
showing vimentin only, C showing TGF-β only and D showing both TGF-β 
and vimentin labelling. (GCL: ganglion cell layer; INL: inner nuclear layer; PR: 
photoreceptor layer). Bar = 100µm. 
 
 
 
          T                       PFT                      F                      PFN                 
 
 
  
GCL 
PR 
INL 
GCL 
PR 
INL 
A B      C      D 
GCL 
PR 
INL 
 
 
 
 
 
 
FIGURE 5.6 Distribution of TGF-β1 protein (red) and vimentin (green) across 
central 17WG retina. Weak immunolabelling is seen in the GCL, with 
moderate labelling in the photoreceptor (PR) layer in the foveal (F) and 
parafoveal regions (PFT- parafoveal temporal, PFN- parafoveal nasal). (INL; 
inner nuclear layer).  Bar = 100µm. 
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FIGURE 5.7 Distribution of TGF-β1 protein (red) and vimentin (green) in (A) 
incipient fovea and fovea, (B) parafoveal and (C) peripheral (nasal) regions of 
a 15 and 19WG human retina. (GCL: ganglion cell layer; INL: inner nuclear 
layer; ONZ: outer neuroblastic zone; PR: photoreceptor layer). Bar = 50µm. 
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FIGURE 5.8 Distribution of TGF-β1 protein (red) and vimentin (green) in (A) 
central retina, (B) parafoveal and  (C) peripheral (nasal) macaque retina at 
fd105(~25WG), fd130(~31WG) and post natal 6 months (p6mo). Inconsistent 
immunostaining of ganglion cells (arrowhead) and mild to moderate staining 
of photoreceptors (asterisk) is observed as well as in the choriocapillaris. 
(GCL: ganglion cell layer; INL: inner nuclear layer; ONZ: outer neuroblastic 
zone; CC: choriocapillaris). Bar = 50µm. 
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HUMAN TGFb1 protein in 13WG photoreceptor layer
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HUMAN TGFb1 protein in 16WG photoreceptor layer
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HUMAN TGFb1 protein in 18.5WG photoreceptor layer
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FIGURE 5.9 Relative levels of TGF-β1 protein determined by optical 
densitometry (OD) in temporal, parafoveal temporal, foveal, parafoveal nasal, 
nasal to disc and nasal regions of human retina at (A) 13WG - prior to FAZ 
formation, (B) 16WG and (C) 18.5WG - during FAZ formation. 
Photoreceptors have not differentiated in the peripheral retina of the younger 
specimens and therefore no measurements have been graphed for these 
regions.  Error bars = SEM. 
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MACAQUE TGFb1 protein in fd85 photoreceptor layer
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MACAQUE TGFb1 protein in fd105 photoreceptor layer
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MACAQUE TGFb1 protein in fd130 photoreceptor layer
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MACAQUE TGFb1 protein in p6mo photoreceptor layer
0
50
100
150
200
Temporal Parafoveal
temporal
Foveal Parafoveal
nasal
Nasal to disc Nasal  
Location
R
el
at
iv
e 
TG
Fb
1 
O
D
 
D 
 
 
FIGURE 5.10 Relative levels of TGF-β1 protein in macaque retina 
photoreceptors at five locations (temporal, parafoveal temporal, foveal, 
parafoveal nasal, nasal to disc and nasal) at four different ages (between 
fd85-p6mo). High levels of TGF-β1 protein are seen in the macaque 
photoreceptors postnatally, particularly in the foveal region. 
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TGF-β1 mRNA  
TGF-β1 mRNA expression could not be detected in these experiments, 
despite multiple attempts at constructing riboprobes for in situ hybridisation. 
The sequence for the riboprobes in each of these attempts was verified to be 
correct by sequencing, so that problems interfering with probe effectiveness 
occurred after this step. The restriction enzymes Apa I and Pst I were 
subsequently treated with T4 DNA polymerase, which catalyses the 
synthesis of DNA in the 5’ > 3’ direction causing the 3’ overhang removal to 
form blunt ends. As this did not work, alternative restriction enzymes were 
used (Nco I and Sal I), that were known not to leave the 3’ overhangs which 
could cause loops to form in the DNA and prevent probe binding to mRNA in 
tissue. Despite these modifications in the methods, the in situ hybridisation 
could not be successfully performed, most probably due an inability to detect 
the very small amounts of TGF-β1 mRNA in the retina, consistent with results 
reported in Chapter 4.  
TGF-β2 PROTEIN   
Location 
Cytoplasmic TGF-β2 protein is detected in photoreceptors and ganglion cells 
of human and macaque retinas (Figures 5.11, 5.12). At 13WG-14WG, low 
levels of immunolabelling are seen in the photoreceptors. However from 
15WG there is prominent immunolabelling involving the entire photoreceptor. 
Moderate to strong labelling is seen in the central photoreceptors compared 
to somewhat lower levels in the periphery of both species (Figures 5.11, 
5.12). TGF-β2 expression was variable in the ganglion cell layer (GCL) of 
human retinas, but more consistent in macaque retinas, with weak to 
moderate staining of ganglion cells and no obvious central to peripheral 
variation. Occasionally individual cells in other retinal layers (not GCL or 
photoreceptor layer) were also immunoreactive for TGF-β2. As described 
above (Chapter 5); using a panel of antibodies for various retinal cell types, 
these cells may be identified as astrocytes or horizontal cells. Vessels in the 
choriocapillaris are also sometimes immunolabelled for TGF-β2 (Figure 
5.12). 
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FIGURE 5.11 Distribution of TGF-β2 (red) and vimentin (green) 
immunolabelling in (A) incipient fovea and fovea, (B) parafovea and (C) 
peripheral (nasal) regions of a 15WG and 19WG human retina. TGF-β2 is 
seen clearly in photoreceptors (asterisks) and in some ganglion cells 
(arrowheads). (GCL: ganglion cell layer; INL: inner nuclear layer; ONZ: outer 
neuroblastic zone; PR: photoreceptor layer). Bar = 50µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
132 
Transforming Growth Factor β Distribution in Central and Peripheral Retina 
A 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
C 
 
 
          15WG                  19WG GCL
INL PR  
GCL 
GCL 
GCL 
PR 
PR 
ONZ 
GCL 
PR 
INL 
INL 
ONZ 
GCL 
GCL 
PR 
HUMAN 
INCIPIENT FOVEA 
 
 
 
 
 
 
 
 
 
PARAFOVEAL 
 
 
 
 
 
 
 
 
 
 
PERIPHERAL 
* *
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
133 
Transforming Growth Factor β Distribution in Central and Peripheral Retina 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GCL 
CC 
 
CENTRAL 
 
 
 
 
 
 
 
PARAFOVEAL 
 
 
 
 
 
 
 
PERIPHERAL 
PR 
INL 
PR 
                 fd 105                        fd 130                        p6mo 
A 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
C 
GCL 
GCL 
INL 
INL 
PR 
GCL 
INL 
GCL 
PR 
PR PR 
MACAQUE 
*
*
*
FIGURE 5.12 Distribution of TGF-β2 (red) and vimentin (green) 
immunolabelling in (A) central, (B) parafoveal and (C) peripheral (nasal) 
macaque retina at fd105 (~25WG), fd130 (~31WG) and p6mo. Weak to 
moderate labelling of ganglion cells (arrowheads) and moderate to strong 
labelling of photoreceptors (asterisks) is observed. (GCL: ganglion cell layer; 
INL: inner nuclear layer; PR: photoreceptor layer; CC: choriocapillaris). Bar = 
50µm. 
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Distribution 
Optical densitometry analyses of immunolabelled sections were used to 
determine the relative levels of TGF-β2 protein in the photoreceptor layer 
(Appendix B). A centro-peripheral gradient of TGF-β2 protein was detected, 
with peak levels of TGF-β2 protein in the central retina for all ages examined, 
but most prominent in the 15WG-17.5WG period (Figure 5.13). TGF-β2 
protein is observed in the foveal region well before formation of the FAZ at 
14WG (Figure 5.13A). 
In the macaque retina, peak levels of TGF-β2 protein are also detected 
centrally in photoreceptors at fd105 (~25WG). In general, TGF-β2 levels 
decrease with increasing age, the lowest relative levels of TGF-β2 being 
measured in the p6mo specimen (Figure 5.14).  
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FIGURE 5.13 Relative TGF-β2 protein levels as indicated by optical 
densitometry (OD), in differentiated regions of temporal, parafoveal temporal, 
foveal, parafoveal nasal, nasal to disc and nasal locations of human retinas 
aged (A) 14WG - prior FAZ formation, (B) 17WG, and (C) 19WG - during 
FAZ formation. Higher levels of TGF-β2 protein are seen in foveal and 
parafoveal regions compared with more peripheral locations. Photoreceptors 
have not differentiated in the peripheral retina of the youngest specimens and 
therefore OD measurements are not included. Error bars = SEM.  
 
136 
Transforming Growth Factor β Distribution in Central and Peripheral Retina 
 
 
MACAQUE TGFb2 protein in fd85 photoreceptor layer
0
50
100
150
200
250
Temporal Parafoveal
temporal
Foveal Parafoveal
nasal
Nasal to disc Nasal  
Location
el
at
iv
e 
TG
Fb
2 
O
D
R
A 
 
 
 
 
 
 
 
 
 
 
  
MACAQUE TGFb2 protein in fd105 photoreceptor layer
0
50
100
150
200
250
Temporal Parafoveal
temporal
Foveal Parafoveal
nasal
Nasal to disc Nasal  
Location
R
el
at
iv
e 
TG
Fb
2 
O
D
B 
 
 
 
 
 
 
 
 
 
 
 
MACAQUE TGFb2 protein in fd130 photoreceptor layer
0
50
100
150
200
250
Temporal Parafoveal
temporal
Foveal Parafoveal
nasal
Nasal to disc Nasal  
Location
R
el
at
iv
e 
TG
Fb
2 
O
D
 
 
 
C 
 
 
 
 
137 
Transforming Growth Factor β Distribution in Central and Peripheral Retina 
 
 
 
 
 
MACAQUE TGFb2 protein in p6mo photoreceptor layer
0
50
100
150
200
250
Temporal Parafoveal
temporal
Foveal Parafoveal
nasal
Nasal to disc Nasal  
Location
R
el
at
iv
e 
TG
Fb
2 
O
D
 
D 
 
FIGURE 5.14 Relative TGF-β2 protein levels as indicated by optical 
densitometry in differentiated macaque retina at temporal, parafoveal 
temporal, foveal, parafoveal nasal, nasal to disc and nasal locations of 
macaque retinae aged (A) fd85, (B) fd105, (C) fd130 (C) and (D) p6mo. Note 
that during prenatal development the relative levels of TGF-β2 protein are 
generally highest in the fovea (between fd105 (~25WG) and fd130 (~31WG), 
then decrease with age. At p6mo (after formation of the FAZ), the level of 
TGF-β2 in the fovea is lower than in corresponding parafoveal locations, and 
when compared to younger ages. Photoreceptors have not differentiated in 
the peripheral retina of the two younger specimens, and therefore 
measurements from the peripheral locations are not included. Error bars = 
SEM. 
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TGF-β2 mRNA 
Location  
TGF-β2 mRNA is expressed in the GCL and photoreceptor layer of human 
and macaque retinas (Figures 5.15, 5.16, 5.17, 5.18). 
Distribution 
Optical densitometry analyses of TGF-β2 mRNA expression in sections were 
used to measure the relative levels of TGF-β2 in the photoreceptor layer 
(Appendix B). A centro-peripheral gradient of TGF-β2 mRNA is seen, with 
peak levels in the central retina for all ages examined (Figures 5.19, 5.20). 
In the developing macaque retina, relative levels of TGF-β2 mRNA are 
highest in central retina before and during the formation of the FAZ. These 
decrease with increasing age, with the lowest relative levels of TGF-β2 being 
measured at p6mo (Figure 5.20).  These data are consistent with the optical 
density measurements of protein expression. 
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FIGURE 5.15 Sample sense (A) and antisense (B) TGF-β2 riboprobe in 
central human retina at 14WG. Sections are also immunolabelled for 
vimentin (green). Similar results were obtained with macaque retinas (not 
shown), (GCL: ganglion cell layer; PR: photoreceptor layer). Bar = 100µm. 
 
 
 
 
 
 
 
 
 
 
 
 
                         PFN                                      F                                          PFT                      
GCL 
PR 
INL 
* *
A    sense       B antisense
GCL
PR
GCL
PR
FIGURE 5.16 In situ hybridisation to detect TGF-β2 mRNA (red) expression 
in central 16WG human retina. Weak to moderate expression is seen in the 
GCL. A centro-peripheral gradient of expression (between asterisks) can be 
detected in the photoreceptor layer (PR), with increased TGF-β2 mRNA 
expression in the foveal (F) and parafoveal regions (PFN, PFT). (INL: inner 
nuclear layer). Bar = 100µm. 
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FIGURE 5.17 In situ hybridisation; showing TGF-β2 mRNA expression (red) 
in (A) incipient fovea and fovea, (B) parafovea and (C) peripheral (nasal) 
regions of a 14WG and 19WG human retina. Sections for 19WG are also 
immunolabelled for vimentin (green). Expression is strong in the GCL in both 
locations at all ages, but is upregulated in the outer retina as the 
photoreceptors (asterisks) differentiate (A compared with C) (GCL: ganglion 
cell layer; INL: inner nuclear layer; ONZ: outer neuroblastic zone; PR: 
photoreceptor layer). Bar = 50µm. 
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FIGURE 5.18 Distribution of TGF-β2 mRNA (red) and vimentin (green) in (A) 
central, (B) parafoveal and (C) peripheral (nasal) regions of fd64, fd105, 
p12wk and p11y macaque retinas. TGF-β2 mRNA is most strongly 
expressed in ganglion cells (arrowheads) and photoreceptors (asterisks) with 
intermediate levels of expression detected in the INL. The images also show 
a decline in levels of mRNA expression from the postnatal period to 
adulthood. (GCL: ganglion cell layer; INL: inner nuclear layer; ONZ: outer 
neuroblastic zone; PR: photoreceptor layer). Bar = 50µm. 
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FIGURE 5.19 Relative levels of TGF-β2 mRNA expression as indicated by 
optical densitometry (OD) in differentiated regions of the photoreceptor layer 
at temporal, parafoveal temporal, foveal, parafoveal nasal, nasal to disc and 
nasal locations in human retinas aged (A) 13WG - prior FAZ formation, (B) 
16.5WG, and (C) 19WG - during FAZ formation. Peak relative amounts of 
TGF-β2 mRNA are seen in the foveal region up to 19WG. Photoreceptors 
have not differentiated in the peripheral retina of the youngest specimen and 
therefore no measurements have been graphed for these regions. Error bars 
= SEM. 
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FIGURE 5.20 Relative levels of photoreceptor TGF-β2 mRNA expression 
assessed by optical densitometry in differentiated regions of temporal, 
parafoveal temporal, foveal, parafoveal nasal, nasal to disc and nasal 
locations in macaque retinas at (A) fd64 - prior to FAZ formation, (B) fd155 - 
during formation of the FAZ, (C) p6d and (D) p11y (both after formation of the 
FAZ). Relative levels of TGF-β2 mRNA are highest in the foveal region in the 
prenatal samples; however in postnatal and adult retinas, TGF-β2 mRNA is 
uniformly expressed across the entire retina. Note photoreceptors have not 
differentiated in the peripheral retina of the youngest specimen and 
measurements are not included. Error bars = SEM. 
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TGF-β3 protein  
Location  
Cytoplasmic TGF-β3 protein is expressed in ganglion cells and 
photoreceptors (Figures 5.21, 5.22, 5.23). This is seen in photoreceptors 
from 14WG and is evident up to 19WG (Figures 5.21, 5.22). TGF-β3 protein 
is weak and variable in the ganglion cells similar to TGF-β2 (see previous 
TGF-β2 section). 
In the macaque retina, photoreceptor outer segments expressed TGF-β3 
protein from fd105 (~25WG), and this is still seen at p6mo (Figure 5.23).  
Distribution 
Optical densitometry analyses of immunolabelled sections were used to 
determine the relative levels of TGF-β3 protein in different regions of the 
photoreceptor layer (Appendix B). A centro-peripheral gradient of TGF-β3 
protein is seen, with peak levels of TGF-β3 protein in the central retina for all 
ages examined, with the steepest gradient detected in the 17WG-18WG 
retina (Figure 5.24). 
In the developing macaque retina, peak relative levels of TGF-β3 protein are 
found centrally between fd105 (~25WG) and fd130 (~31WG), with the lowest 
relative levels of TGF-β3 found at p6mo (Figure 5.25). 
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FIGURE 5.21 Double immunolabelling shows distribution of TGF-β3 protein 
(red) and vimentin (green) across central retina. Staining in the GCL is weak, 
compared with labelling in the photoreceptor layer where there is a centro-
peripheral gradient evident at 17.5WG. (PFT- temporal parafovea; PFN- 
nasal parafovea). (INL: inner nuclear layer). Bar = 100µm. 
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FIGURE 5.22 Distribution of TGF-β3 (red) and vimentin (green) 
immunolabelling in (A) incipient fovea and fovea, (B) parafovea and (C) 
peripheral (nasal) region of a 15WG and 19WG human retina. (GCL: 
ganglion cell layer; INL: inner nuclear layer; ONZ: outer neuroblastic zone; 
PR: photoreceptor layer) Bar = 50µm. 
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FIGURE 5.23 Immunoreactivity for TGF-β3 (red) and vimentin (green) in (A) 
central, (B) parafovea and (C) peripheral (nasal) macaque retina at fd105 
(~25WG) and p6mo. Note TGF-β3 expression in photoreceptors (asterisks). 
(GCL: ganglion cell layer; INL: inner nuclear layer; ONZ: outer neuroblastic 
zone; PR: photoreceptor layer). Bar = 50µm. 
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FIGURE 5.24 Relative levels of TGF-β3 protein determined by optical 
densitometry (OD) at different sample locations in human retinas at (A) 
13WG - prior to FAZ formation, (B) 17WG and (C) 19WG - during FAZ 
formation. The peak protein levels are in central retina for all ages. 
Measurements were not taken from undifferentiated regions of the 
photoreceptor layer. Error bars = SEM. 
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FIGURE 5.25 Relative levels of TGF-β3 protein determined by optical 
densitometry at different locations in macaque retinas aged (A) fd85, (B) 
fd105, (C) fd130 (C) and (D) p6mo. TGF- β3 protein levels increased were 
lower in the fovea compared with parafovea in early development (A), but 
during formation of the FAZ a relative increase in the level of TGF-β3 protein 
in the fovea was detected (B,C). Postnatally TGF-β3 levels remain high in the 
foveal region (D). No measurements were taken from undifferentiated parts 
of the photoreceptor layer. Error bars = SEM. 
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TGF-β3 mRNA 
Location  
TGF-β3 mRNA was detected in both the GCL and photoreceptor layer of 
human and macaque retinas (Figures 5.26, 5.27, 5.28). 
Distribution 
Optical densitometry analyses indicate high levels of TGF-β3 mRNA 
expression in the central compared with surrounding retina at 19WG (Figure 
5.29) when the FAZ is forming; at earlier stages TGF-β3 mRNA distribution in 
photoreceptors is relatively uniform.  
In the macaque retina, elevated levels of TGF-β3 mRNA are evident in the 
central photoreceptors at fd105 (Figure 5.30B), when the FAZ is forming, but 
not in the postnatal period (Figure 5.30C, D).  
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FIGURE 5.26 Sample sense (A) and antisense (B) TGF-β3 riboprobe in 
peripheral 14WG human retina. Sections are also immunolabelled for 
vimentin (green). Similar results were obtained with macaque retinas (not 
shown), (GCL: ganglion cell layer; PR: photoreceptor layer). Bar = 50µm. 
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FIGURE 5.27 Distribution of TGF-β3 mRNA (red) in (A) incipient fovea and 
fovea, (B) parafovea and (C) peripheral (nasal) regions of a 14WG and 
17WG human retina. Low levels of mRNA expression are detected in the 
ganglion cells (arrowheads) compared with photoreceptors (asterisks). 
Sections for 14WG are also immunolabelled for vimentin (green). (GCL: 
ganglion cell layer; INL: inner nuclear layer; ONZ: outer neuroblastic zone; 
PR: photoreceptor layer). Bar = 50µm. 
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FIGURE 5.28 Distribution of TGF-β3 mRNA (red) in (A) central retina, (B) 
parafovea and (C) peripheral (nasal) regions of fd73, fd155, p4mo and p11y 
macaque retina. Photoreceptors (asterisks) show mRNA expression in the 
foetal and early postnatal period but not in adult retina. (GCL: ganglion cell 
layer; INL: inner nuclear layer; ONZ: outer neuroblastic zone; PR: 
photoreceptor layer). Bar = 50µm. 
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FIGURE 5.29 Relative levels of TGF-β3 mRNA expression determined by 
optical densitometry (OD) at different sample locations in human retinas aged 
(A) 14WG - prior to FAZ formation, (B) 16.5WG and (C) 19WG - during FAZ 
formation. Peak TGF-β3 mRNA expression is found in the foveal region of 
the photoreceptor layer, particularly at 19WG. Photoreceptors have not 
differentiated in the peripheral retina of the youngest specimens and 
therefore OD measurements are not included. Error bars = SEM.  
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FIGURE 5.30 Relative levels of photoreceptor TGF-β3 mRNA expression in 
different regions of the photoreceptor layer of macaque retina at (A) fd73 - 
prior FAZ formation, (B) fd105 - during FAZ formation, (C) p12wk and (D) 
p11y - both ages after formation of the FAZ). There is evidence of elevated 
levels of TGF-β3 mRNA in central photoreceptors at fd105, during formation 
of the FAZ, but not earlier (fd73) or later stages (p12wk) of development or in 
the adult. Photoreceptors have not differentiated in the peripheral retina of 
the youngest specimens and therefore OD measurements are not included. 
Error bars = SEM. 
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TGF-βI receptor 
Location  
TGF-βI receptor (TβRI) protein was detected by immunohistochemistry in 
ganglion cells and their axons from 11WG (human) and fd64 (macaque), in 
the astrocytes or Müller cells from 16WG and fd105 respectively and in 
photoreceptors from 16WG and fd85 respectively. 
In the human retina, the TβRI antibody immunolabelled differentiated 
ganglion cells and photoreceptors in both the foveal and parafoveal regions 
(Figure 5.31). Occasional immunoreactive cells in the parafoveal GCL were 
also seen and most likely were either astrocytes or inner processes of Müller 
cells.  
In the macaque retina, the TβRI protein was present in ganglion cells and 
axons, across the entire retina and in the outer segments of the 
photoreceptors although not uniformly. Outer segment labelling was seen in 
the fovea at fd85 and fd105, in the parafovea at fd130 and in the nasal retina 
at fd130, p6mo and p2.5y. TβRI immunolabelling was present in macroglia 
that were later determined to be astrocytes in the parafoveal region at all 
ages examined (Figures 5.32, 5.33). 
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FIGURE 5.31 TβRI (red) and vimentin (green) immunolabelling in the foveal 
and nasal region of (A, B) 11WG and (C,D) 16WG human retinas. 
Immunolabelling is detected in ganglion cells (arrowheads) and 
photoreceptors (asterisks). (GCL: ganglion cell layer; ONZ: outer neuroblastic 
zone, PR: photoreceptor layer). Bar= 100µm. 
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FIGURE 5.32 TβRI (red) and vimentin (green) immunoreactivity in macaque 
retinas at fd105, fd130 and p6mo. TβRI immunolabelling is detected in 
photoreceptors (asterisks, B, E, I), ganglion cells (white arrowheads, A-I) as 
well as in astrocytes (white arrows, E ,H, I). (Black arrow = ganglion cell 
axons (F)). (GCL: ganglion cell layer, INL: inner nuclear layer, PR: 
photoreceptor layer). Bar= 100µm. 
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FIGURE 5.33 TβRI (red) and vimentin (green) immunoreactivity in the foveal 
region of fd130 (A) and p6mo (B), and in the parafoveal (C) and nasal region 
(D) of fd130 macaque retina. Insets (4xzoom) show intense TβRI 
immunolabelling in the photoreceptors (asterisks, A), ganglion cells (white 
arrowheads, B, C, D), ganglion cell axons (black arrows, D) as well as in 
astrocytes (white arrows, C). (GCL: ganglion cell layer, INL: inner nuclear 
layer, PR: photoreceptor layer). Bar= 100µm. 
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TGF-βII receptor 
Location  
TGF-βII receptor (TβRII) protein was detected in the ganglion cells from 
11WG, and in the photoreceptors from 16WG in human retina (Figure 5.34). 
In the macaque, TβRII immunolabelled ganglion cells were seen in the foveal 
region from fd85 and in the parafoveal and nasal region from fd130 (Figure 
5.35). TβRII labelled photoreceptors were also found in the foveal region 
from fd85 and parafoveal and nasal regions from fd130 (Figures 5.36, 5.37). 
In addition, entire photoreceptors in the fovea appeared to express TβRII 
during the fd85-p2.5y period which was later localised to the outer segments 
throughout the retina from p6mo to p2.5y (Figures 5.36, 5.37).  
TβRI is expressed in ganglion cells earlier than TβRII in the macaque retina 
(fd64 versus fd130). Although TβRI was seen in astrocytes, TβRII did not 
colocalise with vimentin (a marker of immature astrocytes). Both TβRI and 
TβRII immunolabelled photoreceptor outer segments, however, postnatally, 
TβRI was confined to the peripheral retina whilst TβRII was found across all 
retinal regions. A B
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FIGURE 5.34 TβRII (red) and vimentin (green) immunoreactivity in the foveal 
and nasal regions of (A,B) 11WG  and (C,D) 16WG  human retina. 
Photoreceptors are not differentiated in the 11WG retina or in the 16WG 
peripheral retina. TβRII immunoreactivity is detected in the ganglion cells (A-
D (white arrowheads)) and differentiated photoreceptors (C (asterisks)). 
(GCL: ganglion cell layer, INL: inner nuclear layer, ONZ: outer neuroblastic 
zone, PR: photoreceptor layer). Bar= 100µm. 
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FIGURE 5.35 TβRII (red) and vimentin (green) immunoreactivity in four 
macaque retinas of different ages. Strong TβRII expression is detected in 
differentiated photoreceptors (A-D, G, H). Ganglion cells are also mildly 
immunoreactive (A, C, F, G). There is no TβRII immunoreactivity in 
undifferentiated retina. Immunoreactivity is also detected in the fibres of 
Henle (FOH, photoreceptor axons) in postnatal retina (C,D). (ganglion cells 
(white arrowheads) and differentiated photoreceptors (asterisks). (GCL: 
ganglion cell layer, INL: inner nuclear layer, ONZ: outer neuroblastic zone, 
PR: photoreceptor layer). Bar= 100µm. 
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FIGURE 5.36 TβRII protein (red) and vimentin (green) immunoreactivity in 
sections of macaque retina from fd105 to p6mo. Insets show labelled 
photoreceptors (asterisks) including immunoreactivity in axon of 
photoreceptor (white arrow in C). TβRII immunolabelling involves the entire 
photoreceptor in the foveal region, pre and postnatally. (GCL: ganglion cell 
layer, INL: inner nuclear layer, PR: photoreceptor layer). Bar= 100µm. 
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FIGURE 5.37 TβRII (red) and vimentin (green) immunoreactivity in a p6mo 
macaque retina. Insets show labelled photoreceptors (asterisks) including 
immunoreactive fibres of Henle (FOH, A). TβRII immunolabelling is initially 
seen in the entire photoreceptor in the fovea but later, in the postnatal retina, 
localises to the outer segments in the peripheral retina. (GCL: ganglion cell 
layer, INL: inner nuclear layer, PR: photoreceptor layer). Bar= 100µm. 
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TABLE 5.2 Summary of TGF-β protein and mRNA distribution 
Marker Type GCL PR Astrocytes Centroperipheral gradient (prenatal) 
protein  +/- + - + TGF-β1 
mRNA NA NA NA NA  
protein +/- ++  - + TGF-β2 
mRNA + ++ - + 
protein +/- ++ - + TGF-β3 
mRNA + ++ - + 
TβRI protein + + ++ - 
TβRII protein + + - - 
GCL: ganglion cell layer, PR: photoreceptor layer, NA: not applicable 
5.4 DISCUSSION 
All TGF-β protein and mRNA isoforms and receptors were detected in human 
and macaque retinas (Table 5.2), TGF-β2 and TGF-β3 mRNA and protein 
were detected at low to moderate levels in the GCL and moderate to high 
levels in the photoreceptor layers of both species. Immunoreactivity for TGF-
β1 was low in both species, being somewhat higher in the PR layer 
compared to the GCL. TGF-β1 was not detectable by in situ hybridisation, 
consistent with PCR studies in Chapter 4. The receptors, TβRI and TβRII 
were detected in the GCL and PR layer during development, but in addition 
there was strong TβRI immunoreactivity in astrocytes. 
There was some suggestion of a centro-peripheral gradient of TGF-β1 
expression in the postnatal monkey retina, but not during vascularization of 
the macular region. However, there was strong evidence of a gradient of 
distribution of both TGF-β2 and TGF-β3 protein in both species; this is 
consistent with distinct gradients of TGF-β3 mRNA expression, and less 
distinct gradients of TGF-β2 mRNA expression observed in both species. In 
all cases, the peak density of labelling was seen in the central retina 
(‘foveal’), and the gradient was strongly evident during the period of 
vascularization of the macular region prior and during formation of the FAZ. 
Furthermore, the localisation of TβRI in astrocytes is consistent with the 
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hypothesis that, gradients of TGF-β expression affect astrocyte proliferation 
and /or migration around the macular region. 
Astrocytes expressing TβRI were associated with the development of, the 
retinal blood vessels in the GCP (ganglion cell layer plexus). These stellate 
astrocytes with long processes migrate into central retina deep in the GCL 
but are excluded from the incipient fovea (reviewed in Provis, 2000). Due to 
the relative hypoxia in the retina just ahead of the advancing front of blood 
vessels when they grow towards the central retina, astrocytes leading the 
actively growing vascular network, express VEGF inducing proliferation of EC 
that follow them (Provis et al., 2000). Immature astrocytes are 
immunoreactive for both vimentin and GFAP as are Müller cells (Provis et al., 
2000). In this study, astrocytes can be readily distinguished from Müller cells, 
with processes running horizontally and radially and, confined to the deep 
GCL, whilst the Müller cells extend vertically throughout all retinal layers 
(Provis et al., 2000).  
An interesting finding in this study was seeing a TGF-β gradient in the outer 
retina, while the blood vessels are located in the inner retina. TGF-β has 
been shown previously to be present in photoreceptors (Lutty et al., 1991; 
Lutty et al., 1993; Pasquale et al., 1993; Pfeffer et al., 1994; Anderson et al., 
1995), astrocytes (Constam et al., 1992; Baghdassarian et al., 1993; 
Anderson et al., 1995) and ganglion cells (Anderson et al., 1995; Close et al., 
2005). However, a developmental study for TGF-β has not been carried out. 
It is possible that TGF-β2 and TGF-β3 protein and mRNA gradients arising in 
the photoreceptors, together with diffusion of oxygen and nutrients from the 
choriocapillaris may affect retinal vascular patterning via effects on astrocytes 
expressing TβRI. It is unclear why TβRI was identified in astrocytes without 
the associated TβRII.  
TGF-β has been shown to upregulate GFAP expression in astrocytes, 
although this may indicate different responses (Reilly et al., 1998). When 
exogenous TGF-β is added to cultured astrocytes their proliferation ceases 
and when TGF-β stimulates neurotrophic factors such as nerve growth factor 
(NGF) produced by astrocytes neuronal survival is promoted (Lindholm et al., 
1992; Baghdassarian et al., 1993; Hunter et al., 1993; Anderson et al., 1995) 
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so that their dual role may vary possibly depending on other growth factors or 
conditions present but would be understandable considering the metabolic 
stress inner retinal foveal neurons are in, in the hypoxic central retina. 
It is also possible that regression of astrocytes from around the edge of the 
FAZ, as astrocytes never enter the fovea is partly due to the anti-angiogenic 
or anti-migratory effects of TGF-β, creating a ‘no-go’ area for the astrocytes 
and hence inhibiting the growth of blood vessels; there would be no template 
for vessels to follow into the incipient fovea (Stone, 2006). 
TGF-β can inhibit endothelial cell proliferation induced by acidic or basic 
fibroblast growth factors (FGF-1, FGF-2) and chemotaxis of endothelial cells 
(Baird & Durkin, 1986; Muller et al., 1987; Bensaid et al., 1989; Lutty et al., 
1991; Pasquale et al., 1993). Interestingly, a gradient of TGF-β expression in 
the GCL rather than in the PR layer was expected due to the proximity of 
astrocytes to the ganglion cells but none was found. This suggests that TGF-
β may either act at a distance or that it has other roles in the retina including 
a neuroprotective function (refer to Chapter 1.2.3). 
Although many in vitro experiments study cells in isolation or in interaction 
with one other cell type in a defined cellular environment, the mechanisms 
controlling retinal development and blood vessel growth are extremely 
complicated. Several types of cells are involved endothelial cells, microglia 
and pericytes, and there may be dose-dependent effects of growth factors, 
consistent with the observed gradients of expression seen in the present 
studies. Combinations of numerous cytokines and changing cellular 
microenvironments are also important. The moderate TGF-β protein levels 
and expression of low mRNA levels for TGF-β2 and TGF-β3 isoforms in the 
GCL (Table 5.2) suggests that regulation of expression of these isoforms is 
translational rather than transcriptional.  
The postnatal period in this study was assessed in macaque retina. 
Immunoreactivity for TGF-β1 protein was only seen postnatally in both the 
GCL and photoreceptors. TGF-β2 and TGF-β3 protein and mRNA profiles 
were similar. After high optical density levels of TGF-β2 and TGF-β3 protein 
and mRNA are observed in fd105 (~25WG), levels fall with age with the 
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lowest optical density recordings recorded postnatally (p6d-p11y) well after 
formation of the FAZ. 
In conclusion, these studies establish a comprehensive developmental profile 
for TGF-β1, TGF-β2 and TGF-β3 mRNA and protein expression and 
distribution, and localisation of TβRI and TβRII proteins for both human and 
macaque retinas. Taken together, these observations support the proposal 
that inhibitory growth factors, such as TGF-β contribute to defining the FAZ 
early in development, well before 23-25 WG in humans and before fd100 in 
macaques. 
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CHAPTER 6 – CONCLUSION
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Conclusion 
In this thesis I have investigated the relationship between development of the 
fovea and its choroidal blood supply, as well as the distribution of TGF-β 
isoforms which might have a role in regulating the patterning and growth of 
blood vessels in central primate retina. 
In primates there is a mismatch in the differentiation pattern of the neural 
retina and the formation of the retinal vasculature. The foveal region 
differentiates early (~11WG), but the surrounding region is not vascularised 
until much later in gestation (~24-6 WG) raising questions concerning how 
the immature central/foveal retina derives adequate oxygen and nutritional 
support. In Chapter 3 it was hypothesised that delayed vascularization of 
central retina might be compensated for by higher rates of endothelial cell 
proliferation in the central choriocapillaris. To the contrary, however, I 
observed reduced rates of EC proliferation in the ‘foveal’ chorioretinal 
locations at all ages studied between 14 and 18.5WG. These data indicate 
therefore, that EC proliferation in the choriocapillaris is not promoted by more 
advanced retinal differentiation, and oxygen uptake, as reported in animal 
models of retinal vascular development (Stone et al., 1995; Stone, 1997; 
Ozaki et al., 1999; Semenza, 2000; Morita et al., 2003).  
Rather, the findings reported in Chapter 3 suggest that mechanisms 
regulating proliferation and growth of the choroidal vasculature are 
independent of differentiation in the neural retina. These findings are 
consistent with reports that 9% of genes expressed by EC vary by more than 
250 fold when choroidal and retinal EC are compared using DNA microarrays 
and QPCR (Smith et al., 2007). 
The RTPCR and QPCR studies in Chapter 4, demonstrated that all three 
TGF-β isoforms are expressed in the developing and adult primate retina, 
with TGF-β2 being the predominant isoform. Higher levels of TGF-β are 
present in developing compared with adult retina, and in central compared 
with peripheral retina. The early expression of TGF-β in the developing 
central retina, and the observed centro-peripheral gradient support the 
hypothesis that the antiproliferative and anti-angiogenic effects of this factor 
may help define the FAZ by suppressing astrocyte and endothelial cell 
proliferation and migration into this region during retinal development.  
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In situ hybridisation and immunohistochemistry studies presented in Chapter 
5 further define the distributions of TGF-β mRNA and protein in the 
developing primate retina. Previous studies have shown that TGF-β is 
present in photoreceptors  (Lutty et al., 1991; Lutty et al., 1993; Pasquale et 
al., 1993; Pfeffer et al., 1994; Anderson et al., 1995), astrocytes (Constam et 
al., 1992; Baghdassarian et al., 1993; Anderson et al., 1995) and ganglion 
cells (Anderson et al., 1995; Close et al., 2005) and a close interrelationship 
in the expression patterns of the different isoforms has been established. 
However, this is the first study of the expression of TGF-β and TGF-β 
receptors during development of the primate retina. The present study shows 
that all three isoforms are expressed in the photoreceptors in the incipient 
fovea, well before formation of the FAZ, although there are differences in the 
timings of expression. While TGF-β1 protein is present in relatively high 
levels postnatally, the other two isoforms are expressed at higher levels 
before and during FAZ formation, diminishing in the postnatal period. It is 
possible that TGF-β1 exerts an antiproliferative, or stabilizing, effect on the 
retinal vasculature in the postnatal period. 
TβRI protein was detected by immunohistochemistry in astrocytes from 
16WG (human) and fd105 (macaque). The high levels of TGF-β2 and TGF-
β3 in central retina during early development, and the presence of TβRI on 
astrocytes in the retina is consistent with the hypothesis that TGF-β signalling 
may regulate vascular growth in central retina during development, by 
inhibiting astrocyte migration and proliferation and thereby, formation of the 
astrocyte template. A difficulty with the hypothesis, however, is that the 
highest levels of TGF- β protein are detected in the outer retina, while vessel 
formation takes place in the inner retina. Further studies are required to 
address this question. To this effect, recent experiments carried out in the 
laboratory show that TGF-β2 does inhibit primate retinal endothelial cell 
proliferation in vitro, but has little direct effect on migration. In contrast, those 
same experiments indicate that FGF-2 directly inhibits endothelial cell 
migration, in vitro (Phillip Romo, Honours 2006-7). The findings indicate that 
combinations of growth factors, and other molecules including those which 
regulate vessel guidance, are likely needed to regulate vascular development 
in central retina. Further research into genetic factors and the corresponding 
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cellular microenvironment that regulates TGF-β (and growth factor) signalling 
will ultimately lead to better understanding of the development of the fovea 
and its vascular supply. 
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APPENDIX A 
Relative quantification of target and reference genes was done by using the 
Pfaffl mathematical equation which despite different cDNA input 
concentrations to mimic different RT efficiencies, all target transcripts as well 
as reference transcripts are affected in parallel (Pfaffl, 2001). 
In this mathematical model it is necessary to determine the “crossing points” 
(CP) or replicate “takeoff points” for each transcript. CP is defined as the 
point at which the fluorescence rises appreciably above the background 
fluorescence (Pfaffl, 2001). The “takeoff point”, is calculated from the second 
derivative of the raw data and is the point determined where the reaction is 
increasing most rapidly. This is the “peak” of the exponential reaction and 
occurs shortly after the “takeoff” of the reaction (Figure B.1). The “takeoff” 
point is estimated as 80% below the peak level (Rotorgene version 6.0, 
Corbett Research).  
 
 
 
 
 
 
 
 
 
 
 
FIGURE A1 Graph shows the peak and the take off level of the reaction 
across time (Rotorgene version 6.0, Corbett Research). 
 
The “efficiency” or “average amplification” of the particular sample is 
calculated by Rotorgene software (Rotorgene version 6.0, Corbett Research) 
which also provides confidence intervals for the data. The average increase 
in the four readings made following the “takeoff” is calculated and is defined 
as the sample's “amplification”. Outlier “amplifications” are removed to 
account for noise in background fluorescence and the non-outlier 
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“amplifications” are averaged to become a run "average amplification". A 
100% efficient reaction would result in an amplification value of two for every 
sample, i.e.  doubling of an amplicon takes place in every cycle. In terms of 
the raw data, the signal should increase by a doubling amount in the 
exponential phase. The more variation there is between the estimated 
amplification values of each sample, then the larger the confidence interval 
will be. The confidence interval, for large N, gives a 68.3% probability that the 
true amplification of the samples lies within one standard deviation. By 
doubling the ± interval, one achieves a 95.4% confidence interval for large N 
(i.e. within two standard deviations). 
 
The mathematical model has been devised to determine the relative 
quantification of a target gene in comparison to a reference gene (Pfaffl, 
2001). The relative expression ratio of a target gene is calculated based on 
efficiency and crossing points’ deviation of an unknown sample versus a 
control, and expressed in comparison to a reference gene using the following 
equation: 
 
Ratio= (Etarget) ∆CP target (control-unknown)      
       
  (Ereference) ∆CP reference (control-unknown)  
 
where E= Efficiency = average amplification     
 ∆CP = change in crossing points = the point where the fluorescence                           
                         rises sharply above the background fluorescence threshold  
                      = replication take off       
Target = gene of interest TGF-β      
 Reference = reference gene = housekeeping gene GAPDH 
 Control = normal sample= Age sample number 1 of central/nasal  
                               retina or central retinal sample of a particular age 
 Treated = experimental sample = Age sample number 2 of     
central/nasal retina (same site as for age sample     
number 1) or nasal retinal sample of the same age as   
control 
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So for the equation;  
 
Ratio=    (Average AmplificationTGF-β)∆Replication take off for TGF-β (Age#1-Age#2) 
    
   (Average AmplificationGAPDH)∆Replication take off for GAPDH (Age#1-Age#2) 
   
 
and ratio=1 then there is no change in relative expression of target gene and 
reference gene. If ratio is greater than one then there is a positive fold 
change eg. If ratio = 1.5 then there is a 50% increase in expression when 
control or age sample number 1 is compared to sample number 2. 
Conversely if ratio = 0.5 then there is a 50% decrease when control or age 
sample number 1 is compared to sample number 2. When ratios are 
calculated the presence of negative numbers is irrelevant as absolute values 
are noted.                   
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APPENDIX B 
 
To assess the validity of using optical density values of mRNA and protein 
expression in samples from retinal regions versus optical density values 
across whole retinal sections, the following analysis was undertaken.  
 
A section from a 16WG retina was selected for optical density analysis. 
Following in situ hybridisation with the TGF-β2 probe and labelling with Fast 
Red/HNPP, the fluorescence (TGF-β2 mRNA expression) was optically 
recorded by combining the 77 images acquired across the whole section into 
a montage (Figure 5.1, Chapter 5). Using the LSM5 Pascal software (Carl 
Zeiss) measurement tool, 13246 measurements at 1µm intervals were taken 
each time a line was traced across the superior, middle and inferior aspects 
of the photoreceptor layer from the temporal end, through the fovea, to the 
nasal end. Similarly, a line was traced across the GCL three times (values 
were subsequently averaged) and once across the outer neuroblastic zone 
(ONZ) in the same direction recording the optical density measurements at 
1µm intervals for comparison. The ONZ layer optical density values provided 
the amount of ‘background’ staining present.   
 
For the photoreceptors, the 13246 optical density values taken at the three 
different levels in the photoreceptor layer were averaged, and then grouped 
into six retinal locations as shown in Table B1. The values were also grouped 
using the same criteria but with 200 tail-values excluded at each retinal 
location for comparison (Table B1).  
 
Additionally, six representative samples of the retinal regions were also 
assembled as a minimontage, to represent the distribution of TGF-β across 
the retina. 
The graphs corresponding to the optical densities across the GCL and the 
ONZ for a section of the whole eye and the minimontage showed little 
variation between retinal regions (Figure B1 and B2). 
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Location 
Range of optical 
density values 
averaged for each 
retinal location 
Range of optical density values 
averaged for each retinal location 
(excluding 200 tail-end values) 
T 1 to 2900  201-2700 
PFT 2901 to 4000 3101-3800 
F 4001 to 5760 4201-5560 
PFN 5761 to 6860 5961-6660 
ND 8400 to 9940 8600-9740 
N 9941 to 13246 10141-13046 
 
TABLE B1 Range of optical density values averaged for each region across 
the retina (T – temporal, PFT – parafoveal on temporal side, F - foveal, PFN 
– parafoveal on nasal side, ND – nasal to disc and N - nasal). Optical density 
values between 6860 and 8400 were excluded, as this area corresponded to 
the optic nerve and the area temporal to the optic nerve which does not 
belong to the PFN region.  
 
 
This is also evident when the median values (MD) (Table B2) and standard 
deviations (SD) (Table B3) are calculated for each set of values. The largest 
variation in SD is seen across the photoreceptor (PR) layer between the 
minimontage and the whole eye possibly due to the differences in the 
average of labelling. Positive labelling seen across the sampled image for a 
retinal region in the multiple sampled images in the whole eye section for a 
particular retinal region, both weakly and strongly labelled areas are included 
in the sample and averaged. The highest optical density values for TGF-β2 
mRNA are noted in the photoreceptor layer on the temporal side of the fovea, 
consistent with the earlier differentiation of the temporal retina (Figures B1C, 
B1D, B1E). 
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  Median 
Whole 
eye  
Median 
Whole 
eye  
excluding 
tail 
values 
Median 
Minimontage
Median 
comparison % 
between whole 
eye & 
minimontage 
Median 
comparison % 
between whole eye 
excluding tail 
values & 
minimontage
  GCL avg 145 147 144 -0.70% -2.09%
  ONZ 55 56 53 -3.77% -5.66%
T PR sup 81 80 80 -1.25% 0.00%
  PR mid 80 79 78 -2.56% -1.28%
  PR inf 81 80 78 -3.85% -2.56%
  GCL avg 143 140 132 -7.94% -5.67%
  ONZ 53 51 50 -6.00% -2.00%
PFT PR sup 98 97 96 -2.08% -1.04%
  PR mid 87 84 83 -4.82% -1.20%
  PR inf 94 94 100 6.00% 6.00%
  GCL avg 143 146 139 -3.00% -5.16%
  ONZ 37 37 40 7.50% 7.50%
F PR sup 145 150 156 7.05% 3.85%
  PR mid 131 136 145 9.66% 6.21%
  PR inf 136 142 144 5.56% 1.39%
  GCL avg 141 144 135 -4.95% -6.68%
  ONZ 35 34 35 0.00% 2.86%
PFN PR sup 104 99 109 4.59% 9.17%
  PR mid 104 99 98 -6.67% -1.54%
  PR inf 100 98 103 2.91% 4.85%
  GCL avg 124 125 126 1.46% 0.40%
  ONZ 38 38 37 -2.70% -2.70%
ND PR sup 95 88 85 -11.76% -3.53%
  PR mid 87 87 82 -6.10% -6.10%
  PR inf 86 84 81 -6.17% -3.70%
  GCL avg 129 129 141 8.62% 8.85%
  ONZ 42 43 41 -2.44% -4.88%
N PR sup 86 86 89 3.37% 3.37%
  PR mid 88 89 88 0.00% -1.14%
  PR inf 85 85 86 1.16% 1.16%
 
TABLE B2 Median values calculated from optical density measurements for 
each retinal layer for all six regions (T, PFT, F, PFN, ND, N) within the 
minimontage, the whole eye, and the whole eye excluding 200 optical density 
tail measurements (at each end of each region). The GCL average for optical 
density in the T region varies 0% compared to the ND region which varies up 
to 12% when the median is compared between the whole eye and the 
minimontage. [Calculation for comparison between minimontage and whole 
eye = (Median minimontage-Median whole eye)/Median minimontage x100. 
Calculation for comparison between minimontage and whole eye excluding 
tail values= (Median minimontage-Median whole eye without tail 
values)/Median minimontage x100.] 
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SD 
Whole 
eye 
SD 
Whole 
eye 
excluding 
tail 
values 
SD 
Minimontage
SD comparison 
between whole 
eye & 
minimontage 
SD comparison 
between whole eye 
excluding tail 
values & 
minimontage 
  GCL avg 38.80 39.49 39.03 0.59% -1.17%
  ONZ 23.18 23.63 21.62 -7.20% -9.29%
T PR sup 16.50 16.36 21.16 22.03% 22.66%
  PR mid 16.97 16.72 18.90 10.21% 11.52%
  PR inf 17.74 16.67 19.48 8.90% 14.44%
  GCL avg 42.25 45.13 40.05 -5.49% -12.70%
  ONZ 18.50 18.38 28.17 34.32% 34.74%
PFT PR sup 15.56 16.23 43.33 64.09% 62.54%
  PR mid 16.00 15.20 45.84 65.10% 66.83%
  PR inf 15.85 15.24 47.37 66.55% 67.82%
  GCL avg 31.26 31.95 40.00 21.85% 20.14%
  ONZ 14.78 13.71 29.63 50.12% 53.74%
F PR sup 34.40 35.69 48.78 29.47% 26.84%
  PR mid 34.78 36.60 52.67 33.96% 30.51%
  PR inf 34.83 34.79 59.95 41.90% 41.96%
  GCL avg 28.13 27.09 33.98 17.23% 20.29%
  ONZ 14.85 15.31 22.23 33.21% 31.14%
PFN PR sup 23.44 19.40 56.25 58.33% 65.51%
  PR mid 23.17 20.29 49.93 53.59% 59.36%
  PR inf 21.10 20.47 45.55 53.67% 55.06%
  GCL avg 32.18 33.23 27.59 -16.65% -20.43%
  ONZ 16.35 16.32 18.36 10.95% 11.15%
ND PR sup 17.95 16.94 25.42 29.39% 33.37%
  PR mid 19.03 16.95 23.13 17.73% 26.75%
  PR inf 17.97 17.13 26.29 31.66% 34.83%
  GCL avg 34.31 32.82 29.02 -18.23% -13.08%
  ONZ 20.25 20.62 19.73 -2.60% -4.49%
N PR sup 16.79 16.08 21.03 20.16% 23.56%
  PR mid 18.77 18.07 21.06 10.84% 14.16%
  PR inf 18.38 18.29 20.72 11.32% 11.76%
 
TABLE B3 Standard deviations calculated from optical density 
measurements for each retinal layer for all six regions (T, PFT, F, PFN, ND, 
N) within the minimontage, the whole eye, and the whole eye excluding 200 
optical density tail measurements (at each end of each region). The GCL 
average for optical density in the T region varies 1% compared to the PR 
bottom in the PFT region which varies up to 67%.  
[Calculation for comparison between minimontage and whole eye = (SD 
minimontage – SD whole eye)/SD minimontage X100. 
Calculation for comparison between minimontage and whole eye excluding 
tail values = (SD minimontage – SD whole eye without tail values)/SD 
minimontage X100.] 
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FIGURE B1 Graphs corresponding to the 13246 optical density values across 
the different layers of section of the whole eye from temporal, through the 
fovea, to the nasal side (T, PFT, F, PFN, ND, N). A. GCL average, B. ONZ, C. 
photoreceptor (PR) superior, D. PR middle and E. PR inferior. The black line 
graph corresponds to moving average of 200 values. The highest optical 
density of TGF-β2 in the photoreceptor layer is seen on the temporal side of 
the fovea, corresponding to earlier differentiation of the retina temporally. 
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FIGURE B2 Graphs corresponding to optical density values across the 
different layers of the retina from the six sample regions (T, PFT, F, PFN, ND, 
N) in a minimontage, from top to bottom; A. GCL average, B. ONZ, C. PR 
superior, D. PR middle and E. PR inferior. Black line graph corresponds to 
moving average of 200 values. 
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